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Abstract: There is considerable recent experimental evidence that suggests that 
stress plays a major role in the development of dependence on drugs of abuse, 
but the potential mechanisms involved are not yet fully understood. 
The aims of this thesis were (I) to examine the effect of stress, and of 
drugs that act on the hypothalamic-pituitary-adrenal axis, on alcohol 
consumption in the C57 strain of mice. (II) to investigate whether corticosterone 
levels or spontaneous locomotor activity could be used to predict subsequent 
alcohol consumption in mice. (Ill) to investigate long-term neurochemical 
changes during abstinence following chronic alcohol administration. (IV) to 
develop a method for measuring brain corticosterone levels. 
Neither total corticosterone levels nor spontaneous locomotor activity 
could predict alcohol preference. Saline vehicle injections increased alcohol 
preference in low alcohol preferring, and raised both circulating corticosterone 
levels and brain corticosterone. The brain concentrations of corticosterone were 
measured by a novel procedure developed during the thesis. A CRF antagonist 
(a-helical CRF) increased alcohol preference in low preferring mice, as did the 
ACTH fragment 4-10. In high preferring mice, ACTH 4-IO reduced alcohol 
preference, whereas a-helical CRF did not alter preference in these mice. 
Inhibition of corticosterone synthesis reduced alcohol preference in high alcohol 
preferring mice but, blockade of corticosterone receptors with specific 
antagonists did not alter alcohol preference. Chronic alcohol treatment followed 
by six days abstinence increased free circulating corticosterone levels and this 
treatment also increased hippocampal corticosterone levels. Dopamine D 1-like 
receptor affinity was increased following the same chronic treatment schedule. 
These results demonstrate an important link between the activation of the 
hypothalamic-pituitary-adrenal axis and alcohol consumption. The results of the 
chronic treatment experiments provide useful information that may aid the 
understanding of the phenomenon of relapse to drinking common in abstaining 
alcoholics. 
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Chapter One 
Introduction 
Outline of the Thesis 
The experiments described in this thesis were performed in order 
to understand the influence corticosterone and stress have on alcohol 
consumption. This work investigated long-term neuronal changes after alcohol 
consumption that might aid the explanation of the phenomenon of relapse 
drinking. The Thesis is divided into two main experimental sections; the first 
(Chapters 2-5 inclusive) examined the effects of stress (repetitive saline 
injections) and pharmacological interventions on the hypothalamic-pituitary 
adrenal (HPA) axis and on alcohol preference in studies performed on C57 mice, 
a strain of mice commonly used in alcohol research. The second section 
(Chapters 6 and 7) investigated potential long-term changes in neurochemistry 
after chronic alcohol administration. The methods used in this thesis are detailed 
in each chapter, rather than in a specific 'General Methods' section. All reagents 
and drugs were purchased from Sigma-Aldrich (U.K.) except where clearly 
described in the text. 
The social and medical cost of alcohol 
Alcohol is one of the most widely used drugs of abuse. The social, 
economic and health related costs that alcohol makes upon society are immense. 
The importance of understanding alcohol dependence and the effects of alcohol 
therefore cannot be underestimated when viewed in the context of the problems it 
causes, some of which are detailed below. 
Alcohol related health problems have been estimated to cost the National 
Health Service (NHS)£ 150 million a year (Shakeshaft et al., 1997). In urban 
hospitals in Britain, 15-30% of male medical and surgical patients and 8-15% of 
women patients have alcohol problems, on the basis that they reported two or 
more problems related to psychological or physical dependence. (Chick et al 
1993). It is estimated that 20% of the workload of GPs arises from the effects of 
heavy drinking, compounded by the problems which arise because alcohol abuse 
creates medical problems for family members (Kaner et al., 1997). In England, in 
1995, there were 20,727 admissions to NHS hospitals for alcohol dependence 
and 2076 admissions for alcohol poisoning (Alcohol Alert 2000). Chronic 
alcoholism constitutes a significant public health problem; it is associated with a 
wide range of diseases and is a significant cause of premature death and 
persistent brain damage; such as Wernicke's encephalopathy, Korsakoff's 
syndrome, cerebellar degeneration and dementia (Alcohol Alert 2000). Excessive 
alcohol is implicated in reproductive (loss of libido, hormonal imbalances, foetal 
abnormalities), cerebrovascular, respiratory, liver, gastrointestinal, heart, and 
circulatory problems (Alcohol Alert 2000). 
The 1987 report Royal College of Physicians: A Great and Growing Evil 
-The Medical Consequences of Alcohol Abuse has estimated mortality 
associated with alcohol consumption to be of the order of 5,000- 8,000 a year. 
The number of deaths attributable to alcohol is a matter of controversy, as death 
certificates do not record alcohol as a contributory cause of death. Alcohol is a 
contributing factor in deaths from a range of other causes: - accidents, suicide, 
cancers and heart disease amongst others. It is estimated that there are 2 million 
people in Britain experiencing symptoms of alcohol dependence (Alcohol Alert 
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2000). The 1993 Health Survey for England classified 9% of men and 5% of 
women who drank as 'problem drinkers', i.e. exhibiting one or more the criteria 
for alcohol dependence or alcohol abuse. A third of road traffic accidents have 
alcohol reported as a contributing factor, and it is an important factor in 
domestic, recreational and work-related accidents (Petersson et al 1982). Family 
disruption, domestic violence, child abuse, public order problems and 
absenteeism from work are all consequences of alcohol abuse. 
Dependence and addiction 
The term 'addiction' is usually taken to mean "a state of physical and 
psychological dependence" .The World Health Organisation (WHO) 
recommended that the term 'addiction' should be replaced by the term 
dependence. In 1974 the WHO defined drug dependence as 'a state, psychic and 
sometimes also physical, characterised by a compulsion to take the drug on a 
continuous or periodic basis in order to experience its mental effects, and 
sometimes to avoid the discomfort of its abstinence (WHO 1974 ). 
The DSMIIV definition of drug dependence describes "a maladaptive 
pattern of substance use leading to clinically significant impairment or distress 
associated with difficulty in controlling substance taking behaviour, withdrawal 
(signs and symptoms that occur when the drug is stopped and is alleviated by 
renewed administration of that drug, or one with similar actions) in the absence 
of the drug and tolerance (state in which drug actions diminish on repeated 
administration) to its effects". 
Dependence can be categorised as physical and psychological. 
Psychological dependence is manifested by compulsive drug seeking behaviour 
in which the individual uses the drug repetitively for personal satisfaction, 
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despite risks to health. Physical dependence is defined in terms of the appearance 
of a physiological withdrawal syndrome. 
The withdrawal syndrome, although clinically important, is not now 
believed to be important in the maintenance of dependence. The alcohol 
withdrawal syndrome manifests itself with overtly physical symptoms 6-8 hours 
after withdrawal. At this time point nausea, tremor and sweating are common. 
This stage is followed 48-72 hours later by a delirious and tremor stage, where 
the person undergoing withdrawal may suffer visual and auditory hallucinations, 
anxiety, restlessness, and paranoia, and in severe cases, epileptic seizures can 
occur (Victor & Adams, 1953). Neuronal hyperexcitability during alcohol 
withdrawal is generally treated with benzodiazepines, such as diazepam 
(Feuerlain & Reiser, 1986). Diarrhoea and tremor, caused by excessive 
sympathetic nervous system activity, can be treated with either ~2 adrenoceptor 
antagonists (Kraus et al., 1995) or a2 adrenoceptor agonists (Baumgarter et al., 
1987). These treatments only offer relief from the symptoms of the withdrawal 
syndrome they do not treat the underlying mechanisms of alcohol dependence. 
Most alcoholics including those abstaining, experience craving, often for 
extended periods of time. Focusing research on the long-term effects of alcohol 
may provide information about the causes of relapse back into drinking. A major 
influence on relapse is conditioning, returning to the environment where drug 
administration occurred being a powerful stimulus. A further characteristic of 
relapse is 'priming', where a small intake of the drug, even long after abstinence, 
results in a strong desire for more drug. Both of these phenomena suggest that 
neurochemical changes, as yet undefined, are still present long after the initial 
withdrawal signs subside. 
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Treatment 
Clinically, pharmaceutical agents used in the treatment of alcoholism 
include disulfiram, the opiate antagonists naltrexone and nalmefene, serotonergic 
agents such as ondansetron, buspirone, and the selective serotonin reuptake 
inhibitors such as citalopram, fluoxetine, paroxetine and sertraline, and other 
agents including lithium and acamprosate (calcium acetyl homotaurinate) 
(Alcohol Alert 2000). 
Disulfiram inhibits aldehyde dehydrogenase and leads to increased levels 
of acetaldehyde when alcohol is consumed, with subsequent adverse physical 
effects such as nausea, headache and weakness. There is little evidence that 
disulfiram enhances abstinence. The opiate antagonists, naltrexone and 
nalmefene, cause a hypothesised reduction in the rewarding properties of alcohol 
by blocking opioid receptors. There is good evidence that naltrexone reduces 
relapse and number of drinking days in alcohol-dependent subjects. There is 
some evidence that naltrexone reduces craving and enhances abstinence in 
alcohol-dependent subjects. ( O'Malley et al., 1992; Volpicelli et al., 1992). 
Acamprosate has been reported to reduce drinking days in alcohol-
dependent subjects (Lhuintre et al., 1985, 1990). In experimental animal models 
acamprosate induces a significant reduction of alcohol consumption (Boismare et 
al., 1984; Le Magnen et al., 1987a & b); Gewiss et al., 1990; Littleton 1995). 
Some signs of physical withdrawal such as hyperactivity and hyper-reactivity are 
reduced by acamprosate (Gewiss et al., 1990; Spanagel et al., 1996). Initially it 
was proposed that acamprosate interacted with GABAA receptors however, it 
does not interact with GABAA binding sites nor does it influence GABAA 
stimulated chloride currents (Zieglgansberger et al., 1997). There is evidence for 
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interactions between acamprosate and NMDA receptors and also voltage 
activated calcium channels (Al-Qatari & Littleton, 1995, 1998). The exact 
mechanism of its action is as yet not fully elucidated. 
The effects of serotonergic agents on alcohol consumption in animal 
models of alcohol consumption are described later in this chapter. In clinical 
studies there is some evidence on the efficacy of serotonergic agents for the 
treatment of alcohol-dependent symptoms in patients with comorbid mood or 
anxiety disorders, although the data is limited (Johnson, 2000). Clinical trials of 
serotonergic agents in primary alcoholics without comorbid mood or anxiety 
disorders have provided minimal evidence on the efficacy of serotonergic agents 
for treatment of the core symptoms of alcohol dependence (Johnson & Ait-
Daoud, 2000). 
Alcohol and the central nervous system 
Alcohol appears to have widespread actions on the CNS, affecting a 
range of neurotransmitters, neuromodulators and ion channels. These include 
actions on GABA, glutamate, dopamine, serotonin, acetylcholine and various 
neuropeptides. Alcohol was originally believed to act via effects on membrane 
lipid fluidity (Overton, 1896). However, not all substances that affected 
membrane fluidity caused intoxication, and alterations in temperature that 
disrupted membrane fluidity did not produce effects similar to alcohol. The site 
of action has also been proposed to be a disruption of lipid protein interactions, 
and the membrane proteins themselves. None of the mentioned mechanisms is 
exclusive. There is strong evidence for a direct action of alcohol upon ion 
channels; results from patch clamp experiments on cell attached patch and 
inside-out patches have suggested that the site of action of alcohol on NMDA 
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receptors is located on a domain located on, or only accessible from, the 
extracellular environment (Peoples and Stewart, 2000). The alcohol-binding site 
is thought to consist of a hydrogen bond acceptor within the protein; binding at 
this site may alter the local protein structure leading to alcohol's effect (Dwyer & 
Bradley, 2000). 
The mechanisms by which alcohol acts on the brain to modify behaviour 
are better understood through investigations on the action of alcohol on the 
functions of specific neurotransmitters. Studies of neurotransmitters and the 
receptors, which they bind, have provided data on both the mechanisms of action 
of alcohol on these molecules as well as clues to their roles in alcohol related 
behaviour. Extensive and comprehensive reviews on alcohol and 
neurotransmitter interactions are widespread in the literature. An exhaustive 
review of all the interactions between alcohol and all the neurotransmitters, 
neuromodulators, ion channels, and receptors would be beyond the scope of this 
thesis because of the vast array of alcohol's actions and reactions. The following 
accounts are a brief summary of the main, or important effects of alcohol on the 
major receptor systems. More detailed information is provided, where relevant, 
in subsequent chapters. 
GABA 
GABA is the main inhibitory neurotransmitter in the CNS. It acts through 
three main types of receptors the ionotrophic GABAA and GABAc receptors and 
also the metabotrophic GABA8 receptor. Sedative and anxiolytic drugs such as 
the benzodiazepines and barbiturates exert their action by enhancing GABAergic 
transmission. The similarity of their actions to the sedative/anxiolytic effects of 
alcohol has led to much investigation on alcohol-GABA interactions. 
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Electrophysiological studies showed that high doses ( 100 mM) of alcohol had no 
effect on GABAs receptors (Frye & Fincher, 1996). However, the GABA8 
receptor has been implicated in the alcohol induced inhibition of NMDA 
responses (Steffensen, et a! 2000). 
GABA8 receptor activation increased alcohol-induced anaesthesia and 
decreased alcohol preference (defined by a two bottle choice between water and 
dilute alcohol) (Daoust et al., 1992; Martz et al., 1983) Chronic alcohol induced 
excitability was unaffected by GABA8 agonists in mice (Mead & Little, 1995; 
Molleman & Little, 1995). GABA8 receptor activation decreased withdrawal 
related anxiety in rats (File et al, 1992). 
Electrophysiological studies on alcohol and GABAA receptor have not 
shown consistent results. Alcohol enhancement of GABA mediated inhibition 
has been shown in the cerebellum of rats, but only in the presence of 
noradrenaline (Freund & Palmer, 1996). Alcohol induced increases in GABA 
mediated inhibition of neurons has been shown in the cerebral cortex (Nestoros, 
1980), spinal cord (Celentano et al., 1988) and the hippocampus (Takada et al., 
1989). Whereas other researchers have shown no effect of alcohol on GABAA 
receptor function (Carlen et al., 1982, Siggins et al., 1987). Chronic exposure to 
alcohol potentiates GABAA mediated responses in the rat periform cortex when 
measured during alcohol treatment (Signore & Yeh, 2000). GABAA receptor 
density has been shown to be increased when measured both during chronic 
alcohol treatment, and immediately on withdrawal after chronic alcohol 
treatment (Unwin & Taberner, 1980), but others report no change in 
electrophysiological change in receptor function after chronic alcohol when 
measured six or twenty-four hours into withdrawal (Buck & Harris 1990). 
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Hippocampal neurons showed no changes in any aspect of GABAA receptor-
mediated transmission during alcohol withdrawal (Whittington et al., 1991 a). 
The potency of alcohol to modulate the activity of GAB AA receptors has been 
shown to be linked to cell type and subunit composition. This order of potency 
is: DRG neurons> a1 P212s >cortical neurons (Mori et al, 2000) 
Glutamate 
Two main classes of glutamate receptor exist, ionotrophic (ligand gated 
ion channels) and metabotrophic (G-protein coupled receptors). There are two 
main subgroups of ionotrophic glutamate receptors; NMDA receptors and non-
NMDA (AMPA /kainate) receptors. These receptors are distinguished by the 
relative selectivity of exogenous ligands (NMDA, AMPA and kainate) to active 
the receptors. 
In rat cultured neurons, alcohol directly inhibited NMDA ion currents 
(Lovinger et a! 1989). AMP Alkainate receptor currents induced by low levels of 
kainate are more effectively reduced by alcohol than those induced by high 
kainate levels (Dildy-Mayfield and Harris, 1992). Alcohol at concentrations of 
between 10 mM and 100 mM decreased NMDA-induced Ca2+ influx (Leslie & 
Weaver, 1993; Hoffman et al., 1989) and reduced NMDA induced release of 
dopamine, noradrenaline and acetylcholine (Gothert and Fink 1989; Woodward 
and Gonzales 1990) amongst other neurotransmitters. It also reduced excitatory 
NMDA transmission in isolated neurons as well as in brain slices and in vivo 
(Leslie & Weaver, 1993). NMDA responses to alcohol vary according to location 
and subunit composition of the receptor (Crews et al., 1983). 
Increases in glutamate transmission and increases in voltage activated 
calcium channels play an important role in neuronal hyperexcitability seen 
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during alcohol withdrawal. Chronic alcohol has been shown to increase NMDA 
receptor binding sites. Membrane and autoradiographic studies have shown 
significant increases in the binding densities for MK-801 (a NMDA receptor 
ligand), 4-8 hours after withdrawal from seven-day liquid diet treatment (Gulya 
et al., 1991, Guppy et al., 1995) and in cultured cerebellar granule cells following 
a 3-day incubation with 100 mM alcohol (Hoffman et al., 1985). Human 
alcoholic postmortem brain tissue has shown increased NMDA-receptor density 
(Freund & Ballinger, 1991 ). Chronic alcohol treatment has been shown to 
increase both AMP A/kainate and NMDA receptor mediated transmission in the 
hippocampus after withdrawal from chronic alcohol treatment (Shindou et al., 
1994; Molleman & Little 1995a,b; Whittington et al., 1995). The changes in the 
activity of hippocampal pyramidal cells during alcohol withdrawal may reflect 
the behavioural signs of withdrawal (Whittington & Little, 1990, 1991, 
Whittington et al., 1991,1992, 1995). 
Dopamine 
Activation of the mesolimbic dopaminergic system by alcohol in rodents 
has been shown using a variety of methods. Increases in dopamine and its 
metabolites in the ventral striatum have been demonstrated using alcohol doses 
of 1-3g/kg (Barbaccia et al., 1982). The mesolimbic dopaminergic system has 
been implicated in reinforcement processes in general and enhanced mesolimbic 
dopaminergic transmission is a common property of most dmgs of abuse (Di 
Charia & Imperato 1985, Samson et al., 1992). 
The alcohol-induced stimulation of dopamine release in the nucleus 
accumbens is dependent on endogenous opioid peptides. Opioid antagonists 
prevent alcohol stimulated dopamine release. Acute alcohol administration can 
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increase the firing rate of dopaminergic neurons of the VT A (Brodie et al., 1988). 
Chronic administration of alcohol decreased dopamine outflow from the nucleus 
accumbens, with a decline in mesolimbic dopaminergic neuronal activity that 
persists as long as 72 hours after withdrawal (Diana et al., 1996). Studies 
involving in vivo electrophysiological recordings in un-anaesthetised animals 
have also demonstrated reduced firing rates and altered firing patterns of 
neurones in the VT A following withdrawal from chronic alcohol treatment. 
(Diana et al., 1995; Grant et al., 1994). Additional information on the alcohol and 
dopamine interactions is discussed in Chapter 7. 
Noradrenaline 
The primary areas for the origin of noradenergic neurons in the CNS are 
the pons and the medulla. These nuclei consist of the following main groupings; 
the locus coemlus complex and its caudate extension, the lateral tegmental cell 
system, and the dorsal medullary system (Lindvall & Bjorkland, 1974 ). 
Experiments investigating the effect of alcohol on noradrenaline 
have not been conclusive. Administration ofFLA-57, a dopamine beta-
hydroxylase inhibitor resulted in a reduction of alcohol consumption in rats 
(Amit et al., 1970). However, lesion studies report an opposite effect, with 
alcohol consumption increasing after noradrenergic lesions and the acquisition 
of oral self-administration of alcohol has been abolished by destmction of the 
dorsal noradrenergic bundle in rats (Kianmaa et al., 1995). Alpha2 adrenoceptor 
antagonists have been shown to reverse the ataxic and hypothermic effects of 
acute alcohol administration in mice (Durcan et al., 1991, 1992) and acute i.p. 
injections of 2g/kg alcohol have been reported to stimulate the synthesis and 
turnover of noradrenaline (Lyness & Smith, 1992) 
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SHT 
Serotonin (or 5HT) is a neurotransmitter widely distributed in the CNS. 
Up to seven 5HT receptor subtypes have been identified (5HTt, 5HT2 ... 5HT7). 
The 5HT 1, 5HT 2, 5HT 3 and 5HT 4 receptors have been pharmacologically well 
characterised. 5HT1 and 5HT2 receptors can be subdivided into 5HT1A, 5HT1810, 
5HTIE, 5HT1p and 5HT2A, 5HT28 and 5HT2c respectively. 5HT3 receptors are 
ligand gated ion channels whereas the other receptor subtypes are G-protein 
coupled receptors. The cell bodies of 5HT neurons are mainly located in the 
medial and dorsal raphe nuclei. 5HT fibres project to the forebrain and terminate 
in several cortical areas, as well as in other brain structures such as the striatum, 
the nucleus accumbens, the ventral tegmental area, the amygdala and the 
hippocampus (Jacobs and Azmitia, 1992). 
There is evidence that drugs of abuse including alcohol may influence 
brain 5HT activity and that 5HT may have a role in the regulation of specific 
aspects of addictive behaviour. Electrophysiological, neurochemical and 
behavioural studies suggest that the effects of alcohol in the CNS are mediated in 
part though action at the 5HT 3 receptor complex. Alcohol at doses of between 
25mM and 1 OOmM enhances cation conductance at the 5HT 3 receptor (Lovinger, 
1991; Lovinger & White, 1991 ). 5HT 3 receptor antagonists block the 
discriminative stimulus effects of alcohol and block the ability of alcohol to 
release dopamine from the nucleus accumbens, and reduce alcohol intake 
measured by preference procedures (McBride et al., 1991). 
An alcohol induced decrease in 5HT1c and 5HT2A receptor activity has 
been demonstrated in xenopus oocytes at 50-150mM (Sanna et al., 1994 ). In 
hippocampal neurons alcohol potentiates 5HT 1 A and 5HT 4 receptors (Lau & 
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Frye, 1996). Alcohol consumption in both humans and experimental animals is 
reduced by drugs that increase 5HT synthesis and/or release, including 5HT lA, 
5HT18, and 5HT 1c agonists and 5HT reuptake blockers (Murphy et al, 1988; 
McBride et al 1991). Therapeutically, in humans drugs, which activate 
serotonergic transmission, appear to be of some potential value in reducing 
alcohol consumption although as yet serotonergic drugs are of limited value 
clinically (Johnson, 2000). 
Levels of 5HT and the metabolite 5-hydroxyindoleacetic acid (5HIAA) 
has been found to be lower in the hippocampus, nucleus accumbens, striatum, 
cortex and the hypothalamus of different alcohol preferring, compared with 
alcohol non-preferring, rats (Zhou, 1994 ). Research has indicated that 5HT 3 
receptor antagonists can reduce alcohol drinking in alcohol preferring rats but the 
efficacy of these drugs is reduced with chronic administration. (Rodd-Hendricks 
et al., 2000) 
Acetylcholine 
Acetylcholine acts at two main classes of receptors, muscarinic and 
nicotinic acetylcholine receptors. At concentrations of alcohol above l OOmM the 
effect of applied nicotine was potentiated on receptors expressed in Xenopus 
oocytes (Covernton & Connelly, 1997) although blood alcohol levels of l OOmM 
have been reported to be fatal to humans (Charness et al., 1989). Electrically 
stimulated acetylcholine release has been shown to be inhibited by alcohol 
possibly through the actions of other neurotransmitters (Hoffman & Tabakoff, 
1985). Microdialysis has produced data that shows a biphasic effect of alcohol on 
acetylcholine release in the hippocampus, with 20mM stimulating release and 
higher concentrations having an inhibitory effect (Henn et a! 1998). The acute 
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actions of alcohol on mesolimbic dopamine release are blocked by the nicotinic 
antagonist, mecamylamine (Blomquist et al., 1992). Effects of prolonged alcohol 
administration on nicotinic receptors have been reported (Nordberg et al., 1985). 
Central nicotinic acetylcholine receptors in the VT A are involved in modulating 
the mesolimbic dopaminergic pathway activating effects of alcohol (Soderpalm 
2000). Administration of quaternary autonomic drugs have indicated that 
enhanced alcohol intake may involve ganglionic and or peripheral muscarinic 
transmission (Ericson et al 2000). 
The effects of chronic alcohol treatment on central cholinergic systems 
have been well studied. In human alcoholics the number of cholinergic neurons 
is reduced, as well as reduced activity of the acetylcholine-synthesizing enzyme, 
choline acetyltransferase (Arendt et al., 1983) this has also been reported in 
animal studies (Arendt et al., 1988). Reductions in muscarinic receptor density 
have been shown in the frontal cortex, hippocampus and putamen of human 
alcoholics (Freund & Ballinger, 1991). Long-term alcohol administration appears 
to reduce cholinergic transmission. 
Opioids 
There is evidence that alcohol induced activation of the endogenous 
opioid system may be part of a neurobiological mechanism that is involved in 
mediating alcohol drinking behaviour. Acute alcohol administration increases 
endorphin (Naber et al 1981, Barret et al 1987) and enkephalin gene expression 
(Schulz et al 1980). Administration of f..l and 8 opioid antagonists reduces both 
alcohol preference and self-administration of alcohol in animal models 
(Froechlich et al 1991 ). The opioid antagonist naltrexone is used in the treatment 
of alcohol dependence in humans and has efficacy in preventing relapse in 
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alcoholics (O'Malley et al 1992, Volipicelli et al 1992). Antagonists at the J..l and 
3 receptors block alcohol induced dopamine release from striatal brain slices 
(Widdowson & Holman 1992). Chronic alcohol administration has been shown 
to up-regulate 3 receptor binding in the rodent brain measured immediately on 
withdrawal from a 21-day liquid diet treatment (Gianoulakis, 1986; Charness et 
al., 1983). 
Voltage dependent ion channels 
Voltage dependent sodium channels are relatively unaffected by 
behaviourally relevant alcohol concentrations. High doses of acute alcohol 
inhibit sodium influx, IC50 of 500mM (five times the fatal blood alcohol 
concentration). The inhibition of sodium flux is an action shared with general 
anaesthetics and closely related to membrane-disordering effects and the effects 
of alcohol (10- 100 mM) on sodium channels are particularly important in 
mediating the behavioural effects of alcohol (Harris et al., 1987). 
Potassium influx is increased in cerebella Purkinje neurons by 20 mM 
alcohol (Carlen et al, 1982), the locus ceorleus (60 mM) and in the rat 
hippocampus alcohol facilitates potassium flux via the calcium activated 
potassium channel at concentrations above 20 mM (Carlen et al., 1982, Yound & 
Sigman, 1981 ). 
Voltage activated calcium channels are affected by behaviourally relevant 
concentrations of alcohol, the effects are specific to channel types and to brain 
region. An alcohol induced decrease in calcium influx has been reported inN, 
P/Q, and L type channels (Wang et al 1991ab) as well asT type channels 
(Twombly et al 1990). Dihydropyridine-sensitive calcium channels have 
previously been shown to be involved in alcohol dependence. Prolonged intake 
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of alcohol results in an increased number of dihydropyridine-sensitive binding 
sites in the central nervous system (Dolin et al., 1987). 
Administration of dihydropyridine calcium channel antagonists decreased 
the development of tolerance to alcohol (Dol in and Little, 1989), decreased the 
appearance of behavioural and electrophysiological signs of withdrawal 
(Whittington & Little, 1991; Whittington et al., 1991) and prevented the up-
regulation of the dihydropyridine binding sites (Dolin and Little, 1989; 
Whittington et al., 1991 ). Cortical membranes showed an increase in binding that 
rises sharply after 3-4 days of alcohol consumption and is maintained until about 
24 h after cessation (Guppy et al, 1995). The mechanism of this up-regulation is 
as yet unresolved. The increase in binding site densities may result from several 
processes, including the presence of a different membrane environment, 
posttranslational modification of the protein, or the uncovering of cryptic sites, or 
may be a result of de novo synthesis (Guppy et al, 1995). Investigations of the 
mechanism of this up-regulation in cultured cells showed that the up-regulation 
was prohibited by addition of the mRNA synthesis inhibitor, anisomycin 
(Brennan & Littleton, 1990). 
Alcohol doses and behaviour 
Acute alcohol administration has been shown to affect a variety of behavioural 
processes. In humans, low blood alcohol concentrations (5 mM) impair motor 
co-ordination and elevate mood (Charness et al 1989). Increased concentrations 
(> 10 mM) are associated with increased road traffic accidents (Verbanck, 1995). 
Concentrations of (20 mM) produce ataxia and sedation (Charness et al 1989). 
Loss of consciousness is reported at high doses (50 mM) and death at (I 00 mM). 
Generally higher blood alcohol concentrations are required in rodents for 
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analogous behavioural effects, in mice the loss of righting reflex is seen at blood 
concentrations of 65mM (Charness et al 1989). 
A study measuring the blood alcohol concentrations of mice after 
administration of alcohol by liquid diet (as used in some of the following studies) 
have shown with a mean daily alcohol consumption of 20g/kg/day, that produces 
blood alcohol concentrations that are in excess of 20 mM (Jones 93 unpublished 
data). Peak blood alcohol concentrations of I 05 mM during liquid diet 
administration of alcohol have been reported (Shih et al., 1996). 
Stress and alcohol 
The term "stress" often is used to describe the subjective feeling of 
pressure or tension or to the physiological processes initiated in response to a 
stressor. The stress response is a complex process; the association between 
drinking and stress is more complicated still. Multiple genetic and environmental 
factors determine addictive behaviour and the individual response to stress. 
Studying the link between alcohol consumption and stress may further our 
understanding of drinking behaviour. 
The stress response 
The maintenance of the body's relatively steady internal state, or 
homeostasis, is essential for survival. Biochemical and physiological function is 
challenged by a wide variety of stressors - illness, injury, and psychological 
factors (depression, fear, etc.). Stressors prompt physiological and behavioural 
changes in a process of continual adaptation, with the goal of maintaining 
homeostasis and coping with the stress. Selye defined stress as "the non-specific 
response of the body to any demand" (Selye, 1976). The non-specific response 
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can arise from a plethora of stimuli some noxious and life threatening (attack and 
injury) to more benign stimuli such as a novel environment. Both the perception 
of what is stressful and the physiological response to stress vary considerably 
among individuals. These differences are based on genetic factors and 
environmental influences that can be traced back to infancy. The responses of an 
individual to a stressor may also vary depending upon the specific situation (De 
Kloet et al 1997). Different stressors may activate different neurochemical 
pathways and elicit the release of ACTH and corticoids (cortisol & 
corticosterone) through different neuroendocrinological mechanisms (Dallman et 
al 1987). 
The stress response is an integrated network involving the central nervous 
system, the adrenal system, and the cardiovascular system. The hypothalamus at 
the base of the brain, initiates the stress response by secreting corticotrophin 
releasing factor (CRF). CRF triggers a series of physiological and behavioural 
reactions, it stimulates the secretion of adrenocorticotrophin hormone (ACTH) 
from the pituitary gland (also known as corticotrophin) into the circulation. The 
adrenal glands, located at the top of the kidneys, in turn are stimulated to secrete 
glucocorticoid hormones. The main glucocorticoid hormones secreted in humans 
is cortisol (in rodents it is corticosterone). Tennination of the stress response is 
controlled by negative feedback. Corticosterone inhibits the secretion of ACTH 
and CRF; ACTH inhibits the secretion of CRF. (See Figure 1.1, which shows the 
HPA axis and feed back loops). Activation of the stress response affects smooth 
muscle, fat, the gastrointestinal tract, the kidneys, and many other organs and the 
body functions that they control. The stress response affects the body's regulation 
of temperature; appetite and satiety; arousal, vigilance, and attention; mood; and 
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more. Physical adaptation to stress allows the body to redirect oxygen and 
nutrients to the stressed body site, where they are needed most. 
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Figure 1.1 The Hypothalamic 
adrenal pituitary axis 
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Figure 1.1 The hypo thalamus at the base of the brain, initiates the stress 
response by secreting corticotrophin releasing factor (CRF). CRF triggers a 
series of physiological and behavioural reactions, it stimulates the secretion of 
adrenocorticotrophin hormone (ACTH) from the pituitary gland (also known as 
corticotrophin) into the circulation. The adrenal glands, located at the top of the 
kidneys, in turn are stimulated to secrete glucocorticoid hormones. Termination 
of the stress response is controlled by negative feedback. Corticosterone inhibits 
the secretion ofACTH and CRF; ACTH inhibits the secretion of CRF. 
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Stress is usually thought of as harmful; but when the stress response is 
acute and transient, homeostasis is maintained and few adverse effects result. 
Under chronic stress, however, when the body either fails to compensate or when 
it overcompensates, damage can occur. Such damage may include suppression of 
growth, immune system dysfunction, and cell damage can result in impaired 
learning and memory. 
There is considerable recent experimental evidence that stress plays a 
major role in the development of dependence on drugs of abuse, but the 
mechanisms involved are not yet fully understood. The majority of experimental 
studies that have demonstrated links between stress and dependence have been 
carried out on drugs that are psychostimulants (Piazza & Le Moal, 1996), but 
corresponding evidence is beginning to emerge for alcohol, as described below. 
Some effects of stress on CNS function have been identified, but it has been 
recognised only recently that stressful experiences may have long-term effects on 
the function of the neuronal pathways that are thought to be involved in the 
development of dependence (Piazza et al., 1993). Stress hormones can cause 
functional changes in many of the neuronal systems on which alcohol acts, but 
the mechanisms involved in the effects of stress on alcohol consumption require 
elucidation. 
The importance of stress in the acute situation as a contributing factor in 
alcohol consumption was suggested many years ago, in the "tension-reduction" 
hypothesis (Pohorecky, 1981 ). This stated that the acute anxiolytic actions of 
alcohol are a major cause of alcohol consumption, because people drink alcohol 
in order to obtain the acute effect of relief of anxiety. This is likely to be an 
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important factor contributing to the consumption of alcohol, particularly in social 
situations, and the resultant high consumption in individual cases may increase 
the likelihood of subsequent development of dependence. There is also evidence 
that alcohol itself stimulates the stress response. Alcohol administration has been 
shown to increase the production of adrenocorticotrophin (ACTH) and increase 
plasma corticosterone concentrations (Ellis 1966). There is now evidence that 
more long term changes may occur as a result of stressful experiences, involving 
alterations in CNS function that last beyond the acute subjective experience of 
stress (Post, 1992; Bulwalda et al., 1999) for example. Lasting behavioural 
changes in rats after a single exposure to a cat (Adamec, 1994 ). Footshock stress 
induced long lasting behavioural changes together with persistent alterations in 
the hypothalamic-pituitary-adrenal (HPA) axis (Desan et al., 1988) 
In clinical studies, it has been found that a higher incidence of stressful 
major life events is associated with alcohol dependence (Gotman & Brown, 
1992). Employment in occupations that provided high strain and low control was 
found to be associated with an increased risk of alcohol abuse (Crum et al., 
1995). Chronic stressful experience that was personally threatening was found to 
be associated with an increased risk of relapse drinking in abstinent alcoholics 
(Brown et al., 1990). The mechanism of these effects is uncertain, although 
prolonged changes in HPA function are found in abstinent alcoholics. A 
decreased ACTH response to administered corticotrophin releasing factor (CRF) 
has been frequently reported in abstinent alcoholics (Adinoff 1990; Ehrenreich et 
al., 1997) and also blunted ACTH and cortisol release in response to stress 
(Vescovi et al., 1997), although the latter may recover more quickly during the 
abstinence period than the former (Ehrenreich et al., 1997). Increased serum 
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cortisol concentrations have also been reported in alcoholics (Farren et al., 1995) 
and decreases in cortisol binding globulin in the plasma have also been observed 
(Hiramatsu and Nisula, 1989; Frajria and Angeli, 1977). 
The role of stress in alcohol consumption has been the subject of recent 
experimental studies. Early work demonstrated increases in voluntary alcohol 
drinking after stress produced by immobilisation (Rockman et al., 1987; Nash 
and Maikel, 1985) or footshock (Volpicelli et al., 1986), although not all studies 
have found such an effect with these stressors (Ng Cheong Ton et al. 1983; 
Fidler and Lolordo, 1996). A consistent pattern has been the demonstration of 
increased alcohol consumption after these more severe stressors in low 
preference animals, with less, or no, effect on the preference of individuals with 
high preference prior to the stress. This pattern was seen by Volpicelli et al. 
(1986) and Rockman et al. (1987). 
Much experimental evidence now implicates the hormones of the HPA 
axis in dependence on drugs of abuse. A possible mechanism for the involvement 
of corticosterone in drug abuse can be seen in Figure 1.2. Rats will self-
administer corticosterone to achieve plasma concentrations of this hormone, 1-
1.5 mM, that are in the stress range (Piazza et al., 1993) and will also self-
administer ACTH (Johaneau-Bowers & Le Magnen, 1979). Adrenalectomy 
reduced self-administration of cocaine by rodents, while the acquisition of such 
self-administration was increased by corticosterone (Goeders & Guerin, 1996). 
Prevention of corticosterone synthesis by administration of metyrapone reduced 
the relapse rate of rats previously self-administering cocaine (Piazza et al., 1994). 
Corresponding behavioural evidence regarding corticosterone has also been 
obtained for alcohol consumption. Administration of corticosterone increased 
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alcohol consumption in rats and administration of metyrapone or adrenalectomy 
decreased alcohol intake (Fahlke et al., 1994a; 1994b; 1995). The situation for 
the other stress hormones is less clear; both ACTH and CRF have been found to 
decrease voluntary consumption of alcohol by rodents (Krishnan et al., 1991; 
Bell et al., 1998). 
Figure 1.2 
Corticosterone and reward 
Enhances dopamine 
release in the nucleus 
accumbens 
Nucleus 
accumbens 
' I VTA 
Enhanced accumbens I 
dopamine release (Piazza & 
Le Moal 1998) 
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I Rewards 
1.------. / I Increases 
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in the VT A firing in the VT A (Cho 
& Little 1998) 
Figure 1.2 Possible interactions between corticosterone and the mesolimbic 
dopaminergic system. Corticosterone may activate or enhance the 'reward 
system' either by increasing VTA firing or enhancing accumbal dopamine 
release. 
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Animal models of dependence 
There is no ideal model for alcohol dependence in animals; an ideal 
model of alcohol dependence in animals should mirror human alcohol 
dependence, involving oral consumption of alcohol in sufficient quantities to 
produce dependence. Alcohol should be consumed in free choice preference to 
other fluids irrespective of taste, smell or calorific value resulting in relevant 
blood alcohol concentrations. Alcohol should be consumed in sufficient 
quantities to cause tolerance and physical dependence. That is expression of the 
symptoms of alcohol withdrawal syndrome upon cessation of treatment. 
Various methods have been developed to produce alcohol intake as 
alcohol has been reported to have an aversive taste to rodents. All researchers do 
not however universally hold this reported aversion to the taste of alcohol. Reid 
(1996) reports that " contrary to laboratory folklore, most rats will consume 
alcoholic beverages and some will become zealous consumers" he does qualify 
this statement with " rats do not, however, avidly consume alcohol under all 
circumstances". The favourite circumstance appears to be when alcohol is 
presented as a sweetened saccharin solution (0.25% ); this does not really produce 
a strong argument against the aversive taste of alcohol. 
Administration to experimental animals has been performed by a variety 
of methods; as sole drinking fluid (Mello, 1973), via repeated injections (e.g. 
Freud, 1969), by replacing water and food with an alcohol containing liquid diet 
(e.g. Lieber & Decarli, 1986), and inhalation of alcohol vapour (e.g. Goldstein & 
Pal., 1971 ). Despite none of these methods reaching the ideal model for specific 
experimental situations each have their own advantages. 
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Administration of dilute alcohol as sole drinking fluid has been used to 
produce physical dependence in rodents (Mello, 73). High alcohol preferring 
strains of rodents; Fawn Hooded, P & HAD rats (Li et al., 1993, 1994: Li and 
McBride, 1995) and C57 (Unwin & Taberner, 1982) mice have all ingested 
consistently high doses of alcohol when presented as sole fluid. Chronic 
treatment with 24% alcohol as sole fluid has been shown to lead to the 
production of physical dependence in C57 strain mice (Whittingham & Little, 
1988). 
Alcohol can be injected intra-gastrically (i.g) or intra-peritoneally (i.p) 
(Yanagita et al 1969) this method has disadvantages as with the rapid metabolism 
of alcohol it is difficult to attain consistent and stable blood alcohol levels and 
frequent injections become necessary. Also, repeated injections of alcohol have 
been reported to damage rat intestines at doses of 20% alcohol v/v. Inhalation of 
alcohol produces consistent high blood alcohol levels however alcohol intake in 
this method is not voluntary and inhalation rather than ingestion is also less than 
ideal. Laboratory animals selectively bred for high and low alcohol consumption 
constitute a widely accepted animals model of experimental alcoholism. 
It has been reported that if a high alcohol-drinking animal is to be used to 
model for screening therapeutic agents and to elucidate the biochemical basis of 
alcoholism, then the animal should meet certain criteria. The animal should drink 
extraordinary amounts of alcohol, for comparison to other models the pattern of 
the amounts of alcohol drunk and the preference for alcohol over water should be 
comparable to other lines. In addition the desire to consume alcohol should 
remain in the presence of highly palatable but necessarily rewarding solutions. 
Different drugs previously shown to decrease alcohol consumption by either 
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alcoholic or other animal models should reduce the consumption of alcohol in the 
new animal model. (McMillen & Williams, 1995). The consumption of alcohol 
in the presence of another highly palatable liquid (flavoured chocolate drinks are 
the normal substance used) is not necessarily a good constraint on the model of 
alcohol consumption in any given rodent strain, as the palatable distracter may 
itself be 'rewarding'. There is consistent evidence linking the consumption of 
sweets and alcohol in both humans and animals (Kampov-Polevoy et al., 2000). 
Prolonged neuronal changes 
High rates of relapse to drug use after long periods of abstinence 
characterise the behaviour of experienced users of drugs of abuse (Jaffe, 1990), 
66.5% of alcoholics who had undergone a period of abstinence had once again 
become alcoholics after 3 years of initial treatment (Helzer, 1985). 
There is both behavioural and neurochemical evidence that chronic intake 
of alcohol can have very prolonged effects. Recent work has shown that the 
effects of amphetamine and cocaine on locomotor activity of mice were 
increased up to two months after cessation of chronic administration of alcohol 
by liquid diet (Manley and Little, 1997), which supports the possibility of long 
term neurochemical changes. Electrophysiological evidence has been obtained 
showing prolonged changes in VTA neuronal activity after the cessation of 
withdrawal hyperexcitability following chronic alcohol treatment (Bailey & 
Little, 1997; Bailey et al., 1998). 
Aims 
The high probability of relapse amongst abstaining alcoholics presents an 
important area for research. Understanding the neuronal mechanisms that cause 
relapse may help uncover more effective treatments for alcohol dependence. One 
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of the factors that are reported to be important in relapse is stress. The 
mechanisms that underlie the relationship between stress and alcohol 
consumption and relapse to consumption are poorly understood. The experiments 
performed in this thesis were designed to provide more information on the 
relationship between stress and alcohol consumption. 
Activation of the HPA axis resulting in increased levels of corticosterone, 
CRF and ACTH is believed to play a role in both alcohol consumption and 
relapse to alcohol drinking. The aim of this thesis is to investigate the influence 
of corticosterone, CRF, ACTH and stressful environmental manipulations on 
alcohol consumption. This thesis also aims to investigate potential long-term 
neurochemical changes both in the mesolimbic dopaminergic system and the 
HP A axis that may provide information to explain the neurochemical basis of 
relapse. 
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Section one 
Alcohol preference studies 
This section (chapters two, three, four and five) reports on preference studies 
performed on C57 mice. Originally bred by C. A. Little in 1921, the C57 strain of 
mouse has been extensively used in alcohol research because of its reported high 
alcohol preference (McLearn and Rodgers, 1959; Phillips and Crabbe 1991; 
Belknap et al., 1993). The animals used in the following set of experiments are 
C57/BL10 (line ScSn) from the stock originally bred in Bristol Medical School. 
The breeding line was subsequently moved to Durham University. 
Although, the C57/BL10 mouse has been widely used as an "alcohol 
preferring" strain i.e. this strain fits the criteria described in the introduction, 
these mice, in our laboratory, demonstrate considerable variability in alcohol 
consumption. (Watson et al., 1996). When placed in a free choice situation 
between a bottle of dilute (8%) alcohol and a bottle of water, a considerable 
percentage demonstrate a low preference for alcohol, consuming less 30% of 
their total fluid as water (an alcohol preference ratio of less than or equal to 0.3); 
others demonstrate a high preference for the dilute alcohol, drinking over 70% of 
their total fluid as dilute alcohol (an alcohol preference ratio of greater than or 
equal to 0.7) (Little et al., 1999). The alcohol preference distribution is seen in 
both sexes. Selective breeding from the low preferring and high preferring mice 
produces a similar preference distribution as that from unselected breeding pairs 
(Little et al., 1999). Similar variability in preference is also seen in mice of the 
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C57/BL6 strain (Little et al., 1999), so the variation in alcohol consumption is 
not confined to the line bred in our laboratories. 
The majority of neurochemical studies on C57 mice and alcohol 
preference have used the BL6 substrain. Ng et al. (1996) demonstrated lower 
enkephalin gene expression in mesolimbic areas in alcohol-naive C57/BL6J 
animals, compared with the DBA/2J strain, which was increased by alcohol 
consumption. 
With the C57 we have an inbred (genetically identical) strain of mouse 
that demonstrates two distinct behavioural phenotypes i.e. high and low alcohol 
preference. Vulnerability to alcohol dependence has its roots (at least in part) in a 
variety of genetic and early environmental factors, to age, stress and co-existing 
psychoactive conditions. C57 mice have a genetic vulnerability to high alcohol 
consumption, yet some of these mice do not consume high levels of alcohol. 
Uncovering the neuronal factors behind this could be an important step in 
understanding the basis of individual vulnerability to alcohol dependence. 
The use of selectively bred alcohol preferring strains of rodent is a 
valuable tool in alcohol research. High alcohol preferring animal models have 
been used, with some success, in testing pharmacotherapies for alcoholism. 
Various agents that alter 5HT, dopamine, GABA and opiate functioning have 
been shown to decrease alcohol consumption in high alcohol preferring rodent 
lines (Lumeng et al., 1995). The opioid antagonist naltrexone, in addition to 
reducing alcohol consumption in high alcohol preferring rodent strains, has been 
shown to decrease the mean number of drinking days per week, the frequency of 
relapse, and reduce the desire to drink (O'Malley et al., 1992; Volipicelli et al., 
1992). Reductions in human, and selective rodent strain alcohol drinking by the 
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same agents supports the predicative validity of the use of selectively bred strains 
for evaluating therapies. It also supports their use in the basic scientific research 
into the behaviour and neurochemistry of alcohol use and dependence. 
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Chapter Two 
Predicting Alcohol preference 
Introduction 
Background 
To the majority of people, alcohol drinking is an enjoyable social 
pastime, but to some it can present a dependence problem. The individual 
variation in vulnerability to the reinforcing effects of addictive drugs is a clinical 
feature of the development of dependence. Large individual differences in 
conditioned and unconditioned responses to drugs have been noted in 
experimental animals (Piazza & Le Moal 1996). Although it is widely accepted 
that genetic and environmental influences underline the basis of individual 
vulnerability to alcohol abuse or dependence, the exact mechanisms for this are 
poorly understood. The ability to predict alcohol preference or susceptibility to 
drug self-administration would provide a powerful tool in uncovering 
vulnerability to drug a breeding of laboratory rodents for alcoh nd alcohol 
dependence. 
Selective breeding 
The aversion most rodents have of alcohol has led to the selective ol 
preference, in order to develop a rodent model for alcoholism. A number of 
selectively bred lines of high and low preferring rats have been bred including; 
Alcohol-Preferring (P) and Alcohol-Nonperferring (NP), High Alcohol Drinking 
(HAD) and Low Alcohol Drinking (LAD). High alcohol consumption has also 
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been discovered in strains that were originally bred for other purposes for 
example the Fawn Hooded strain demonstrates high alcohol consumption but 
was originally bred for research into a blood disorder arising from 5HT 
transporter dysfunction in platelet cells (Kirchmaier et al., 1990). 
Selected lines of high alcohol preferring rats naturally show similar high 
alcohol drinking but, given the myriad of factors influencing home cage drinking 
and the selective breeding procedure for their creation, they undoubtedly 
represent different genotypes. Neurochemical, and immunohistochemical 
comparisons between high and low preferring rats have demonstrated a number 
of consistent differences between high and low preferring lines. Amongst the 
neurotransmitter systems notably implicated in high alcohol consumption is 5HT 
(e.g. Murphy et al., 1982, Gongwer et al., 1989, Wong et al., 1988; Zhou et al., 
1994). One of the most consistent neurochemical and neuroanatomical findings 
seen in P/NP and HAD/LAD rats is the deficiency of 5HT in the alcohol 
preferring lines (McBride et al., 1991 ). Compared with rats that drink small 
amounts of alcohol, the high alcohol-consuming rats have reduced 5HT in 
several brain regions including the prefrontal cortex and the nucleus accumbens. 
These differences may be caused by a relative reduction in 5HT containing axons 
in these areas and a compensatory up-regulation of 5HT receptor activity (Li & 
McBride 1995). High preferring rat lines have also shown a higher density of 
GABAergic axon terminals in the nucleus accumbens. (McBride et al., 1991). 
The endogenous opioid systems are involved in the regulation of alcohol 
drinking. High and low alcohol-drinking lines differ in their opioid activity in the 
absence of alcohol as well as in alcohol-stimulated opioid activity in the nucleus 
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accumbens and pituitary gland (Nylander et al., 1994). In the present study the 
high alcohol preferring C57 strain of mice, a 'high' preferring strain was used. 
Methods of predicting alcohol preference 
Reports have shown that saccharin-induced increases in daily fluid intake 
in selectively bred rat lines (Knapp et al., 1997), and saccharin intakes in 
heterogeneous rat lines (Overstreet et al 1993) can predict ethanol consumption. 
However, the relationship between voluntary saccharin intake and alcohol intake 
has been brought into question recently, as it has not consistently demonstrated 
(Overstreet, 1999). Other measurements, including immobility in a forced swim 
test, and time spent on the open arms of the elevated plus maze, have been 
reported to correlate positively to alcohol consumption. However, these measures 
are not consistently associated with high alcohol intake (Knapp et al., 1997). 
The observation by Prasad and Prasad ( 1995) of an association between 
high basal levels of corticosterone and an enhanced corticosterone response to 
stress and high voluntary alcohol consumption in rats is of particular interest. 
This proposed link between corticosterone and alcohol consumption fits with 
other observation on corticosterone's influence on alcohol consumption (Fahkle 
& Hansen 1999). Chronic stress is known to cause a variety of behavioural 
manifestations some of which include an enhanced individual predisposition to 
dmg-seeking behaviour (Piazza and Le Moal, 1996). The mechanism by which 
high basal corticosterone levels intluence alcohol consumption is not understood. 
The observed link between corticosterone and alcohol consumption may be 
mediated by the effect of corticosterone on one or more of these 
neurotransmitters and neuromodulators that are also involved in alcohol (and 
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other drugs of abuse) intake. It is also possible that the circulating levels of 
corticosterone may directly influence alcohol consumption. 
Locomotor activity and drug self-administration 
The reaction of animals to a novel environment, activation of the HPA 
and exploratory behaviour, provide the basis of a method that is reported to be 
able to predict susceptibility to drug self-administration. Piazza and eo-workers 
have shown that naive rats when exposed to a novel environment, exhibit a wide 
range in locomotor activity; this observed locomotor activity is positively 
correlated to psychostimulant self-administration (Piazza & Le Moal 1996). 
Psychostimulants, as well as opiates, nicotine and alcohol exert their initial 
effects through different sites in the brain. They all cause similar changes in the 
mesolimbic dopamine pathway, acutely enhancing transmission in the 
mesolimbic dopaminergic system from the VT A to the nucleus accumbens. The 
enhanced dopaminergic activity in the nucleus accumbens has been postulated to 
be the primary factor in determining the susceptibility to high levels of drug self-
administration (Koob and Bloom 1988; Piazza & Le Moal 1998). 
Studies using comparisons between high responding and low responding 
(for operant self-administration) rats selected as such on the basis of their 
locomotor activity in a novel environment have demonstrated a number of 
neurochemical differences between the groups of rats. High responders were 
shown to have reduced expression of tyrosine hydroxylase and cholecystokinin 
(CCK) in the mesencephalon and increased expression of preproenkephalin, 
preprodynorphin and preprotackykinin in the striatum and nucleus accumbens 
(Lucas et al., 1996). 
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In the many substrains of C57 mice in addition to the ethanol preference 
other common patterns of behaviour have been described. In general C57 mice 
show high levels of open field exploration, with low levels of anxiety-related 
behaviour in an open field, and high learning capacity in many memory tasks 
(Crawley et al., 1997). The BL/10 substrain has a high startle reactivity (Paylor 
and Crawley, 1997). However, no clear correlations have been found between 
ethanol preference and particular behaviours or the effects of alcohol on 
behaviour (Phillips and Crab be, 1991 ). 
Aims 
The aims of this study were (i) to characterise the previous observations 
on consumption and preference, (ii) to measure blood corticosterone 
concentrations, prior to screening for alcohol preference, and to examine the 
relationship between alcohol consumption and corticosterone levels to examine 
whether corticosterone levels could be used to predict preference. (iii) And to 
discover whether spontaneous locomotor activity could predict subsequent 
alcohol preference. 
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Methods 
Stock animals 
All the mice were "bred in house". After weaning (19 to 21 days) the 
mice were transferred to new cages in single sex groups of 10 per cage. The 
cages contained mice from different litters. They were housed at 21 ± 1 °C, with 
55± 10% relative humidity, and a 12 hour light/dark cycle, with the light phase 
between 08:00h and 20:00h, and free access to tap water and laboratory rodent 
chow (CRM) at all times. 
Alcohol preference measurements 
Mice were taken from the stock cages and individually housed with two 
fluid bottles made continuously available to them. One bottle containing tap 
water and the other, alcohol (1 00% ethanol, Fisher Scientific) diluted with tap 
water to a concentration of 8% v/v. Measurements of fluid intake were made, 
three times per week (Monday, Wednesday and Friday, at 09.00- 10.00 a.m.). 
The amount drunk from each bottle was used to calculate the ratio between 8% 
ethanol and water. The screening was continued for 3 weeks, as the mice show a 
stable alcohol preference by the third week of screening. The mean of the 3 
measurements in the third week of screening was used to assign the animals 
alcohol preference. 
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Experiment One 
Characterisation of alcohol preference 
This experiment was performed to investigate the relationship between 
alcohol preference and the amount of alcohol consumed (g/kg/day). Male mice, 
25-35g (n=96), were screened for alcohol preference using the standard 
screening procedure described below. 
Experiment Two 
Prior locomotor activity and preference 
This experiment was performed to investigate whether alcohol preference 
could be correlated with locomotor activity. Male C57 mice (25-30g), n=46, 
were taken from their stock cages, between 10 a.m. and 4 p.m. (during the light 
phase), and then placed into locomotor activity meters and spontaneous activity 
was monitored for 30 minutes. These mice were then screened for alcohol 
preference using the alcohol preference screening protocol described earlier. A 
control group, n=46, was screened for alcohol preference in parallel, but without 
exposure to the activity meters. Therefore accounting for the effects of the stress 
of the procedure. Locomotor activity and preference screening were performed in 
the same animal holding room. 
Locomotor activity measurement 
Spontaneous locomotor activity prior to screening was measured using 
Opta-Varimex-Mini activity meters operated by the interruption of 15 infra-red 
beams. A clear perspex cage (50 x 32 x 15 cm), containing a small amount of 
sawdust was placed between a metal frame containing the infra-red emitters and 
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sensors placed 1 inch apart. The mice were placed in the locomotor activity 
boxes for 30 minutes prior to undergoing the alcohol preference procedure. 
Static, mobile, and rearing activities were monitored. 
General (or total) locomotor activity does not refer to a single class of 
behaviour; depending on the recording technique, it can comprise many different 
motor movements. For this reason the activity measurements were divided into 
static, mobile and rearing counts. Static activity was measured by counts of beam 
breaks in a non-sequential fashion, e.g. grooming and digging in the sawdust. 
Mobile activity was measured by the consecutive breaking of beams. Rearing 
activity was counted when the upper layer of beams was broken. 
Experiment Three 
Corticosterone levels and preference 
The purpose of this experiment was to investigate whether there was any 
correlation between total plasma corticosterone levels and alcohol preference. 
Immediately prior to the screening procedure, blood samples were taken from 
two groups of stock male C57 mice (25-45g). One group of mice (n=23) had 
blood samples taken between 8 and 9 am (at the start of the light phase- lights 
on) and an other group (n=23) between 8 and 9 p.m. (at the start of the dark 
phase - lights off). Parallel control groups were used; these underwent the same 
handling procedure but did not have a blood sample taken. The samples were 
then used to assay the total corticosterone levels, using anti-corticosterone 
antibodies supplied by Sigma (see later). After the mice had their blood samples 
taken they were moved to another holding room for alcohol preference screening 
as described earlier in experiment one. 
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A second experiment using the same protocol was performed on male 
C57 mice (25-30g, n=23 per treatment). The radioimmunoassay in this group 
was performed with antibodies supplied by ICN (see later). After these mice had 
the blood samples taken they were placed in single cages for screening, the 
screening procedure was performed in the same room as the blood samples were 
taken. 
Blood sample collection 
Blood sample collection was performed according to the method of 
Durschlag et al. 1996. The mouse was removed from its home cage. With the tail 
held in the middle with the thumb and forefinger, the middle or the ring finger 
stabilised the tail dorsal to the surface of the incision, while the mouse was 
restrained by slightly pressing on its back with the remaining fingers. Blood 
samples were obtained by lacerating the ventral blood vessels with the pointed 
end of a razor blade with a short, rapid motion slightly oblique to the vessels. 
The blood was collected in heparinized microtubes, and centrifuged at 5000xg 
5°C for 15 minutes (Microcentaur, Sanyo). The plasma samples were then stored 
at -20°C until required for radioimmunoassay (RIA). After collecting the sample, 
the bleeding was halted by applying slight pressure to the wound with cotton 
buds. 
Radioimmunoassay 
Two suppliers of antibodies were used Sigma and ICN. The Sigma 
antibodies lost activity when stored (although they were stored in accordance 
with the manufacturer's instructions). 
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In radioimmunoassay, a limited amount of specific antibody is reacted 
with corresponding labelled tracer, in this case eH] 1 ,2,6, 7, corticosterone 
(specific activity 65-70m Ci/mol Amersham, U.K.). Upon addition of increasing 
amounts of corticosterone, a correspondingly decreasing fraction of the tracer is 
bound to the antibody. After separation of the bound from the free tracer by 
dextran-coated charcoal, the amount of remaining radioactivity is counted and 
used to construct a standard curve against which the unknown samples are 
measured (see Figures 2.i and 2.ii). 
Buffers used 
Antibody diluting buffer: 
0.05M Tris HCl pH 8, 
O.IM NaCl, 
O.l%NaN3 
Tracer, sample, and charcoal slurry buffer: 
0.05M Tris HCI pH 8, 
O.IM NaCl, 
0.1% NaN3, 
0.01% BSA 
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Figure 2.i and 2.ii These figures show the standard curves generated for the 
corticosterone RIA measurements. Figure 2.i Shows the standard curve 
generated by the ICN-supplied antibodies and Figure 2.ii Shows the curve 
generated by the Sigma-supplied antibodies. Both types of antibody are specific 
of corticosterone showing <0.1% binding for other related steroids. The 
concentrations of the standards required by the two assays were different; the 
ICN-supplied antibody required dilution of the samples. 
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Sigma supplied antibodies 
A 0.1 ml (diluted I: 1 0) volume of plasma or standard was pi petted into a 
1.5ml eppindoff tube to which 0.5ml of antibody solution was added. The tubes 
were vortexed and allowed to stand for 30 minutes. The 0.1 m! of 150pM tritiated 
corticosterone (in the modified Tris buffer previously described, with the 
addition of 0.1% BSA) was added and the tubes were incubated at 37°C for one 
hour. The tubes were then placed in an ice bath and when cooled 0.2 m! of 0.5% 
w/v dextran coated charcoal was added to remove unbound antibody. The tubes 
were then incubated for a further 15 minutes before being centrifuged at 4°C, x 
2750g (bench top centrifuge) for 15 minutes. A portion of the supernatant was 
removed (0.25ml) to a scintillation vial and 3ml of scintillation fluid added, and 
the samples were then counted in a liquid scintillation counter (Tri Cab 2100 
TR., Packard, Berks.). 
ICN supplied antibodies 
Plasma samples were diluted I :5000 in antibody diluting buffer and 
0.5ml aliquots were then heated to 98°C in a water bath to degrade the plasma 
proteins. The samples were allowed to cool and then 0.1 ml of diluted labelled 
corticosterone (I 0,000 cpm) and 0.1 ml of antibody were added. The tubes were 
mixed and then incubated at 4°C overnight. The following day 0.5ml of ice-cold 
0.5% dextran-coated charcoal was added and the tubes were then incubated for a 
further twenty minutes on ice; finally the tubes were centrifuged (2750 xg) for 15 
minutes at 4°C. The supernatant was decanted and 4ml of liquid scintillation 
fluid added before scintillation counting. 
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Statistical analysis 
The correlation to alcohol preference from the corticosterone assays and 
locomotor activity measurements were analysed statistically using regression 
analysis. Comparisons of alcohol preference between treated groups were made 
using a Mann-Whitney test, for non-parametric data. Two-way analysis of 
variance, and where appropriate, Fisher's post-hoc tests, were used to analyse the 
RIA data. 
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Results 
Experiment One 
The mice demonstrated the biphasic distribution previously reported 
(Figure 2.1 ). The majority of mice were either high preferring (40%) or low 
preferring ( 44%) with few intermediate-preferring animals (l6% ). There was no 
significant difference in the total fluid consumption of high and low preferring 
mice (Figure 2.2). There was a positive correlation between alcohol preference 
ratio and g/kg/day of alcohol consumed (y=l2.65+0.068; r=0.94, t=26.719, 
P<O.OOOI)(Figure 2.3). 
Alcohol preference ratio did not correlate with total fluid consumption 
(Figure 2.4). Alcohol consumption in high preferring mice was up to ten times 
greater in g/kg/day ( 13 ± 0.5 g/kg/day) of alcohol than low preferring mice (2 
±0.2g/kg/day)(Figure 2.5). 
All the data presented is the mean preference of the final three 
measurements of the three week screening. Previous work has shown that 
preference in these mice is stable after three weeks of screening (Little et al., 
1999). 
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Figure 2.1 The alcohol preference frequency distribution of male C57 mice (n-
96) that underwent three week, two bottle, alcohol preference screening. The 
alcohol preference ratio is the ratio of the amount of dilute alcohol (8%) 
consumed divided by the total fluid intake. 
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Figure2.2 The mean total (+1-SEM)jluid consumption in high (n=35) 
and low preferring (n=41) male C57 mice after three weeks of preference 
screening. 
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Figure 2.3 The intake of alcohol ( glkglday) and the alcohol preference 
ratio of C57 mice during alcohol preference screening. Correlation between 
alcohol preference and alcohol consumption in C57 mice. (r=0.94) 
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Figure 2.4. The total fluid intake of male C57 mice during alcohol preference 
screening. Total fluid intake had no relationship to alcohol preference. 
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Figure 2.5. The alcohol intakes in high (n=35) and low preferring (n=41) 
C57mice. High alcohol preferring mice consumed significantly more alcohol 
(glkg/day) than low alcohol preferring mice. (*P<O.OOJ). 
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Experiment Two 
Mobile locomotor counts between 0-15 minutes (Figure 2.6) and 16-30 
minutes (Figure 2.7) showed no correlation with alcohol preference (r<0.1). 
Static locomotor counts between 0-15 minutes (Figure 2.8) and 16-30 minutes 
(Figure 2.9) showed no correlation with alcohol preference(r<0.1 ). Rearing 
locomotor counts between 0-15 minutes (Figure 2.10) and 16-30 minutes (Figure 
2.11) showed no correlation with alcohol preference (r<O.l). Alcohol preference 
was not dependent upon prior exposure to the activity meters. There was no 
significant difference between the preference ratios of the mice that were placed 
in the activity meters compared to those of mice that were screened without 
exposure to the activity meters (P>0.5). 
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Figure 2.6 Prior mobile locomotor activity and subsequent alcohol preference in 
C57 mice. There was no correlation between initial mobile locomotor activity (0-
15 minutes) and alcohol preference after three weeks of alcohol preference 
screening. 
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Figure 2.7 Prior mobile locomotor activity and subsequent alcohol preference in 
C57 mice. There was no correlation between mobile locomotor activity ( 16-30 
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minutes) and alcohol preference after three weeks of alcohol preference 
screening. 
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Figure 2.8 Prior static locomotor activity and subsequent alcohol preference in 
C57 mice. There was no correlation between static locomotor activity (0-15 
minutes) and alcohol preference after three weeks of alcohol preference 
screening. 
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Figure 2.9 Prior static locomotor activity and subsequent alcohol preference in 
C57 mice. There was no correlation between static locomotor activity ( 16-30 
minutes) and alcohol preference after three weeks of alcohol preference 
screenmg. 
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Figure 2.10 Prior rearing locomotor activity and subsequent alcohol preference 
in C57 mice. There was no correlation between rearing locomotor activity ( 0-15 
minutes) and alcohol preference after three weeks of alcohol preference 
screening. 
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Figure 2.11 Prior rearing locomotor activity and subsequent alcohol preference 
in C57 mice. There was no correlation between rearing locomotor activity ( 16-
30 minutes) and alcohol preference after three weeks of alcohol preference 
screening. 
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Experiment Three 
Circadian fluctuations of corticosterone levels were seen m both the 
sigma and ICN assays. The corticosterone levels of high and low preferring mice 
at the respective time points did not differ, but the time at which the samples 
were taken affected corticosterone levels. 
Higher levels of total corticosterone were seen at lights off using the 
sigma-supplied antibodies (lights on vs. light off P<0.005). The same pattern 
was seen in the assays that used the ICN supplied antibodies (lights on vs. light 
off P<O.Ol). 
Corticosterone levels measured using the Sigma antibodies differed from 
levels assayed with ICN antibodies. The Sigma antibodies gave higher levels at 
both lights off and lights on compared to the ICN antibodies, (F3, 65 = 18.53 
P<O.OOOl) (Figure 2.13c ). 
At either time point (in both methods), lights on or lights off, there was 
no correlation between corticosterone levels and alcohol preference, There was 
no relationship between corticosterone levels and alcohol preference in selected 
high, intermediate or low preferring populations (Figures 2.14 a, b, c and d). 
There was no difference in the subsequent preference of mice that were 
either sampled or un-sampled (Fig 2.15). Also the time of day that the screening 
procedure was started (lights on or lights off) did not affect alcohol preference 
(fig 2.16). 
55 
Figure 2.13a 
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FIGURE 2.13 Figure 2.13a Shows the corticosterone levels in high and low 
preferring mice measured using Sigma antibodies (n=9 per group); 2.13b Shows 
the levels using ICN antibodies (n=9 per group). Figure 2.13c show the levels 
measured by both methods in all the mice. (*p<O.OJ ICN lights off vs. lights on; 
**P<O.OOJ Sigma lights on vs. lights off; two way ANOVA (supplier X time), aF 
3.65 =18.5 P<O.OOOJ). Lights on describes the samples taken at the start of the 
light phase. Lights off describes the samples taken at the start of the dark phase. 
56 
• High lights oJ 
D Low lights of 
• High lights 01 
D Low lights or 
Figure 2.14a 
140 
• 
120 
~ 
0 100 • 
.!:l 
(I) 
• > 80 ~ 
~ 
• 8 60 ~ • tll 
• .SI • • ~ 40 • • • 0 
• 
, 
() 
20 • • 
0 
0 0.2 0.4 0.6 0.8 1 
Alcohol preference ratio 
Figure 2.14 a. Initial corticosterone levels and subsequent alcohol preference in 
C57 mice. The total plasma corticosterone levels were measured at lights on 
using the ICN supplied assay kit. There was no correlation between 
corticosterone levels and alcohol preference. 
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Figure 2.14 b. Initial corticosterone levels and subsequent alcohol preference in 
C57 mice. The total plasma corticosterone levels were measured at lights off 
using the ICN supplied assay kit. There was no correlation between 
corticosterone levels and alcohol preference. 
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Figure 2.15. The average alcohol preference of C57 that prior to screening had 
either blood samples taken (sampled) or were handled but no blood samples 
were taken unsampled (n=46 per group). The sampling procedure had no effect 
on subsequent alcohol preference (Mann-Whitney test P>0.5). 
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Figure 2.16 Alcohol preference ratios of mice that were started on the alcohol 
screening procedure at either lights on, the start of the light phase, (n=46) or 
lights off, the start of the dark phase, (n=46). 
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Discussion 
Corticosterone Assays 
The discrepancy in absolute corticosterone levels recorded by the two 
methods has a number of possible explanations. A methodological explanation 
could explain part of the difference. The methods are broadly similar, i.e. RIA 
with a dextran/charcoal separation of antibody-bound and free tracer. The Sigma 
protocol, however, does not require a boiling step in sample preparation. Boiling 
the sample is used to destroy the plasma proteins aiding antibody/target binding. 
Although the Sigma antibody/corticosterone binding may be unaffected by the 
presence of plasma proteins, the binding of either endogenous corticosterone or 
added tracer to the plasma proteins which would be separated by the dextran 
charcoal in addition to the antibody tracer complex does not seem to be 
accounted for with this method, making a very real possibility of artificially high 
or low measures dependent on plasma protein content rather than corticosterone 
content. For this reason the ICN antibodies were used in all of the subsequent 
experiments in this thesis. The Sigma antibodies were also less stable than those 
from ICN. 
Another possible reason for the difference in values may have been the 
treatment of the stock animals, although every care was taken to standardise the 
conditions in which the animals were housed both before and during any 
treatments. However, there is a possibility that the group that was assayed using 
the Sigma antibodies may have been fed a different laboratory chow. This is 
highly speculative, the only evidence for this is that the initial group contained 
animals that were over 35g, an excessive weight even for very mature C57 mice. 
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Since this experiment there have been no stock C57 mice that weighed over 35g. 
In the two experiments the experimental protocol varied slightly, this might also 
explain the difference in the measured values. The first experiment used blood 
samples that were taken from mice that had been moved from the holding rooms 
to another room to be sampled. This transfer may have been responsible for the 
higher measured corticosterone levels. 
The two experiments did, however, produce comparable results even 
though the absolute levels that measured were different. Firm conclusions about 
the relationship between circulating levels of total corticosterone and alcohol 
preference could therefore be made on the basis of the results form both 
experiments. 
C57 mice and alcohol preference 
The C57 mice in these studies show the same bimodal distribution of 
alcohol preference that was originally uncovered in Bristol. This effect has been 
consistently shown over a number of years (Little et al., 1999), but the cause of 
this variation has not yet been identified. The high preferring mice can drink 
15g/kg/day of alcohol. This is a large amount of alcohol even for high preferring 
strains of rodents; high preferring rat strains are normally reported to consume 6-
9g/kg/day (Samson et al., 1998a, 1998b; Colombo, 1996). The low preferring 
mice can drink less than 1g/kg/day, an intake similar to other strains of low or 
alcohol avoiding rats (Samson et al., 1998a, 1998b). The relatively large amount 
of alcohol ingested by these mice compared with the high alcohol preferring rat 
strains may be explained by faster alcohol metabolism. 
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.!Locomotor activity and aRcohoi preference. 
The ability of alcohol to increase locomotor activity is reported to be a 
measure of its rewarding efficacy (Pohorecky, 1981 ). The "psychomotor 
stimulant theory of drug addiction", proposed that the stimulant action of drugs 
of abuse is mediated by the same mechanisms that mediate reward and 
reinforcement. However, the relationship between alcohol and motor activation 
in various rat and mice strains is far from clear. Studies have found a relationship 
between alcohol administration and locomotor activity in some mice strains but 
not others (Cunningham et al., 1992). Rats of selected high preferring lines have 
been shown to exhibit a greater response to ethanol-induced locomotor activation 
than low preferring rats (Wailer et al., 1990; Hilakivi et al., 1984). 
There was no correlation between locomotor activity and alcohol 
preference for the whole population screened or for high or low subsections of 
the tested population. Testing of locomotor activity after alcohol preference 
screening also showed no relationship in these C57 mice (Little et al., 1999). 
Reasons as to why no correlation was found may be explained by the differences 
in responding measures rather than the rewarding aspects of alcohol compared to 
other drugs of abuse. This method measured alcohol preference, an established 
method of modelling some aspects of alcohol dependence, whereas the Piazza 
studies model rewarding behaviour through operant responding. These methods, 
although broadly answering some of the same questions, are very different. 
Preference to alcohol as measured by standard two bottle preference procedures 
does not correlate to operant responding for alcohol in all situations. A study by 
Samson and colleagues ( l998a) have shown, using a variety of high and low 
alcohol preferring selectively bred rat strains, that preference does not correlate 
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to restricted access operant responding - where the animal is placed in the 
operant chamber for a limited amount of time. However, unlimited access 
operant responding does correlate to alcohol preference (Samson et al., 1998b ). 
The possibility that high responders and high locomotor activity. 
Reported in other cases, may in fact be measures of a similar underlying 
behaviour not directly related to high levels of drug self administration cannot be 
discounted. The enhanced locomotor activity is proposed to be a measure of an 
enhanced response to novel environments and therefore be linked to risk-seeking 
behaviour linked to drug abuse. 
Another possible explanation is that some of the characteristics of the 
C57 mice may themselves be responsible for the lack of correlation. As stated in 
the introduction, many substrains of C57 mice in addition to the ethanol 
preference share other common patterns of behaviour including high levels of 
open field exploration, low levels of anxiety related behaviour in an open field, 
high learning capacity in many memory tasks (Crawley et al., 1997), and a high 
startle reactivity (Paylor and Crawley, 1997). It is possible that the inherent high 
locomotor activity amongst C57 mice prevented the observation of any potential 
relationship between activity and alcohol preference. 
Corticosterone levels and preference 
The lack of correlation between total corticosterone levels and alcohol 
preference was an unexpected finding given the reports of a relationship between 
the two (Prasad & Prasad 1995). The main difference between this study and the 
Prasad study was that they measured the excreted corticosterone levels and the 
present study measured the total blood corticosterone levels. In this set of 
experiments, which measured only the total corticosterone levels, it was not 
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possible to measure the free and bound corticosterone, as, at the time when the 
experiments were performed, the procedures were not available in our laboratory. 
Corticosterone is excreted in urine and the levels found in urine are 
reported to be correlated to the levels of free corticosterone found in the 
circulation. Corticosterone is found in the circulation as either bound or free. 
Bound corticosterone describes corticosterone bound to a specific corticosterone 
binding globulin or other non-specific proteins in the blood. Normally the 
proportion of free corticosterone is about 10% of the total level. Under times of 
certain types of stress the proportion of free corticosterone rises dramatically 
(Savu et al., 1981). High levels of corticosterone in urine are linked to high 
circulating free corticosterone. The levels of total circulating corticosterone do 
not necessarily relate to the free levels. Free corticosterone is 'available' to its 
target sites either in the periphery or centrally. However, elevated total 
corticosterone levels have been demonstrated in response to stress and it is the 
total corticosterone levels that are generally discussed in the literature when 
examining a HP A response, although this might not be the most accurate 
measure of corticosterone response. 
However, the link between free corticosterone levels and alcohol 
preference is not itself clear-cut. In their experiments, Prasad and Prasad 
investigated the basal and activated (levels after a stress) corticosterone levels 
and their link to alcohol preference in selected high preferring P rats and low 
preferring NP rats. They also examined the same relationship in unselected 
Sprague-Dawley rats. The comparison between the selected alcohol preferring 
strains and alcohol avoiding strains is limited because the strains are different. 
Multiple comparisons between many different strains are nonnally necessary to 
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gain meaningful data, hence a more complete investigation, would be necessary 
for a firmer conclusion. The suggested link between the alcohol preference of 
Sprague-Dawley rats and their corticosterone levels is valid because it is an intra-
strain comparison. The significance of this correlation in the context of alcohol 
dependence or an individual susceptibility to alcohol dependence is less clear, as 
the alcohol preference of the rats was low (all the measured preference ratios 
being less than 0.4). 
A specific relationship between circulating total corticosterone levels and 
alcohol consumption has not been established, but this does not exclude the 
relationship between the HPA axis and corticosterone. There are a multitude of 
possible sites and systems in the HPA that could modulate alcohol consumption. 
Some of these will be discussed and examined in later chapters. 
There is more scope for investigation; the levels of free and bound 
corticosterone should be measured as total corticosterone levels present a limited 
picture of HPA axis activity. In addition these levels (free and bound 
corticosterone) could be measured in response to stress prior to preference 
screening rather than the baseline levels of total corticosterone could provide a 
more definite conclusion on the ability to predict alcohol preference by 
measuring HPA axis activity. 
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Chapter Three 
Repeated stress and preference 
Introduction 
Studies have assessed the influence of both acute and chronic stress on 
drinking behaviour and the development of alcohol dependence. Alcohol 
drinking problems have been reported to be closely related to a variety of 
stressful experiences including illness, the death of somebody close, and from 
chronic occupational stressors, that were combined with a 'sense of 
powerlessness' (Seeman & Seeman, 1992). Crum et al., (1995) showed that men 
in high-strain jobs, those that had high demands and low control, had a higher 
risk of developing alcohol user disorders. 
A relationship between stress and alcohol consumption in laboratory 
animals has become well established. Since the original observation by 
Masserman and Yum ( 1946), that 'neurotic' cats showed an increased preference 
for a mixture of milk and 5% alcohol to milk alone, numerous studies have been 
conducted examining the link between stress and alcohol consumption. The 
'tension-reduction' hypothesis states that people drink alcohol in order to obtain 
the acute effect of relief of anxiety (Conger 1956, Williams 1966, Pohorecky 
1981). However, Pohorecky (1981) has also argued that in humans alcohol can 
increase anxiety with time during a drinking binge. Alcohol consumption is 
reported to reduce the magnitude of an organism's response to stress (Levenson 
et al., 1980). Drinking to reduce stress, in individual cases may result in high 
consumption leading to, potentially, the development of dependence. 
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Increases in voluntary alcohol drinking after stress produced by 
immobilization has been reported (Rockman et al., 1987; Nash & Maikel, 1985), 
an effect that others have failed to demonstrate (Ng Cheong Ton et al. 1983; 
Fidler & Lolordo, 1996). Stress induced suppression of the maintenance, but not 
acquisition, of alcohol consumption in rats has been reported (Ng Cheong Ton et 
al. 1983). A consistent pattern has been the demonstration of increased alcohol 
consumption after these more severe stressors in low preference animals, with 
less, or no, effect on the preference of individuals with high preference prior to 
the stress. (Volpicelli et al., 1986; Rockman et al., 1987). The effect of stress is 
also seen in the self-administration of other drugs of abuse. Exposure to 
footshock stress potently reinstates heroin (Shaham & Stewart, 1995) and 
cocaine (Erb et al., 1996; Ahmend & Koob, 1997) self-administration. Acute 
stress facilitated self-administration only when drug availability was present a 
short time after the stress (Shaham, 1993) whereas after repeated stress animals 
showed enhanced self-administration of amphetamine even if the stress was 
absent for weeks (Shaham 1993, Pizza & Le Moal, 1998), indicating that 
persistent physiological changes occurred leaving the animal prone to enhanced 
self -administration. 
Use of C57 mice 
As previously stated alcohol is aversive to the majority of rodents. 
Although high preferring mouse and rat strains have been developed, their use in 
modelling alcohol consumption and dependence behaviour has some limitations, 
the most notable of which is, paradoxically, their consistent high voluntary 
alcohol consumption. When examining the factors that cause or are influenced by 
alcohol consumption, misleading weight may be given to discoveries that are 
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influenced unduly by a particular genotype. This can be illustrated by the Fawn-
Hooded rat. The Fawn-Hooded rat will drink large quantities of alcohol and is 
described as a high alcohol preferring strain of rat. The functioning of the CNS 
serotonergic system in this type of rat is abnormal compared to outbred strains. 
The influence of 5HT on alcohol consumption is well established, however using 
such a strain will provide only (more) evidence on the links between 5HT and 
alcohol consumption. In the 'high preferring' C57 mice, however, the existence 
of low preferring mice allows a greater scope for investigation (see chapter two). 
This enables the investigation of environmental or pharmacological factors that 
alter alcohol preference that are independent of, and not constrained by the 
influence of a particular genotype that already defines the strain. Previous work 
with these mice has shown that mild environmental disturbances such as moving 
the mice down several floors in a lift (unpublished data) increase alcohol 
preference. 
Repeated saline injections increased the alcohol preference of low 
preferring C57 mice (Little et al., 1999). Low and high preferring mice were 
injected with the CCK8 receptor antagonist CAM 1028, to investigate potential 
actions of this novel anxiolytic on alcohol consumption. This was shown to have 
no effect on alcohol preference when administered to high alcohol preferring, 
and no 'apparent' effect on low alcohol preferring, mice. However, the repeated 
saline vehicle injections in the low preferring mice caused an increase in 
preference Antagonists at the CCK8 subtype of receptor have been reported to 
decrease anxiety-related behaviour in animal tests, although differences in the 
results of studies on this have been reported (Hughes et al., 1990; Singh et al., 
1991 a; Dawson et al., 1995). These drugs are effective in decreasing anxiety-
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related behaviour in mice when such behaviour is increased during the acute 
phase of alcohol withdrawal (Wilson et al., 1998), but had only small protective 
action against the convulsive aspects of the alcohol withdrawal syndrome 
(Wilson & Little, 1998 ). 
Those results suggested that the actions of the CCK8 antagonist in 
preventing the increase in alcohol consumption caused by minor stress in low 
preferring C57 mice was due to an interaction with the neuronal changes 
involved in the response to the minor stress, rather than a direct effect on the 
mechanisms that control alcohol drinking in the absence of stress. 
Aims 
The general aim of this section of experiments was to investigate the 
effects of repeated mild stressful procedures on alcohol preference in low alcohol 
preferring C57 mice. Initially the effects of diazepam on alcohol preference in 
low preferring mice were examined. This was performed in order to discover 
whether the effect of injection induced increases in alcohol preference, that had 
been shown to be inhibited by CAM1028, could be inhibited by the anxiolytic 
drug diazepam. Also an examination of the effects of repeated dilute tween 
vehicle injections, saline injections, or needle insertion (but no injection) 
compared to handled (but not injected mice) was performed to uncover whether 
the injection procedure itself or the disturbance of handling was responsible for 
the increase in alcohol preference. Single saline injections were given to mice to 
see if the increase in preference was a function of time or if the repeated stress 
was necessary for the increase. Repeated saline injections in the absence of 
alcohol were performed to discover whether the increase in preference was 
dependent on the availability of alcohol. 
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Method§ 
Male C57 mice were used for all the following experiments. The 
conditions, housing, and alcohol screening procedure have been described in 
Chapter Two. The mean alcohol preference ratios for the last week of 
measurements (the third week, when the measured ratios were stable) were used 
to allocate mice to the preference categories. Mice with a ratio of 0.7 and above 
for the consumption of 8% alcohol over water were classed as "high" preference, 
and those showing a ratio of below 0.3 were classed as "low" preference. The 
following experiments were performed on male C57 mice that had undergone the 
screening procedure and were designated low preferring mice i.e. their alcohol 
preference was below 0.3 during the last week. 
Effects of vehicle and diazepam injections 
A study was carried out to examine whether the handling of the mice or 
the act of injection plus the handling was the crucial factor in the effects of the 
saline injections. Parallel groups of male mice (25-30g, n=9), were either picked 
up, positioned ready for injection then returned to the home cage or picked up, 
positioned and injected with (lf..Ll/kg) 0.9% saline. These treatments were 
continued for 3 weeks daily and measurements of alcohol preference were made 
three times per week (lp.m- 2p.m. Monday, Wednesday and Friday) throughout 
the experiment. The treatment schedule of three weeks was chosen because the 
saline induced increase in alcohol preference was first observed (Little et al., 
1999) after 10-15 days. A three week treatment schedule should, therefore 
provide sufficient time for any alterations in preference to develop. 
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The effects of diazepam (1 mg/kg, i.p.) were examined in a further study 
on mice previously screened and classed as low alcohol preferring animals. This 
dose of diazepam was chosen as it had previously been shown to reduce anxiety 
related behaviour on the elevated plus-maze (Cole & Rodgers, 1995). Three 
parallel groups of mice were used: one was injected with diazepam, 1 mg/kg 
(male mice 25-30g, n = 7), the second with the tween vehicle (male mice 25-30g, 
n = 8), and in the third (male mice 25-30g, n = 9) the animals were picked up, 
positioned ready for injection then returned to the home cage. The tween vehicle 
was a suspension of 0.05% tween in saline. Tween was used as the vehicle in 
these injections as diazepam is insoluble in water or other polar solvents, so it 
was necessary to administer the diazepam in a detergent suspension. 
Measurements of alcohol preference were made once daily for three weeks at 
2.p.m. All the mice were weighed once a week (Wednesday). 
Repeated /single injection 
This experiment further examined the previously demonstrated 
phenomenon that daily intraperitoneal injections of isotonic saline increased the 
alcohol preference of low preference mice when given over a period of three 
weeks. Also examined was the effect of a single saline injection on alcohol 
preference when monitored for three weeks after the injection. The mice (male 
mice 25-30g, n=8) were injected once daily with isotonic (0.9%) saline 
(O.OOlml/kg) every day for three weeks or were handled as if to be injected but 
placed back into their cage without injection (male mice 25-30g,n=8) or were 
injected on the first day only (this group was left undisturbed except for bottle 
weighing). These treatments were continued for 3 weeks and measurements of 
alcohol preference were made three times per week (lp.m- 2p.m. Monday, 
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Wednesday and Friday) throughout the experiment. All the mice were weighed 
once a week (Wednesday). 
Injections without alcohol available 
Two groups (25-30g, n = 8 per treatment group) of low preference male 
mice were continued on single housing and given tap water as the sole available 
fluid and either (i) handled daily as if an injection was going to be made, but not 
injected or (ii) injected once daily with (lOml/kg) isotonic saline, by the 
intraperitoneal route. These procedures were carried out at 2 p.m. each day. At 
the end of the three week period, the animals were provided with a free choice 
between 8% v/v alcohol and tap water and fluid consumption measured, three 
times per week (Monday, Wednesday and Friday) for the week immediately 
following the procedure. All the mice were weighed once a week (Wednesday). 
Sham injection and alcohol preference 
Two groups (male mice 25-30g, n = 8 per treatment group) of low 
preference male C57 mice were continued on single housing and provided with a 
free choice between 8% v/v alcohol and tap water for the duration of the 
experiment. For three weeks, they were either (i) handled daily as if an injection 
was going to be made, but not injected or (ii) received an intraperitoneal insertion 
of a syringe needle but no injection of fluid ('sham injection'). These procedures 
were carried out at 2pm each day. Fluid consumption was measured three times 
per week (Monday, Wednesday and Friday) for the three weeks of the treatment. 
All the mice were weighed once a week (Wednesday). 
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Statistical analysis 
All data is presented as mean ±SEM. A priori assumptions enabled the 
comparison between treatments (at three weeks) and baseline values to be 
performed using t-tests in all the experiments except the 'sham' injection 
experiments where analysis of variance and when appropriate Fisher's post-hoc 
test was used. Significance was set at P<0.05. 
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Results 
Injections and preference 
The results from the study comparing the alcohol preference of mice, 
previously classed as "low preference", after either handling or saline injections, 
are illustrated in Figure 3.1 a. During the third week of treatment, the group, 
which received the injections, showed significantly higher preference than those 
that were just handled (P < 0.02). No changes were seen in the total fluid 
consumption of either group during the saline administration. Figure 3.1 b 
illustrates the alcohol preference of mice, previously classed as "low preference", 
after diazepam ( 1 mg/kg), Tween vehicle, or handling alone. By the third week, 
the alcohol preference after Tween injections or diazepam showed significant 
increases from baseline (both P < 0.01) but there was no effect of handling 
compared with the corresponding baseline (P > 0.1). Within the third week, the 
mean preference after Tween injections was higher than that after handling, but 
the difference did not reach significance. The difference between diazepam and 
handling was significant, but there was no significant effect of diazepam 
compared with Tween vehicle. The administration of diazepam had no 
significant effects on the alcohol preference, compared with injection of its 
vehicle (P > 0.1) . No changes were seen in total fluid consumption of any group 
during the drug or vehicle administration. 
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Figure 3.1a The change in alcohol preference, over three weeks in saline 
injected C57 mice (filled boxes) compared with handled only mice (open boxes) 
(* P<0.02). Figure 3.lb Increased alcohol preference in tween and diazepam 
(DZ) injected mice compared to baseline(** P<O.OJ ). 
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Repeated or single daily injections with access to alcohol. 
A single injection of saline did not alter alcohol preference in low 
preferring mice, compared either with pre-treatment baseline preference values 
or the handled only controls, when measured three weeks after administration of 
the injection, the time point at which multiple saline injections were shown to 
increase alcohol preference. Repeated saline injections, as in the previous study 
increased alcohol preference when compared both to the handled only mice, 
P<0.05 and the pre-treatment baseline p<0.05. The baseline being the mean of 
the final three measures in week three of the screening. Repeated saline 
injections also increased alcohol preference in mice compared to those that 
received a single saline injection P< 0.05(Figure 3.2). 
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Figure 3.2 The mean alcohol preference in mice before (baseline) and after 
receiving a single saline injection, daily saline injections or handling alone. 
Results are the mean preference ±SEM of the third week of treatment (n=8 per 
group). *P<0.05 daily injections vs. baseline; **P<0.05 daily injections vs. 
handled; ***P<0.05 daily injections vs. single. 
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The administration of daily i.p. injections of saline increased the alcohol 
preference of low preference mice, when access to alcohol was available only at 
the end of the injection schedule (Figure 3.3). The alcohol preference ratio was 
significantly higher in those mice that received the saline injections, both 
compared with the baseline measured prior to the injections (P < 0.0001) and 
compared with the alcohol preference of mice that received only handling during 
the three weeks (P < 0.001 ). Total fluid consumption was unchanged by either 
treatment. 
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Figure 3.3 Subsequent alcohol preference in previously identified low preferring 
mice that received, daily saline injections or were only handled without access to 
alcohol. Results are the mean preference± (n=B per group). *P<O.OOJ saline 
injections vs. baseline; **P<O.OI saline injections vs. handledfinal. 
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Sham illljectedl ami akohoi JPreference 
The sham injections significantly increased the alcohol preference of low 
preference mice (F 5,30 = 5.42, P = 0.0089) compared with the preference of the 
parallel group of mice that were only handled (P < 0.001 for week 2 and 
P<O.Olfor week 3) and compared with the baseline preference (P<O.Ol for two 
weeks and P<0.05 for the third week) of the mice (Figure 3.4). Total fluid 
consumption was unchanged by either treatment. In contrast to previous 
experiments the sham-injected mice showed an increase in alcohol preference in 
the second week of treatment, rather than the third week seen in the saline 
injected. For this reason the measurements form the second week of treatment 
are included in the figure below. 
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Figure 3.4 Weekly alcohol preference ratios in mice that were handled or 
received a daily sham injection. Daily sham injections increased alcohol 
preference, at week two compared to the baseline measures (*P<O.OJ) and 
handled mice (**P<O.OOJ ), this increase was maintained at week three 
compared to baseline($ P<0.05) and handled only mice($$ P< 0.01). 
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Discussion 
The results have demonstrated that daily injections of saline significantly 
increased the alcohol preference ratio of low preference mice. Handling the mice 
without injecting them did not increase alcohol preference. It was not necessary 
for alcohol to be available during the screening procedure for an increase in 
preference to develop nor was it necessary for any fluid to be injected to increase 
preference. Saline injection induced increases in alcohol preference are not 
confined to Durham C57 mice; increases in alcohol preference have been 
reported in rats following six days of injection (Stromberg et al., 1997). The 
tween vehicle injections caused an increase in alcohol preference. An increase in 
alcohol preference was also seen after repeated injections of diazepam at a dose 
previously shown to be anxiolytic (Cole & Rodgers, 1995). 
Other mild stimuli (O'Callaghan et al., 2001) have been shown to 
increase the alcohol preference of low preferring C57s. The movement of these 
mice, by lift, down seven floors (between laboratories at Bristol Medical School) 
increased the alcohol preference of low alcohol preferring mice. This increase in 
alcohol preference was only seen two months after the move. However, not all 
disturbances appear to increase preference. Moving cages of animals between 
rooms did not alter preference even though this procedure may increase 
corticosterone levels (see Chapter Two). Neither exposure to ultrasound nor 
repeated cage cleaning altered the preference distribution. In those cases alcohol 
preference ratios were measured over three weeks after the disturbance (Watson, 
Cole & Holt unpublished data). Alcohol preference in defeated low alcohol 
preferring C57 mice (from a resident intruder situation) was increased, but only 
after repeated defeats (five days). Single defeats or repeated exposure to a novel 
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cage did not alter alcohol preference (Holt, 2001 ). All these manipulations can be 
described, as 'stressful' whether they can be ranked according to the severity of 
stress is debatable. The common thread when a stressor alters preference appears 
to be the repetitive nature of the stress (except in the case of the movement of the 
animals via a lift). The type of stress also appears important. Stressors that 
comprise a physical component such as electric footshock and tail-pinch induce 
an increase in self-administration of drugs of abuse. Other stressors lacking a 
physical component, e.g. decapitation of conspecifics, can also enhance self-
administration. Decapitation of conspecifics also results in increased in CCK8 
receptor binding that is also seen after repeated saline injections (Harro et al., 
1996). 
Penetrating the mice with a needle but without injecting any fluid was 
performed to ensure that the increase in preference was not caused by any 
physiological change in fluid balance. An injection of 1 Oml/Kg is a substantial 
amount of fluid to give to a mouse i.p and may have influenced the fluid balance 
of the animal, although this is the normally used (in our laboratory) volume for 
administering drugs. Prior to the sham injections it was postulated that perhaps 
the stressor might not have been the injection but the temperature of the saline or 
tween. Normally injections are performed with the temperate of the solutions at 
approximately room temperature. Given that a mouse's core temperature is 37-
400C a volume of fluid at 21 °C injected into the body cavity could activate a 
number of vigorous homeostatic processes to maintain the normal core 
temperature. These homeostatic processes could have been responsible for the 
increase in alcohol preference. 
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The studies on the saline injection procedure demonstrated that it was not 
necessary for alcohol to be available during the experience for the increase in 
alcohol preference to be seen. It was also unnecessary for saline to be injected, 
since the sham injection procedure also had the effect of increasing the alcohol 
preference, with a similar time course to that seen in the original demonstration 
of the effect of the saline injections (Little et al., 1999). This suggests that the 
effect is due to the stress of the procedure. 
Perhaps the two most important aspects of these results were firstly that 
the effects of disturbance in increasing alcohol preference were slow in onset, 
and, secondly, that the disturbance that increased the preference was relatively 
mild in comparison with some of the stressors used in other laboratories that alter 
alcohol consumption. These results have important implications for studies on 
this strain. Firstly, injections of saline or drug vehicles are normally considered 
routine procedures without behavioural consequences, so the effects 
demonstrated in the present studies may be an important, previously 
unrecognised, factor. In addition, animals bought from outside sources undergo, 
for example, the stresses of transport before they reach laboratories. It is possible 
that while the animals used in many laboratories show high alcohol preference, 
they may not have begun life with such preference. 
The effects of the minor stress in increasing the alcohol preference of low 
preference C57 mice provides a valuable model for the study of the mechanisms 
involved in increases in alcohol consumption. An important aspect is the nature 
of the change in the alcohol consumption, whether, for example, involves 
alterations in the rewarding, or aversive, effects of alcohol. Further studies on 
this model are in progress to investigate these aspects. 
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An advantage of this model is that the stress applied is not excessive. 
Major stressful experiences, such as restraint or footshock, have a profound 
effect on the metabolism and brain neurochemistry and are therefore likely to 
cause many changes some of which may not be related to alterations involved in 
alcohol consumption. Stress such as restraint can inhibit a large proportion of the 
normal behavioural repertoire, but the present model does not affect the normal 
behaviour, such as eating or drinking of water, and alters only the alcohol 
consumption. 
The saline injections were described as stressful and measurement of 
corticosterone levels, both circulating and brain, were elevated in injected 
compared with handled mice (see Chapter Five). Although the increased alcohol 
preference by vehicle injections was consistently demonstrated, and an increase 
in corticosterone levels was shown after single saline injections there is no 
evidence that the two factors are linked. 
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Chapter Four 
The action of steroid antagonists~ A CTH? CRF and 
metyrapoll1le on alcohol preference in C57 miceo 
Introduction 
The experiments in previous chapter show a link between stress between 
and alcohol consumption, however, in Chapter Two no relationship between total 
corticosterone levels and alcohol preference was found. This finding does not 
necessarily refute the wealth of experimental evidence that reports a link between 
corticosterone and alcohol consumption (e.g. Fahkle & Eriksson, 2000). 
Activation of the HPA axis (the stress response) is described in detail in Chapter 
One. Briefly, following stress, CRF is released; this stimulates the release of 
ACTH that in turn stimulates the synthesis and release of corticosterone. Release 
of corticosterone, CRF and ACTH is controlled by negative feedback (see Figure 
1.2). Following the results from chapter one it is proposed that the control of 
alcohol consumption by stress may be a result of the negative feedback control 
on levels of CRF and ACTH rather than a direct effect of corticosterone itself. In 
this chapter the influence of the various major components of the stress response 
(ACTH, CRF and corticosterone) on alcohol consumption were examined. 
It has previously been shown that both surgical adrenalectomy and 
inhibition of corticosterone synthesis by administration of the corticosterone 
synthesis inhibitor metyrapone reduces alcohol consumption in rats (Fahkle et 
al., 1995; 1994b ). The levels of total circulating corticosterone were not 
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correlated to alcohol preference in C57 mice (Chapter Two). Metyrapone was 
administered to high alcohol preferring C57 mice to examine whether a reduction 
in circulating levels of corticosterone could reduce alcohol consumption. 
Corticosterone and corticosterone receptors. 
Most of the effects of corticosterone are believed to be mediated via its 
intracellular receptors. These receptors are typical steroid hormone receptors. 
This family includes the receptors for all the steroid hormones (other examples 
include oestrogen, androgen and progesterone receptors). Corticosterone binding 
to the receptors produces translocation of the activated hormone-receptor 
complex to the nucleus where it interacts with specific DNA sequences to 
produce its effects on metabolism and homeostasis. 
There are two types of corticosteroid receptor (Reul & de Kloet, 1985): 
the mineralocorticoid (MR, type I corticosteroid) receptor and the glucocorticoid 
receptor. The glucocorticoid receptor (GR, type II corticosteroid receptor) is a 
polypeptide chain of about 780 amino acids (Hollenberg et al., 1985). 
Unoccupied GR is present in the cell cytoplasm as part of a heterocomplex 
comprised of three different heat shock proteins. These proteins play a key role 
in the receptors' ability to be activated by the ligand. The GR has a lower affinity 
for corticosterone than MR, with a Kd of 5-l OnM, but it shows a high affinity for 
the synthetic steroid dexamethasone (Kd - 1 nM) (Reul and de Kloet, 1985). The 
MR, stmcturally similar to the renal mineralocorticoid receptor, has a tenfold 
higher affinity with Kd's for corticosterone and aldosterone of between 0.5 and 1 
nM (Reul and de Kloet, 1985). 
Ligand-activated corticoid receptors attach to specific DNA 
sequences, classically as homodimers, however GR and MR can form 
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heterodimers (Rupprecht et al., 1993). These may be more potent than 
homodimers of MR or GR for DNA binding and gene transcription. The 
proportion of homo to heterodimers produced depends on tissue region and the 
availability of ligand. Some researchers have proposed that there is an additional 
membrane-bound low affinity corticosterone receptor although most of the 
evidence has been produced by work on newts (Orchinik et al., 1988; Orchinik 
& Murray, 1994; Orchinik & McEwan, 1994; Orchinik, 1999). Sze (1996) has 
described a low affinity (Kd 1 OOnM) binding site in rat brain synaptic 
membranes. 
ACTH and pro-opiomelanocortin related peptides 
ACTH is a 39-aminoacid straight chain peptide derived from pro-
opiomelanocortin (POMC). This is the precursor for ACTH, and a,~ and y 
melacortin secreting hormone (MSH), as well as ~-endorphin. At times of stress, 
CRF stimulates the release of ACTH from the hypothalamus, POMC is cut by a 
series of post-translational proteolytic cleavages and ACTH (as well as ~­
endorphin) is released. ACTH stimulates corticoid production and secretion in 
the adrenal glands and lipolysis in adipocytes. 
Hypothalamic neurons contain most of the brain POMC related peptides. 
However, ACTH is also found in the amygdala, cerebral cortex, brain stem, and 
cerebellum - even after ablation of the hypothalamus. This suggests that ACTH 
is synthesised in other brain regions in addition to the hypothalamus (Civelli et 
al., 1982; Romangnano & Joseph, 1983; Schwartzberg & Nakane, 1983; Pilcher 
and Joseph, 1984; de Souza et al., 1985). A number of functionally active ACTH 
fragments have been identified e.g. ACTH4. 10, ACTH1. 13 , and ACTH18. 39 , also 
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known as CLIP (or corticotrophin-like intermediate lobe peptide) and ACTH 1_13 • 
Fragments of ACTH have been shown to have differing activities for steroid 
biogenesis; ACTH 1_24 and ACTH5_24 are full agonists, whereas (ACTH 7_23) is a 
partial agonist and ACTH 7_25 is an antagonist (Lin et al., 1991). ACTH5_9 is 
required for full receptor activation; ACTH 1_4 and ACTH10_20 have greater 
peptide receptor affinity (Lin et al., 1991 ). 
Only a small proportion of systemically administered ACTH is reported 
to enter the brain, about 1-2%. Estimates of systemically injected ACTH4_10 
report about 0.01% of the amount injected penetrates the brain (Potaman et al., 
1991). However, 0.04mg/kg ACTH4_10 has demonstrated anticonvulsant activity 
in pilocarpine induced seizures when injected i.p. (DeWied & Wolterink, 1988). 
ACTH 4_10 is also devoid of any adrenal activating properties (DeWied & 
Wolterink, 1988) i.e. this fragment does not stimulate either the synthesis of, or 
the release of corticosterone. 
ACTH and ACTH fragments interact with multiple receptor subtypes. 
ACTH shows activity at the melanocortin receptors (MC-R) MC1-R (involved in 
pigmentation), MC2-R (adrenal function), MC3-R (cardiovascular regulation), 
MC4-R (energy homeostasis) and MC5-R (exocrine secretion). Overlapping 
sequences in the POMC molecule for ACTH and the various types of MSH as 
well as the activity of other ACTH fragments produce an array of actions that 
make a definitive functional assessment difficult (Pranzatelli, 1994). 
A CTH and alcohol consumption 
Alterations, either endogenous or pharmacologically prompted, in 
corticosterone levels will result in reactive alterations in other areas of the HP A. 
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The relationship between alcohol consumption (and drug self-administration) and 
ACTH has not been investigated fully. Rats will self-administer ACTH 
intravenously (Johaneau-Bowers & Le Magen, 1979), and it has also been shown 
that acute injections of ACTH (lOmg/kg) increase the rates of lever pressing 
during extinction of food-reinforced behaviour (De Weid & Jolles, 1982). 
Administration of ACTH4_10 in high consuming rats has been reported to reduce 
alcohol consumption (Krishnan et al., 1991 ). 
Corticotrophin releasing factor (CRF) 
CRF, a neuropeptide secreted by hypothalamic and extra-hypothalamic 
neurons, is thought to mediate stress-related behaviours. Hypothalamic CRF 
facilitates the release of ACTH from the anterior pituitary, and ACTH in turn 
elicits the release of glucocorticoids from the adrenal cortex. CRF binding sites 
are extensively distributed throughout the brain (De Souza, 1995). CRF binds 
two subtypes of CRF receptor (CRFR), CRFR1 and CRFR2. The latter exists as 
two splice variants, the neuronal CRFR2 alpha and the peripheral CRFR2 beta. 
CRFR is a G protein-dependent receptor which acts mainly through G(s) 
enhancing cAMP production (Eckart et al., 1999). Besides the two receptors, a 
37 kD CRF binding protein (CRF-BP) binds several CRF peptides with high 
affinity (Eckart et al., 1999). CRFR and CRF-BP do not share a common amino 
acid sequence representing the ligand binding site CRFR1 is not only involved in 
the hypophyseal stimulation of ACTH release, but hippocampal CRFR l mediates 
enhancement of stress-induced learning. CRFR1 may also be involved in basic 
anxiety. In contrast, at least in the mouse, CRFR2 of the lateral intermediate 
septum mediates tonic impairment of learning (De Souza, 1995). In response to 
stressful stimuli or after local injection of high CRF doses, CRFR2 mediates 
anxiety (De Souza, 1995). Several studies have identified a relationship between 
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CRF and factors associated with alcohol intake. One in vitro study showed that 
alcohol administration had a direct stimulatory effect on CRF release from rat 
hypothalamic organ culture system (Redei et al., 1988). In rats increased levels 
of CRF mRNA have been shown using in situ hybridisation following 
intravenous or i.p. injections of alcohol (Rivier et al., 1990; Rivier & Lee, 1996). 
It has been reported by Bell and eo-workers ( 1988) that intra cerebroventricular 
(i.c.v.) injections of CRF reduced alcohol intake in a limited-access (lh/day) 
model of voluntary alcohol drinking. 
CRF has anxiogenic actions and CRF antagonists have been reported to 
show anxiolytic properties. Anxiogenic-like responses on the elevated plus maze 
(reductions in % time spent on the open arms of the maze and reductions in the 
%open arm entries) are seen in rats during alcohol withdrawal. The CRF 
antagonist a-helical CRF 9 -41 when given i.c.v. has been shown to reverse this 
anxiogenic-like response (Baldwin et al., 1991) 
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Aims 
This study examined the effects of inhibition of corticosterone synthesis 
in high preferring C57 strain mice. The work aimed to examine the effects of 
selective corticosterone type I and II receptor antagonists in order to classify the 
interaction between corticosterone and alcohol consumption with respect to a 
particular receptor subtype. Administration of a corticosteroid receptor 
antagonist would be expected to reduce alcohol preference if corticosterone 
receptors were involved in the mechanism governing stress induced alcohol 
consumption. Reducing the levels of corticosterone will reduce the negative 
feedback on both CRF and ACTH secretion, resulting in increasing levels of both 
these peptides. These increased levels of peptides may be responsible for 
alterations in alcohol consumption induced by stress and so the effects of the 
CRF antagonist a-helical CRF 9.4 1 and the ACTH fragment, ACTH 4. 10, on 
alcohol intake in low and high preferring mice were investigated. 
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Methods 
Drugs used 
Metyrapone reduces cortisol and corticosterone production by inhibiting 
the 11-~-hydroxylation reaction in the adrenal cortex. The apparent half-life of 
elimination averages l to 2 112 hours. Within 2 days after initiation of treatment, 
about 40% of the administered dose is excreted in the urine, mostly in the form 
of glucuronides (IUPharrn, 2001 )A 50mg/kg dose of metyrapone was chosen for 
this study as this dose had previously been reported to reduce alcohol 
consumption in high preferring rats. 
Spironolactone and RU38486. A number of specific antagonists exist for 
both mineralocorticoid receptors (e.g. spironolactone) and for glucocorticoid 
receptors (e.g. RU38486). The i.c.v. infusion of selective antagonists allows 
definition of receptor specific corticosterone receptor mediated events in intact 
rats (De Kloet, 1991 ). The central administration of these drugs was chosen in 
preference to systemic administration so that any actions that might have been 
recorded could be attributed to direct central effects without the complications of 
any peripheral actions. 
a-Helical CRF is CRF receptor antagonist that binds both receptor CRF 
subtypes (Eckart et al., 1999). This drug has previously been shown to reduce 
alcohol preference and fluid consumption in rats when administered (i.c.v. 5J.Lg) 
to rats (Bell et al., 1998). 
ACTH 4.10. ACTH 4-Io is a fragment of ACTH that has been shown to 
reduce alcohol consumption in rats at a dose of IOmg/kg (Krishnan et al., 1991 ). 
93 
This study used the same dose for this reason. The fragment particular fragment 
was also chosen as it lacks steroid synthesising and releasing effects (DeWied & 
Wolterink, 1988) and so interpretation of any results would not be complicated 
by ACTH stimulated corticosterone release. 
Akolnon preference measurements 
All tests of preference were made on male C57 (25-30g) mice. The mice 
were screened for alcohol preference (as previously described). High preferring 
mice (those with an 8% alcohol to total fluid ratio of greater than 0.7) and low 
preferring mice (those with an 8% alcohol to total fluid ratio of less than 0.3) 
were selected for subsequent experiments. 
Metympone injections 
Metyrapone was given, by the intraperitoneal (i.p.) route (50mg/kg in the 
first instance) to male high preferring C57 mice (25-30g n=6 per group), each 
evening at 5 p.m., with controls receiving vehicle 0.05% tween (see Chapter 
Three). The amounts of 8% alcohol and of water consumed were measured at 10 
p.m. the next day. This experiment was then repeated, with the drug dose 
increased to twice daily injections (9 a.m. and 5p.m) of metyrapone (lOOmg/kg) 
(n=6 per group). Alcohol preference was measured at 4 p.m. for seven days. The 
increased dose (I OOmg/kg) was used to reduce the possibility that the lack of 
effect of the lower dose was due to faster metabolism in mice. 
I.C.V. injection procedure 
Dmgs were administered to the unanaesthetised mice by the i.c.v. route using a 
custom made holder for the head through which a needle could be guided to 
pierce the skull. The mouse's snout was fitted into a rectangular holder with 
adjustable flanges and a collar that fitted round the neck, thus holding the neck 
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secure. A block was mounted on the holder, with a guide hole, to position the 
injection needle into the third ventricle; the distance from the collar to the guide 
hole was 6 mm. The needle was a steel cannula (27 gauge) through which 
microlitre volumes of drug could be injected. The mouse was held firmly by the 
neck collar while the drug was injected (2Jll volume) into the third ventricle. The 
process took no more than thirty seconds. Immediately after release most of the 
mice appeared dazed for a short time (5-20 seconds). If any mice did not return 
to apparently normal behaviour after more than thirty seconds they were 
excluded from the experiment (n= 1 ). 
Corticosterone antagonists 
To male C57 mice (25-30g) either 0.05% tween vehicle, 150ng of 
RU38486 or 150 ng spironolactone was given by the intracerebroventricular 
(i.c.v.) route (2Jll volume), using a stereotaxic apparatus that enables injection in 
conscious mice (n=8 per group). The injection was given at the start of the dark 
phase (8 p.m.). The doses of antagonists were chosen because they have both 
been shown to be effective doses in reducing anxiety-like behaviours on the 
elevated plus maze (RU 38486) and in the black box I white box test 
(spironolactone) (De Kloet, 1991). Fluid consumption was then measured six 
hours later and the alcohol preference ratio calculated as described in Chapter 
Two. The measurements were taken six hours later as measured central effects 
of both RU38486 and spironolactone appear to fast acting and transient (Be 
Kloet, 1991). 
A CTH 4.10 injections 
Previously screened male low and high alcohol preferring mice (25-30g) 
received i.p injections of ACTH4. 10 (1 0 mg/kg) or saline vehicle (n=6 per group). 
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In addition two groups of previously screened low preferring mice (25-30g) 
received i.p injections of either lOmg/kg ACTH4_10, 5mg/kg ACTH4_10 or saline 
vehicle(n=8 per treatment). The mice were injected at 5p.m. and the preference 
was measured at 10 a.m. the next day. The low preferring groups also had their 
preference measured at 12, 24 and 36 hours after receiving injections. Preference 
was monitored for the following two days. 
C.RF antagonist 
Previously screened low alcohol preferring mice (25-30g) received an 
i.c.v. injection of either a-helical CRF 9_41 (Tocris Cookson Ltd, Bristol, U.K.) 
5Jlg in 2Jll, or saline vehicle (n=8 per group) at 4 p.m. Fluid consumption was 
measured at 16, 36 and 60 hours after the injection. 
Statistical analysis 
In the results data is expressed as mean ± SEM. A priori assumptions 
enabled comparison between treated and untreated groups in the corticosterone 
antagonist experiments to be performed using Students' t-test. The other 
experiments were analysed by two way analysis of variance followed by 
Dunnett' s post hoc-test were appropriate. 
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Results 
RU38486 and Spironolactone Drugs 
Fluid consumption and mouse weight, in the high alcohol-preferring mice 
used, were not affected by the injection procedure. The effects of the 
administration of RU38486 are shown in figures 4.1 a and 4.1 b. Following the 
administration of RU38486 (150ng) there was no significant alteration in alcohol 
preference or total fluid consumption. Spironolactone administration also had no 
effect on alcohol preference (Figure 4.2a) or total fluid consumption (Figure 
4.2b) when compared with vehicle administration alone. 
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Figure 4.1. Figure 4. I a shows the mean preference ratio ± sem of male C57 
mice and Figure 4. I b shows the total fluid consumption of the same mice ( n=8 
per group) following i.e. v. injection of I 50ng RU38486 or tween vehicle. 
Administration of the drug did not alter alcohol preference or total fluid 
consumption when measured six hours after the injection. 
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Figure 4.2. Figure 4.2a shows the mean preference ratio± sem of male C57 
mice and Figure 4.2b shows the total fluid consumption of the same mice (n=8 
per group) following i.e. v. injection of 150ng spironolactone or tween vehicle. 
Administration of the drug did not alter alcohol preference or total fluid 
consumption when measured six hours after the injection. 
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Metyrapone injections 
Administration of metyrapone in a daily single injection of 50mg/kg did not alter 
the alcohol preference compared to tween control (Figure 4.3). However when 
this drug was given twice daily at a dose of lOOmg/kg it significantly reduced 
alcohol preference when measured during the treatment (P<O.OO 1, for day 6, day 
5, day 4 and day 3 of the treatment schedule compared with the corresponding 
vehicle injections Figure 4.4). At this dose no effect of the drug was observed on 
total fluid consumption (Figure 4.5). The body weights of the animals that 
received metyrapone injections were also unaltered (26 ± 1 g both before and at 
the end of the treatment). 
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Figure 4.3 Figure 4.3a shows the mean alcohol preference ratio +1- SEM of 
male high alcohol preferring C57 mice after an i.p injection of 50mg/kg of 
Metyrapone. This dose did not significantly alter alcohol preference. Figure 4.3b 
shows that total fluid consumption in the same mice was also unaltered by 
administration of metyrapone 
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Figure 4.4 The alcohol preference of C57 mice when either injected twice daily 
with metyrapone (JOOmglkg) Or tween vehicle. Metyrapone injections 
significantly reduced alcohol preference measured on days 3, 4, 5 and 6 
compared with the both vehicle treated group and the pre-injection baseline 
measures. (****P<O.OOJ day 6 vs. vehicle; ***P<O.OOJ day 5 vs. vehicle; 
**P<O.OOJ day 4 vs. vehicle; *P<O.OOJ day 3 vs. vehicle), 
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Figure 4.5 The total fluid intake in high alcohol preferring C57 mice treated 
with either I OOmg/kg metyrapone or vehicle injection. Injection schedule did not 
alter total fluid intake compared between treatments or to baseline values. 
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ACTH 4.1o injections 
Administration of the ACTH fragment ACTH 4. 10 ( IOmg/kg) in high 
preferring mice decreased (P<0.001 vs. control and P<0.001 vs. baseline) alcohol 
preference, measured 12 hours after the injection was given (Figure 4.6). This 
effect was transient and after twenty four hours preference had returned to pre-
treatment levels. The ACTH fragment did not alter fluid consumption. 
However in low preferring animals injections of 5mg/kg and 1 Omg/kg 
ACTH4. 10 increased alcohol preference. Figure 4.7 shows 24 hours after the 
injection the larger dose of ACTH4. 10 increased alcohol preference (F=5.6 
P<O.Ol) compared with baseline (P<O.Ol) and vehicle injected (P<0.05) animals. 
However, alcohol preference in the vehicle injected mice was increased 48 hours 
after the injection (P<O.Ol). 
Injections of 5mg/kg ACTH4. 10 increased alcohol preference 36 hours 
after the injection (F=3.6 P<0.05) compared with both baseline values and the 
saline vehicle injected group (P<0.05). This increase was not seen at the earlier 
measurement time point, 12 hours. This data can be seen in Figure 4.8. 
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Figure 4.6 Alcohol preference of mice (n=6 per group) that either received a 
single injection of ACTH ( JOmglkg) or saline vehicle, preference was measured 
12 hours and 36 hours after the injection (*p<O.OOJ) ACTH4.10 injected 
compared with both baseline and vehicle control). 
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Figure 4.7 Administration of 10 mg/kg ACTH 4_10 increased alcohol preference 
in low preferring mice, 24 hours after injection, compared with both baseline 
(*P<O.OJ) and vehicle injected controls (**P<0.05). 48 hours after the 
injection alcohol preference was increased in the vehicle injected group 
compared with both baseline(*** P<0.05) and ACTH injected mice. 
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Figure 4.8 Administration of 5mglkg ACTH 4_10 increased alcohol preference in 
low preferring mice, 36 hours after injection, compared with both baseline and 
vehicle injected controls (**P<0.05). 
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Figure 4.9 Alcohol preference in low preferring C57 mice after a single 
injection of a-helical CRF 941 . Administration of the CRF antagonist 
significantly increased alcohol preference compare to baseline and vehicle 
injected mice ( P<O.OJ ). Alcohol preference in vehicle injected mice 
increased 60 hours after the single injection **(P<O.OJ ). 
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Discussion 
Metyrapone injections 
Fahkle et al., ( 1994a,b) have shown decreases in voluntary alcohol 
consumption in rats following adrenalectomy. This reduction was reversed by 
administration of 200mg of corticosterone, as a subcutaneous pellet, over 60 
days . Fahkle and colleagues also demonstrated a reduction in alcohol 
consumption in rats when the formation of corticosterone is blocked using 
metyrapone. They report a reduction in intake after a single injection of 50mg/kg 
of metyrapone in the rat. In the present study a 50mg/kg injection had little effect 
on alcohol preference, but a twice daily injection of the larger dose (lOOmg/kg) 
was effective in reducing alcohol consumption. Another difference from the 
findings of the present study was that no change in total fluid consumption was 
seen; in the Fahkle study there was a small significant reduction in total fluid 
consumption. The reduction in alcohol intake caused by metyrapone is not likely 
to be due to accumulation of corticosterone precursors , as decreases in alcohol 
consumption in rats are precipitated by surgical adrenalectomy that reduces 
corticosterone levels, but without the accumulation of corticosterone precursors. 
A mechanism explaining the influence of corticosterone on alcohol consumption 
is not easy to find, and is complicated more by the results of the antagonist 
results. 
Receptor antagonist administration 
The animals did not appear to have an aversive reaction to the 
metyrapone, although no quantifiable measures were taken to assess the 
' malaise' reported to be a side effect of the drug (Fahkle et al., 1994b). The lack 
of effect of both RU38486 and spironolactone on alcohol preference, given the 
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effect of suppression of corticosterone synthesis on alcohol consumption, is on 
first inspection surprising. However, previous reports have failed to demonstrate 
an effect of both centrally (Fahkle et al., 1999) and systemically (Fahkle et al., 
1995) administered corticosterone antagonists on alcohol consumption. 
To conclude that corticosterone type I and type II receptors are definitely 
not involved in corticosterone's modulation of alcohol intake may not be 
possible just on the evidence of this study or the previous studies on rats. It may 
be the case that the doses of the antagonists were not effective as they may have 
been too low. The doses of the drugs used had an anxiolytic effect when given 
i.c.v. in rats (De Kloet, 1991). They were also the maximum doses possible to be 
given using the apparatus for conscious i.c.v. administration. Both drugs are 
insoluble in water or other polar solvents and dissolving them in organic solvents 
might cause vehicle effects, so the method of suspending the drugs in dilute 
tween was used. Previous work (Watson, 1992) established that 0.05% tween has 
no adverse effects on mice when administered i.c.v. in a volume not exceeding 
5f.ll. Higher doses of antagonist suspensions are beyond the limit of the current 
apparatus. It cannot be discounted that the drugs when administered I.C.V. as in 
this study, or systemically as in the rat studies, may in fact not be reaching their 
targets in sufficient concentration to be effective. Unpublished data from this lab 
(Seth, 1999) has shown that sub-cutaneously administered corticosterone failed 
to increase alcohol preference in C57 mice, and i.p injections of corticosterone 
have been ineffective in raising alcohol preference in low alcohol consuming rats 
(Fahkle et al., 1994a). Administration of corticosterone by subcutaneous pellets 
and by direct implantation in the brain (only when implanted into the ventral 
striatum, but not the hippocampus, septum, or thalamus) has both been effective 
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in increasing alcohol consumption (Fahkle & Eriksson, 2000). It may be possible 
that with direct implants into selected brain areas some effect of the antagonists 
may be seen. 
Although the link between alcohol consumption and corticosterone is 
becoming well established, it does not necessarily hold that corticosterone type I 
or type 11 receptors are involved in the maintenance of self-administration or 
preference. In addition to the results obtained from the present study, Fahkle et 
al., (1994a; 1995) have shown that type I and type 11 agonists are equally 
ineffective in modulating alcohol intake when administered both systemically 
and centrally. The mechanism of corticosterone influence on preference could be 
mediated by another as yet unidentified corticosterone receptor; perhaps even the 
elusive membrane bound receptor that has been suggested by some researchers 
(Sze and Towle 1993, Chen et al., 1993; Orchinik, 1999). There is, however, no 
evidence that this 'receptor' does not bind RU38486. The evidence for this 
receptor is mainly based on the observations that corticosterone has rapid actions 
that, because of the speed are not genomic. RU38486 has been shown to inhibit 
the potentiation of excitatory amino acid responses in the VT A neurons (Cho & 
Little, 1999), this would suggest that rapid non-genomic actions if not mediated 
by the classical GR are mediated by another receptor that at which RU38486 acts 
as an antagonist. This would suggest that an alternative receptor for 
corticosterone is not candidate for the influence of corticosterone on alcohol 
consumption. 
A CTH4.10 and CRF injections 
A single dose of ACTH4_10 transiently reduced the alcohol preference of 
high preferring C57 mice. A similar effect has been demonstrated in rats 
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(Krishnan et al., 1991). However in low preferring mice both doses increased 
alcohol preference. This increase in preference fits with the observation that 
injections of ACTH (lOmg/kg) increase the rates of lever pressing during 
extinction of food-reinforced behaviour (De Weid & Jolles, 1982) i.e. that ACTH 
promotes reward related behaviour. 
There are a number of plausible pathways for explanation of the 
reduction of alcohol consumption seen in high alcohol preferring mice. An 
interesting observation is that a reduction or ablation of corticosterone levels 
enhances ACTH release (Dallman et al., 1992). This is a consequence of reduced 
corticosterone feedback on the hypothalamus and this lack of inhibitory feedback 
increases CRF and ACTH release. It remains an interesting possibility that the 
presence or absence of corticosterone may influence alcohol consumption not by 
a direct central mechanism, but indirectly through decreased negative feedback 
on hypothalamic and pituitary peptides. 
However, the injections in low preferring mice increased alcohol 
preference. The effects of ACTH on alcohol consumption would appear to be 
dependent upon the behavioural (i.e. whether the animal is low or high alcohol 
preferring) state of animal. The mechanism of action of ACTH induced increases 
in alcohol consumption is not clear but the relationship between POMC and 
endogenous opioids would seem to be a likely candidate. Various lines of 
correlative and experimental evidence indicate that endogenous opioids play an 
important role in the reinforcing properties of alcohol. Alcohol preference in 
C57BL/6 mice correlates with hypothalamic ~-endorphin levels alcohol is also 
reported to increase plasma ~-endorphin levels (Gianoulakis et al., 1996), A 
correlation between increased ~-endorphin and the risk of alcoholism in humans 
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has been proposed (Gianoulakis et al., 1996). POMC in addition to being the 
precursor of ACTH is also the precursor of ~-endorphin. Administration of 
ACTH may interact with the endogenous opiate system thereby altering alcohol 
consumption. 
Administration of the CRF antagonist increased alcohol preference in low 
preferring mice. These results appear to support previously reported observations 
that CRF decreases alcohol preference (Bell et al., 1998). This appears to 
confirm the influence of CRF on alcohol intake. Recent experiments in the 
1 aboratory (Croft, 200 I) have shown that a-helical CRF antagonist had no effect 
on alcohol preference, or total fluid consumption in the high preferring mice. 
Inhibition of corticosterone synthesis increases the levels of ACTH and 
CRF, because of reduced negative feedback. It is possible that high levels of both 
or either peptide in the absence of high levels of corticosterone have an 
inhibitory effect on alcohol consumption. This idea fits with the reduction in 
alcohol intake seen in the high preferring mice after ACTH administration and 
the increase seen in low preferring mice seen after CRF antagonist 
administration. 
Vehicle induced increases in preference 
Increases in alcohol preference were observed after administration of the 
i.c.v. saline, this increase may have been due to the stress of the injection 
procedure. It developed over time and so was not seen in the initial i.c.v. 
injection experiments performed using the corticosteroid receptor antagonists 
because measurement in those experiments did not continue after six hours. The 
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CRF antagonist may have blocked the development of this increase, possibly by 
an anxiol ytic action (Bald win et al., 1991). 
An i.p injection of saline increased preference 48 hours after the 
injection. In Chapter Three the effects of single saline injections on alcohol 
preference were reported. It was found that single saline injections did not 
increase alcohol preference, however, this was measured only three weeks after 
the injection, not two days as in the present case. Increases in preference were 
not seen after a single saline injection in the experiments on the effect of CCKB 
antagonists on alcohol intake in low preferring mice (Little et al., 1999). In these 
experiments preference was measured daily. A single injection of saline could 
increase alcohol intake, but this may have been an isolated case as in the other 
two studies it has not been seen. 
Future work 
The experiments using the corticosterone antagonist described in this 
thesis used a single (large dose) on high preferring mice. Repeated injections of 
both antagonists in low preferring mice could be undertaken to examine whether 
they would block the increase in alcohol preference seen after vehicle injections. 
More work using more doses and different ACTH fragments needs to be 
performed, in both high and low preferring mice to gain a better understanding of 
the influence of ACTH on alcohol consumption. An investigation into the factors 
that govern the availability of the different fragments could also provide valuable 
information about factors governing stress and alcohol dependence. Similarly a 
more complete examination of the effects of CRF and its antagonists, using more 
doses, in both high and low preferring mice needs to be performed. 
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Chapter Five 
Blood and brain corticosterone levels 
Introduction 
Background 
In Chapter Three increased alcohol preference after multiple saline 
injections was described. The injection procedure was assumed to activate the 
HP A, thereby increasing the circulating levels of corticosterone and decreasing 
levels of CRF and ACTH. In this chapter a series of measurements of 
corticosterone levels in response to saline injections, handling and baseline levels 
in stock mice were measured. As described in Chapter Two, circulating 
corticosterone is either bound to CBG or 'free'. Measurements of levels of both 
free and bound corticosterone were undertaken in order to define fully the 
corticosterone response to these manipulations. 
The consensus has generally been that only non-protein bound (free) 
steroids are available for movement out of capillaries and into cells. There they 
either cause a biological response or are cleared from the circulation via a variety 
of metabolic pathways. It is reasonable to think that CBG acts as a buffer to 
provide a reservoir of corticosterone that is immediately available during times 
of stress, or at other times when activation of the HPA necessitates large 
increases in corticosterone. In stress CBG levels can rapidly decrease and so 
increase the amount of free or available corticosterone in the circulation (Brien, 
1991). 
However, it is also possible that the reduction in CBG is a mechanism of 
excretion of increased levels of cmticosterone, as free corticosterone can be 
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excreted whereas bound corticosterone is not excreted. The question of what 
exactly a measure of free corticosterone is should be remembered. In addition to 
measurements of blood corticosterone levels, the brain levels of the hormone in 
selected areas (the cerebral cortex, hippocampus, and striatum) were also 
measured. 
Despite the increasing interest in the central effects of corticosterone, 
only circulating levels of total corticosterone in the blood tend to be routinely 
measured. Other markers of HPA axis activity are also measured including 
ACTH, adrenaline, noradrenaline, CRF and CBG levels, but it is very 
infrequently that free and bound levels of corticosterone are measured. The 
circadian changes in corticosterone blood levels spanning the 24 hr photoperiod, 
and changes seen during and after stress (of almost every kind) have been 
reported extensively (Bulwalda et al., 1999; De Kloet et al., 1996). The effects of 
different behavioural and pharmacological manipulations on central 
corticosterone receptors have also been reported in numerous studies. The central 
effects of corticosterone are of interest to many researchers investigating a 
spectrum of physiological, pharmacological and endocrinological areas, yet none 
measure brain levels of corticosterone. Changes in Kd, Bmax, expression of 
mRNA of corticosterone receptors, and of metabolising enzymes are all of value 
in assessing adaptations of neurotransmitter and hormonal systems, but of equal 
importance, but ignored, are the levels of ligand in these systems. Investigators 
into stress, and the HP A axis responses to stress will measure other parameters 
of HPA activation e.g. ACTH levels and CBG levels. Measurement of brain 
corticosterone levels is not performed and seems to be ignored. Literature reports 
of central corticosterone levels appear to be confined to one paper in the mid 
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seventies that examined brain corticosterone levels in neonatal and perinatal rats 
(McEwen et al., 1974). The previous reports on brain corticosterone levels were 
performed without the advantage of the now commercially available RIA kits. 
However, these corticosterone RIA kits are normally used for the assessment of 
corticosterone levels in blood, saliva, or urine. It was, therefore necessary to 
develop a novel procedure to measure brain corticosterone levels. 
Saline injections and corticosterone levels 
The increase in alcohol preference caused by repeated saline injections 
develops slowly, as shown in the previous experiments; the increase is normally 
apparent after three weeks. In this study the effect of multiple saline and single 
injections on corticosterone levels was investigated. The effect of multiple 
injections was examined using previously identified low alcohol preferring C57 
mice. Alcohol when given i.p (Ellis, 1966) or as liquid diet (Tabakoff et al 1978) 
has profound effects on the HPA axis, increasing co1ticosterone levels. In 
Chapter Three it was demonstrated that the injection-induced increase in alcohol 
consumption was not dependent on the availability of alcohol during the 
injection schedule. Therefore corticosterone levels could be measured after 
giving the injection procedure alone, thus avoiding the complication of changes 
in corticosterone levels caused by increased alcohol consumption. The effect of a 
single saline injection on blood and brain corticosterone levels was also 
examined; this was performed in na·ive mice. Although the existence of two 
distinct sub-populations of alcohol preferring animals was demonstrated, there 
was no evidence for a biphasic distribution of total corticosterone levels (Chapter 
Two). 
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Corticosterone levels in the hippocampus were measured because it is an 
important target for the action of adrenal steroids. It expresses a high number of 
both glucocorticoid and mineralocorticoid receptors (DeKloet et al., 1996). 
Adrenal steroids modulate the excitability of hippocampal neurons and influence 
the magnitude of long-term potentiation (e.g. DeKioet et al., 1997). They also 
participate (along with excitatory amino acids) in regulating neurogenesis of 
dentate gyrus granule neurons and stress induced atrophy of the dendrites in CA3 
(McEwen et al., 1993, 1995, 1998). The striatum (including the caudate, putamen 
and the nucleus accumbens in this study) was chosen because it has been shown 
both in vivo (Rouge-Pant et al., 1998) and in vitro (Rouge-Pant et al., 1999) that 
administration of corticosterone to this area increases dopamine release. This is 
reported to be the mechanism by which corticosterone influences reward related 
behaviour. Little work is performed on the effects of corticosterone in the cortex. 
This region was chosen to contrast with the hippocampus and striatum. 
Glucocorticoid receptors are also found in the cortex and so this region was also 
chosen for investigation. 
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Methods 
Effects of single saline injections on blood and brain corticosterone levels 
Group housed male C57 mice (25-30g) were from stock cages and either 
injected with saline (i.p 0.1ml/10g) (n=6), or handled but not injected (n=6). The 
procedure was performed at the midpoint of the light cycle (12-1 p.m.).The mice 
that were handled were removed from their home cage and held as if to receive 
an injection, but not injected, then placed back into the home cage. Ten minutes 
after the intervention the mice were removed from its home cage and taken to the 
a work bench outside the room and killed by cervical dislocation before blood 
and brain samples were taken (cortex, hippocampus & striatum) for 
corticosterone RIA. The mice were taken out of the room to be killed to avoid 
elevating the corticosterone levels of the other mice, vocalisation by the mouse 
being killed or the scent of blood may have induced rises in the corticosterone 
levels of the remaining mice. Fresh disposable gloves were used on each 
occasion. 
In response to stress there is a rapid elevation of corticosterone 
measurable after 1-2 minutes; this increase subsides after about one hour 
(Tannenbaum et al., 1997). Ten minutes was, therefore, chosen as the time point 
for sampling as the time when peak or near to peak corticosterone levels might 
be measured in response to the injection stress. 
An additional group of mice (n=6) was used, these mice were taken 
individually from the stock cages for immediate sampling. These samples were 
assayed after the ethanol extraction procedure detailed below. 
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Effects of repeated saline injections on blood and brain corticosterone levels 
in low preferring mice 
Mice were identified as low alcohol preferring using the three week preference 
screening procedure (as described in Chapter Two). These mice (n=6 per group) 
were either only handled, or injected with saline, once daily (at 2-3 p.m.) for 
three weeks (21 days). On day 22 the mice were killed at the time when they 
would have been due to receive their injection or, for the other group, to be 
handled. These brain samples were assayed using the protocol detailed below. 
Corticosterone assays 
Total blood corticosterone levels 
The RIA assay for blood corticosterone levels was performed as 
described in chapter two using the antibodies supplied by ICN. 
Free corticosterone assay 
The method used for measuring free corticosterone levels had been 
previously described (Meaney et al., 1992). In this method a known 
concentration of labelled corticosterone is incubated with a plasma sample. The 
labelled corticosterone will compete with endogenous bound corticosterone for 
CBG, so measuring the amount of added tracer bound will give the proportion of 
endogenous tracer that is bound; if the total levels are measured the free 
corticosterone levels can then be calculated. 
20 111 of 3H corticosterone tracer (stock 3H cortciosterone with a specific 
activity of 79 Ci/mmol, diluted 111000 to give 10,000 cpm) was added to 50 J.d 
of each plasma sample and incubated for 30 minutes at 37°C. The mixture was 
placed on ice for 10 minutes and 1 ml of dextran treated charcoal was added; this 
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was kept on ice for 5 minutes more before centrifugation. Triplicate samples of 
2001-11 of the supematant were added to a scintillation vial, 5ml of scintillation 
cocktail was added and then counted in a scintillation counter. 
Free corticosterone cakuHatiollll 
% Free Corticosterone = { ( cpm added-cpm counted)/cpm added} x 100 
[Free Corticosterone] =%Free Corticosterone x [Total Corticosterone] 
Preparation of brain areas for RIA 
Two methods of preparation were used to measure the brain levels of 
corticosterone. The first involved a simple homogenisation step before RIA, the 
second involved ethanol extraction of the corticosterone from the brain sample 
before RIA. The ethanol extraction method was used to overcome the potential 
(although not obvious) problems of the dispersion of corticosterone in the 
suspension. It was theoretically possible that the tracer corticosterone may have 
bound to fragments of membrane lipids, or proteins. This may have resulted in 
artificially high measured brain corticosterone levels after the separation 
procedure in the final RIA. 
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Method one 
Homogenate RIA 
The brain samples were homogenised in four volumes distilled water 
(w/v). To 0.05ml aliquots of the resultant suspensions 0.45ml of Tris-HCl buffer 
was added. The standard radioimmunoassay procedure was then performed on 
these samples. 
Tracer recovery 
Although method one appeared to produce reliable results, a test to 
investigate the distribution of corticosterone in the homogenate was performed. 
Although it was assumed that the endogenous corticosterone and added tracer 
would be evenly dispersed in the homogenate and they would be freely available 
to bind with the antibody, this could not be certain. To investigate this 20f.ll of 
tracer (I 0,000 cpm) was added to brain samples, then 1 ml of either distilled 
water (n=6) or 100% ethanol was added (n=6). These samples were then 
homogenized and centrifuged 20 minutes 6000 xg. The supernatants were 
decanted into scintillation vials and the radioactivity counted in a liquid 
scintillation counter. The percentage of recovery of tracer was then calculated. 
Method two. 
Alcohol extraction of corticosterone. 
The brain regions for the mice were homogenised in x4 volumes of 100% 
ethanol and then centrifuged for 20 minutes at 13,000xg. The supernatants were 
then decanted into test tubes and placed in a drying oven. When the ethanol had 
evaporated the sediment was first dissolved in lOml 100% ethanol before the 
addition of 1.5 ml standard RIA buffer (Tris-HCI, NaCI, NaN3, BSA). The 
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samples were then assayed for corticosterone using the ICN antibodies and the 
standard protocol. 
Statistical analysis 
The results are expressed as mean± SEM. One way analysis of variance 
was used to analyse the affects of the different treatments on blood and brain 
corticosterone levels. Significant interactions were followed by analysis of the 
main effects and if appropriate Fisher's pots hoc test. 
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Results 
The recovery of tracer from the samples homogenised in 100% ethanol 
was over 90%. Those samples that were homogenised in water had a recovery 
level of below 78%. These results are illustrated in Figure 5.1. 
Figure 5.1 
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Figure 5.1 The percentage recovery of3H corticosterone after homogenisation 
and centrifugation in either I 00% ethanol or distilled water. Recovery of tracer 
after ethanol was greater than 90%. 
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Corticosterone levels after a single injection 
For clarity the results of the brain level measurements are expressed in 
graphical form firstly according to treatment and then according to brain region. 
Corticosterone levels in the brain regions of stock mice 
The corticosterone levels significantly varied between the different brain 
regions with treatment groups (F 2,45 = 3 P<0.001 ). Post-hoc analysis in stock 
mice showed hippocampal levels of corticosterone were significantly higher than 
both cortical (P<0.05) and striatal (P<O.OOl) levels. However there was no 
significant difference between striatal and cortical levels (Figure 5.2). 
Corticosterone levels in the brain regions of handled mice 
In the mice that were handled without being injected, hippocampal levels 
were significantly higher than both cortical (P<O.OOl) and striatal (P<O.OOI) 
levels. Cortical levels were higher than striatal (P<O.Ol) (Figure 5.3). 
Corticosterone levels in the brain regions of injected mice 
Saline injected mice had significantly higher hippocampal than cortical 
(P<0.05) and striatal levels (P<0.05). There was no significant difference in 
cortical and striatal (Figure 5.4). 
Corticosterone levels in the hippocampus of all treatment groups 
Hippocampal levels were significantly different in the three groups (F 2,15 
=7.28 P<0.05). Post-hoc analysis showed significantly higher levels in injected 
mice compared to handled (P<0.05) and stock (P<O.OOl). There was no 
difference between stock and handled mice (Figure 5.5). 
Corticosterone levels in the cortex and striatum of all treatment groups 
There was no difference in corticosterone levels in the cortex of the 
groups (Figure 5.6). Striatal levels, however, were significantly higher (F 2,15 
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=176 P<O.OOOl) in the injected mice compared to both the stock (P<O.OOl) and 
the handled mice (P<O.OOl). Handled mice had significantly lower levels than 
stock mice (P<0.05) (Figure 5.7). 
Circulating levels of corticosterone 
Analysis of variance showed total circulating levels of corticosterone in the 
different treatment groups were significantly different (F2,15 = 4.5 P<0.05), post-
hoc analysis revealed elevated levels in the mice that received saline injections 
compared with the stock mice P<O.Ol ). (Figure 5.8). Levels of free 
corticosterone were significantly higher in the injected mice (F2,15 =10.4 
P<O.OOl) compared with both handled (P<0.005) and stock (P<O.OOl) mice 
(Figure 5.9). 
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Stock mice 
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Figure 5.2 corticosterone levels in the hippocampus, cortex and striatum of stock 
C57 mice. Hippocampal levels were higher than striatal (*P<O.OOJ) and cortical 
(**P<0.05) 
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Figure 5.3 Corticosterone levels in the hippocampus, cortex and striatum of 
handled C57 mice. Hippocampal levels were higher than striatal (*P>O.OOJ) and 
cortical (**P<O.OOJ ). Cortical levels were higher than striatal levels 
(***P>O.OJ ). 
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Figure 5.4 Corticosterone levels in the hippocampus, cortex and striatum of 
injected C57 mice. Hippocampal levels were higher than striatal (*P>O.OOJ) and 
cortical (**P<0.05). 
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Figure 5.5 corticosterone levels in the hippocampus of stock, handled and 
injected mice. Injected mice had higher corticosterone Levels than both stock 
(*P<0.05) and handled mice (* *P<O.OOJ). 
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Figure 5.6 No difference in cortical corticosterone Levels between the treatment 
groups. 
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Figure 5.7 
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Figure 5.7 Increased corticosterone levels in the striatum of injected mice 
compared to both handled (*P<0.05) and stock mice (**P<0.05). Handled mice 
had lower levels of corticosterone than stock mice (***P<0.05). 
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Figure 5.8 Total blood corticosterone levels. Saline injections significantly 
(*P<O.OJ) increased corticosterone levels compared to the stock mice, but not to 
those that were handled. 
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Figure 5.9 Free blood corticosterone levels. A single saline injection 
significantly increased corticosterone levels compared to the stock mice 
(*P<0.005) and handled mice (**P<O.OOJ ). 
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Injected 
Repeated saline injections 
Total Blood corticosterone levels showed no change between those handled and those 
injected (Figure 5.10). The blood levels measured were comparable to the levels 
measured in the mice that received a single saline injection in the previous experiments. 
There was no difference in hippocampal corticosterone levels between the two 
treatment groups. Cortical levels also did not differ between treatments (5.1 1) . However, 
corticosterone levels varied significantly in the two brain regions (F1,11=10.64, 
P=0.0039). 
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Figure 5.10 No difference in total blood corticosterone levels between mice that 
received three weeks of daily saline injections and those that received three 
weeks of handling . 
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Figure 5.11 
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Figure 5.11 No difference in cortical or hippocampal corticosterone levels 
between injected and handled mice, after three weeks of either daily saline 
injections or handling .. Hippocampal corticosterone levels were higher than 
cortical corticosterone levels irrespective of the treatment (*F 1,11 =10.64, 
P<0.005). 
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Discussion 
Brain corticosterone levels 
Ethanol extraction produced a reliable, high level of recovery of labelled 
corticosterone when the procedure was tested for efficiency. Ethanol extraction 
was used as corticosterone is an organic insoluble (in polar solvents) compound, 
which will preferentially partition into an organic solvent. Although other similar 
molecules (other steroids) could be extracted at the same time the use of RIA 
using specific corticosterone antibodies means that contamination of the sample 
did not present a problem. The differential pa1tition of corticosterone (as 
described in the methods section of this chapter) when the brain sample was 
suspended in water may have produced artificially high corticosterone 
measurements so the ethanol extraction method was adopted as the method of 
choice. Comparison of the levels measured in both preparations used would 
argue against this being a problem. However, it could not be guaranteed that this 
was not the case and so ethanol extraction became the preferred method. 
There are, at least two, potential criticisms that could be levelled at each 
procedure. The first is the problem of corticosterone degradation by an 
endogenous enzyme, 11 ~-hydroxysteroid dehydrogenase (Sekl, 1997). This 
enzyme catalyses the conversion of the active glucocorticoids, corticosterone and 
cortisol, to inert 11 keto-products (11-dehydrocorticosterone, cortisone), thus 
regulating access of glucocorticoids to receptors. The enzyme shows bi-
directional activity in tissue homogenates and microsomal preparations, but may 
predominantly function as an 11~-reductase . Extraction of the corticosterone in 
l 00% ethanol should make the impact of this enzyme negligible, but it should be 
a factor considered when refining the assay method further. One potential 
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solution would be to use inhibitors of this enzyme such as licorice or its 
derivatives (Sekl, 1997). 
The second criticism that needs attention is the possibility of 
corticosterone being detected that originates from the cerebral circulation rather 
than the brain itself. The levels of corticosterone from this potential artifact are 
thought to be minimal, but are a factor that needs careful consideration when 
refining the assay. In the method now used in the laboratory, mice are 
transcardially perfused with saline in order to exsanginate and so avoid the 
potential for circulatory artifacts. 
Brain corticosterone levels after single injection or repeated saline 
injections 
In all the treatments; stock, handled and injected, the corticosterone levels 
in the hippocampus were the highest. The mice that received saline injections 
had the highest hippocampal corticosterone levels. The hippocampal formation is 
an important brain structure in episodic, declarative, and spatial learning and 
memory. It also exerts control over ACTH secretion and so is important in the 
functioning of the HPA axis (Vale et al., 1981 ). Hippocampal neurons express 
receptors for corticosterone (McEwen et al., 197 4 ). The two receptors mediate a 
variety of effects on neuronal excitability, neurochemistry and structural 
plasticity (DeKloet et al., 1996). Increased corticosterone levels in the 
hippocampus could, therefore, exert an influence on behaviour and could provide 
a possible mechanism for the increased alcohol preference seen after repeated 
saline injections. However, when the levels of corticosterone were measured in 
the hippocampus after three weeks of saline injections there was no difference 
between the saline injected hippocampal levels and the handled hippocampal 
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levels. This observation could be explained by an adaptive response to the 
repetitive injection stress, resulting in a reduced corticosterone secretion after 
multiple injections compared to the increased levels recorded after the a single 
injection. 
Corticosterone levels in the striatum of injected animals were higher than 
those of handled and stock animals. Corticosterone can have profound effects on 
the mesolimbic dopaminergic system- the reward pathway. In the VTA, 
corticosterone has been shown to potentate excitatory amino acid induced 
neuronal activity (Cho & Little, 1999). Corticosterone has been shown to 
increase dopamine output in the nucleus accumbens (Rouge-Pant et al., 1998; 
Piazza et al., 1993). Suppression of glucocorticoid secretion has opposite effects 
(Piazza et al., 1994). During stress, a selective block of stress-induced release of 
corticosterone reduces dopamine release by 50% (Piazza et al., 1994). The 
development of long-lasting sensitisation of the dopaminergic response to 
psychostimulants and opioids is suppressed by the blockade of corticosterone 
secretion. The increases in corticosterone levels in the stratum in the saline 
injected mice for the above reasons could present a plausible mechanism for the 
increased alcohol preference seen after repeated saline injections. 
An unexpected finding was the higher levels of corticosterone in the 
striatum of the stock mice when compared to those of the handled mice even 
though the levels of free (potentially available) corticosterone were higher in the 
handled mice. This result suggests that circulating corticosterone cannot be an 
absolutely reliable guide to central availability. These results suggest that the 
mechanism that allows the entry of corticosterone into specific brain regions 
must be more than a passive process. If the entry of corticosterone into the 
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specific regions of the brain occurred as a result of passive diffusion the levels of 
corticosterone measured in the different brains regions would be similar and the 
levels would relate directly to the circulating levels of free corticosterone or even 
total corticosterone. This is not the case therefore an active mechanism would 
seem a likely explanation. The densities and availability of corticosterone 
receptors could also explain the differences in the levels of corticosterone 
between the different brain regions. The hippocampus has a the highest density 
of both MRs and GRs these receptors, whereas in the cortex and striatum there 
are relatively fewer receptors. These receptors could act as a reservoir for the 
circulating corticosterone and so explain the regional differences in the levels. 
The effects of repeated saline injections on blood and brain corticosterone 
levels showed no changes in levels between the two groups. Only total blood 
corticosterone levels were measured in this experiment as the method for 
measuring the free levels had not been established in the laboratory at the time. 
There were differences in the corticosterone levels in brain regions measured, but 
not between the treatment groups. This is in contrast to the acute studies that 
showed differences between the treatments, this might be explained by an 
adaptive response to repeated stress. The lack of difference between the two 
groups led to the addition of the extract control (stock) group in the acute studies. 
Although, it should be noted that the striatal levels were not measured in this 
study, due to lack of time. 
Future work 
The development of an assay to measure brain corticosterone levels presents a 
massive opportunity for future work. Any experiment previously performed on 
stress reactions, manipulations of the HPA, chronic or acute stress that has been 
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previously performed that measured circulating levels of corticosterone could 
benefit with the additional information of measuring brain corticosterone levels. 
A literature search on the Webb of Science data base with the search words 
corticosterone levels ( 1984-present) produces thousands of reports of a vast 
array of different experiments all of which reported circulating levels of 
corticosterone as part of the experiment and none of which reported brain levels. 
A comprehensive list of the potential for future work could run into volumes 
even before totally novel ideas are considered. 
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Section Two 
Previously alcohol preference and the factors modulating that preference 
have been examined in C57 strain mice. In this section the following group of 
experiments (Chapter Six and Seven) investigate the effects of alcohol 
administration and abstinence on TO mice. The experiments were performed 
after the acute withdrawal phase had passed in order to examine possible changes 
in the HPA axis (Chapter Six) dopaminergic receptors (Chapter Seven) that 
might aid the understanding of the phenomenon of relapse. 
The experiments were performed after a 23 day chronic alcohol treatment 
(administered via a liquid diet) and a 6 day period of abstinence. The alcohol 
administration schedule was chosen as this produced changes in locomotor 
activity responses to psychostimulants develop after six days abstinence, whereas 
a shorter 10 day treatment did not (Manley & Little , 1997). 
Long-term changes in neuronal and behaviour responses have been 
reported during abstinence at 24 hours, 6 days and 2 months of withdrawal 
(Bailey et al., 1997; Manley & Little, 1997). The following studies were intended 
to be performed at all these three time points, but time constraints meant that 
only the 6 day period was examined, except in the locomotor activity 
experiments in Chapter six where additional experiments were performed at 24 
hours post withdrawal. 
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Chapter Six 
Corticosterone and abstinence 
Introduction 
Corticosterone and dependence 
As mentioned previously the HPA axis has an important influence on 
drug and alcohol dependence related behaviour. This chapter examined potential 
long-term changes in the levels and actions of corticosterone after chronic 
alcohol administration followed by a period of abstinence. 
Studies of drug self-administration , in particular psychostimulant drugs, 
have shown that physical and psychological stressors facilitate the reinstatement 
of drug taking even after prolonged periods of withdrawal; in addition to 
facilitating the initial acquisition (Shaham and Stewart, 1995; Piazza et al. , 
1993). The relationship between stress and relapse in alcohol dependence is less 
well defined but a connection is becoming clearer. Amongst absti nent 
alcoholics, severe and chronic life stressors may lead to alcohol relapse. Brown 
and colleagues 1990) studied a group of men who completed inpatient 
alcoholism treatment and later experienced severe and prolonged psychosocial 
stress prior to, and independent of, any alcohol use. The researchers found that 
subjects who relapsed experienced twice as much severe stress before their return 
to drinking as those who remained abstinent (Brown et al, 1990). 
Relapse is one of the major problems in the treatment of alcoholics. 
Alcoholics attempting to stop drinking will frequently go through the acute 
withdrawal syndrome and remain abstinent for weeks or months, but then 
relapse back to excessive and uncontrolled drinking. Prolonged effects of 
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excessive alcohol consumption, including craving and anxiety are seen in 
alcoholics after months or even years of abstinence. Rates of relapse amongst 
recovering alcoholics are very high. In alcoholics 1-2 years following therapeutic 
treatment rates of relapse of 74-90% (McKenna et al., 1993) and 80% (Naranjo 
& Kadlec, 1991) have been reported. 
Acute administration of ethanol causes a dose dependent rise in plasma 
corticosterone levels in rats (Ellis, 1966). This adrenal response is dependent 
upon an increase in ACTH hormone secretion. Dexamethasone blocks the 
alcohol induced rise in plasma steroid (Adinoff et al., 1991). The influence of 
alcohol on corticosterone levels is considered to be exerted in a large part 
through the release of CRF. Removal of endogenous CRF or blockade of CRF 
receptors has been shown to reduce significantly the alcohol induced response of 
ACTH and corticosterone in rats (Rivier et al., 1996). 
The effect of chronic alcohol administration on the HPA axis is not well 
defined. Alcohol is reported to alter the levels of plasma corticosterone but this is 
dependent on the method of alcohol administration even if the blood alcohol 
concentrations achieved are similar (Koranyi et al., 1987). Both persistent 
activation (Ellis, 1966; Tabakoff et al., 1978), or tolerance (Spencer and 
McKwen, 1990), of the HPA axis activity following ethanol administration has 
been shown. Chronic alcohol intoxication also leads to the disturbance of the 
normal diurnal variation of plasma glucocorticoids in rodents and in humans 
(Adinoff et al., 1991). 
Persistent alterations in corticosterone levels are believed to produce 
adaptive responses in glucocorticoid receptor function. Stressful life events are 
believed to play an important role in the etiology of mood disorders (Anisman & 
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Zacharko, 1982; Shrout et al., 1989). Stress, even short lasting, can have 
profound and long lasting effects that may persist or develop after the stressor is 
no longer present (Post, 1992). These changes include persistent reduction in 
plasma CBG levels (Buwalda et al., 1999). The activation of the HP A by alcohol 
can be regarded in physiological terms at least as stressful. Whether alcohol 
ingestion is perceived as stressful is another matter, the tension reduction 
hypothesis would seem to suggest the contrary. This hypothesis suggests that 
drinking alcohol is performed to reduce stress rather than to promote stress; the 
validity of that hypothesis must be questioned in light of the evidence linking 
physiological stress reactions and alcohol consumption. 
An investigation into whether alcohol induced changes in corticosterone 
levels could produce a lasting effect on anxiety related behaviour was performed. 
In the following experiments mice were administered alcohol for 21 days. After 
this the mice were placed on the elevated plus maze and the effects of the 
glucocorticoid receptor antagonist RU38486 on maze behaviours were 
investigated. The next set of experiments were designed to investigate the effects 
of corticosterone on locomotor activity following long-term withdrawal from 
alcohol treatment. Finally the levels of free, total and brain region corticosterone 
levels were measured to investigate whether changes in blood corticosterone 
levels reported during alcohol administration persist or develop further during 
long-term withdrawal. Long-term withdrawal is the term used in this work to 
describe a period of abstinence after chronic alcohol treatment (enough to 
produce physical dependence) that outlasts the acute withdrawal 
hyperexcitability. The importance of this was first discussed in the introduction. 
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The plus maze 
The elevated plus maze paradigm is currently one of the most widely 
used animal models in behavioural pharmacology. The test is based on the 
aversion of rodents for open spaces and is reported to be bi-directionally 
sensitive to manipulations designed to influence anxiety. The efficiency of the 
test is dependent on a number of factors. If the strain of mice (or rats) has a low 
anxiety baseline, anxiolytic effects may prove hard to detect, conversely high 
anxiety baselines make anxiogenic effects hard to detect. Ethological measures 
were taken as well as the spatiotemporal measures to improve test sensitivity 
(Cole & Rodgers, 1995). 
In this study an examination of the effects of i.c.v. injections of the GR 
antagonist RU38486 on mice behaviour on the elevated plus maze following six 
days of withdrawal from chronic alcohol treatment was undertaken. The purpose 
of this study was to investigate the possibility of long term changes in 
corticosterone receptor activity after alcohol treatment. 
Glucocorticoids act on a variety of homeostatic processes including the 
behavioural expressions of fear and anxiety. Administered corticosterone, at 
levels designed to mimic stress-induced levels, increased anxiety related 
behaviour in a time-dependent fashion in the black/white box induced anxiety 
test. The most effective treatment time was 5 minutes after injection (Smythe et 
al., 1997). The plus maze and the social interaction test have demonstrated 
anxiolytic effects of corticosterone (Korte et al., 1996). Korte and colleagues 
have demonstrated an anxiolytic effect of both MR (spironolactone, dose of 
150ng) and GR antagonists (RU 38486, dose of 150ng) in the elevated plus maze 
after exposure to a conditioned stressor. RU38486 (150ng) has been shown to 
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increase the time spent in the open arms of the plus maze when exposure was 
preceded by exposure to an environmental stressor (Korte et al., 1996). 
Locomotor activity 
The assessment of motor activity, first encountered in this Thesis in 
Chapter 2, is a common behavioural test used generally to define sedative and 
stimulant actions of drugs. Measuring the effects of corticosterone on locomotor 
activity in alcohol treated mice was chosen as a simple test for changes in the 
effects of corticosterone. 
Classically steroid hormones receptors exert their effects acting as ligand-
dependent transcription factors. Non-genomic (rapid) effects of corticosterone 
have been reported extensively in the literature. In rats, injections of 
corticosterone have been shown to have rapid stimulatory effects on locomotor 
activity. The administration of corticosterone produced a transient increase in 
locomotion in a novel environment an effect seen within seven and a half 
minutes that disappeared within 60 minutes of drug administration (Sandi et al., 
1996). Rapid effects of corticosterone are best defined in male Taricha (newts) 
(Orchinik et al., 1998) and have also been described in white-crowned sparrows 
(Breuner et al., 1997). The assessment of the effects of corticosterone on 
locomotor activity in this study were divided into two basic experiments. The 
first was an investigation of the effects of corticosterone and the glucocorticoid 
receptor antagonist RU 38486 on locomotor activity in alcohol naive (stock) 
mice. The doses of corticosterone used (2.5-20mg/kg) were taken from a 
previous study that demonstrated an increase in locomotor activity after 
corticosterone injection in rats (Sandi et al., 1996). The second was an 
investigation of the effects of corticosterone on activity in alcohol treated mice at 
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two time points (i) twenty-four hours after the removal of alcohol and (ii) six 
days after the removal of alcohol. 
Corticosterone levels 
The elevated plus maze test and locomotor activity monitoring described 
above were designed to investigate possible behaviourally detectable changes in 
corticosterone receptor characteristics following alcohol administration. The 
effect of alcohol treatment and long-term withdrawal on the levels and 
availability of ligand (corticosterone) could provide important information that 
may help explain the effects of stress on relapse. Earlier in this chapter studies 
that have examined total corticosterone levels during alcohol administration or at 
intervals just after administration were described. There is no information 
regarding the circulating levels of total or free corticosterone at times after the 
acute withdrawal phase. The same is true for brain corticosterone levels. 
In rats following stress, activity within the HPA axis is reported to subside 
rapidly and total corticosterone levels are normally indistinguishable from pre-
stress levels as little as 1 hour. However, other measures of HPA axis activity 
such as CBG binding have been shown to still be increased in rats 24 hours after 
a single exposure to restraint stress (Tannenbaum et al., 1997). The levels of 
CBG are linked to the availability of corticosterone, so in this study the levels of 
free as well as total corticosterone were measured, also the corticosterone levels 
in the cerebral cortex, hippocampus and striatum were measured. These brain 
region were chosen for the reasons outlined in Chapter Five. 
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Methods 
Drugs Used 
Aldosterone, a MR agonist, corticosterone a mixed GR and MR agonist 
(Baxter & Rousseau, 1979) and RU 38486 a specific GR antagonist (DeKioet, 
1991 ). 
Animals 
Adult male TO mice 14-1 8 weeks (26-40g, bred in the Psychology 
Department, Durham University), were housed in groups of ten (cage size: 45 x 
28 x 13 cm). They were maintained in a temperature-controlled environment 
(21±°C) under reverse light/dark phase (lights on 2000 hours, lights off 0800 
hours). The mice were maintained under reverse light/dark phase so that the 
behavioural testing and the measurement of corticosterone levels could be 
performed during their active phase (i.e. the dark phase). 
Administration of alcohol 
Alcohol was administered by a 23 day liquid diet (Lieber & Di Carli, 1986) 
schedule, previous described by Manley and Little (1997). In the administration 
all mice received a control diet for an initial period of three days. The mice 
undergoing ethanol treatment were then given a diet containing 3.5% ethanol for 
two days, followed by a 5% containing diet for nine days and finally an 8% diet 
for the last nine days of the treatment. Control groups were pair-fed iso-
calorifically match control diet. There was no significant differences between the 
weights of the control and ethanol groups at the end of the treatment. The mean 
dai ly intake was 21.5 ± 2 g/kg/day. 
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Part 1 
The elevated plus maze 
Twenty minutes before testing each mouse (control or ethanol diet) 
received an intracerebroventricular injection (2~1) of either tween vehicle , 50ng, 
lOOng, or 150ng of RU38486 ( n values of 7-8 per treatment group) The i.c.v 
injection procedure was described in Chapter Four. On the test day the mice were 
removed from the holding room and moved to the test room and habituated to 
that room for one hour prior to the start of the tests. 
Apparatus (the elevated plus maze) 
The elevated plus maze was a modification of the apparatus validated for 
NIH Swiss mice by Lister (1987). Two open arms (30 x 5 x 15 cm) and two 
closed arms (30 x 5 x 15 cm) extended from a common central platform (5 x 5), 
the entire apparatus was elevated to a height of 45cm above floor level. The 
maze floor was made from black Plexiglas, whilst the side and end walls were 
of clear Plexiglas. The open arms had a slight lip (0.25cm) to help prevent 
animals falling from the maze. All testing was conducted under dim red light 
(2x60W). 
All testing was conducted during the mid-portion of the dark phase of the 
light/dark cycle. The mice were transported to the test laboratory at least one 
hour prior to testing. Testing commenced with the placement of a subject on the 
central platform of the maze facing an open arm. The mice were tested twenty 
minutes after receiving an injection, this has been demonstrated as the optimum 
time for the anxiolytic action of RU 38486 on the plus maze (Korte et al., 1996). 
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A standard five minute test duration was employed, and the maze was thoroughly 
cleaned between tests using damp and dry cloths. The maze exposure sessions 
were recorded using a video camera at a 45° angle to the maze. The camera was 
linked to a monitor and video-recorder in an adjacent laboratory. Video tapes 
were later scored blind to treatment conditions, using the Hindsight program. 
Behaviours recorded were: number of closed and open arm entries (arm 
entry was defined as all four paws moved onto an arm), number of rears, and 
time spent on various sections of the maze including the central platform. These 
data were used to calculate the percentage open entries (open entries I total 
entries x 1 00) and the time percentage time spent in open and closed arms. In 
addition to these measurements, percentage time on the central platform; rearing 
frequency, the frequency of discrete behaviours such as head dipping 
(exploratory movement of head/shoulders over the sides of the maze), stretch-
attend postures (SAP; an exploratory posture in which the mouse stretches 
forward and retracts to the original position without forward motion) were 
recorded. Head dips and stretch attend postures were differentiated as 
unprotected (on or from the open arms) or protected (on or from the central 
platform or closed arms). 
Part 2 locomotor activity 
(i) Stock mice 
Adult male TO mice 14-18 weeks (26-40g) maintained under normal 
light/dark phase (lights on 0800 hours, lights off 2000 hours) were tested in the 
locomotor activity meters in the holding rooms. corticosterone (20mg/kg), RU 
38486 (20mg/kg), corticosterone plus RU 38486 combination, both at 20mg/kg 
or dilute tween vehicle (0.05% tween in normal saline), for each treatment n= 11. 
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A second experiment was also performed using the same basic procedure except 
that the mice were given aldosterone injections ( 1,2 and 4 mg/kg n= 14 per 
group). Injections were given and the mice placed in the activity meters 
immediately after injection and their activity monitored for 30 minutes. The time 
from injection to activity measurement was minimal as the locomotor activating 
affects of corticosterone are rapid in onset and are transient. The experiments 
were performed between 10 a. m. And 4 p.m. (i.e. during the lights on). 
(ii) Liquid diet treated mice 
Mice received either alcohol liquid diet or control liquid diet (schedule 
described earlier in the methods section). When the diet schedule was complete 
the mice were then given standard laboratory chow and left undisturbed until 
testing. One group of mice (control and alcohol) were tested 24 hours after the 
removal of the liquid diet. The other group (control and alcohol) were tested six 
days after the removal of the liquid diet. 
Activity testing 
For the 24 hour and six day experiments the mice were tested in the 
holding rooms. Groups of control and diet mice were given either tween vehicle, 
2.5mg/kg, 5mg/kg, 10 mg/kg or 20 mg/kg corticosterone injections (n=6-9 per 
injection group). Activity was monitored after a ten minute habituation period to 
the activity boxes. The experiments were performed from 10 a.m.- 4 p.m. (i.e. 
during the dark phase). 
Part 3 Corticosterone levels 
Corticosterone assays 
The mice were treated with the liquid diet using the schedule previously 
described. When the diet schedule was complete the mice were then given 
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standard laboratory chow and left undisturbed for six days then the mice (n=6 per 
group) were killed and tlunk blood samples collected into heparinized tubes for 
the total and free corticosterone assays. The brains were removed and the 
cerebral cortex, hippocampus and striatum dissected out over ice, the samples 
were then rapidly frozen until required for the assay. The total corticosterone 
levels were measured using the ICN antibodies and procedure described in 
chapter two. The proportion of free corticosterone and hence total corticosterone 
levels were assayed using the methods described in chapter five. The brain 
corticosterone levels were measured by RIA after ethanol extraction. 
Statistical analysis 
The locomotor data and the plus maze data was analysed by one way analysis of 
variance. When indicated, further comparisons between groups were performed 
using a Fishers' post-hoc test. Significance was set at P<0.05. Comparison 
between the two experimental groups, in the corticosterone levels experiments, 
were performed using Student's t-test. 
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Results 
Plus maze 
Analysis of open arm stretch attends (Figure 6. 1), open arm head dips 
(Figure 6.2), central square rears (Figure 6.3), central square stretch attends 
(Figure 6.4), central square head dips (Figure 6.5), closed arm rears (Figure 6.6) , 
closed arm stretch attends (Figure 6.7), closed arm entries (Figure 6.8) and open 
arm entries (Figure 6.9) showed no significant changes in any of the behaviours 
between diet treatment and/or drug administration. 
Figure 6.1 
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Figures 6.1 - 6.12 Behaviour on the elevated plus maze in male TO mice that 
receive alcohol or control liquid diet followed by six days abstinence and then 
i.e. v. injections of RU38486. Figure 6.1 No significant effect of diet or drug 
treatment on open arm stretch attends 
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Figure 6.2 No significant effect of diet or drug on open arm head dips 
Figure 6.3 No significant effect of diet or drug on central square rears 
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Figure 6.5 No significant effect of drug or diet on central square head dips 
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Figure 6.6 No significant effect of drug or diet on closed arm rears 
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Figure 6.7 No significant effect of drug or diet on closed stretch attends 
Figure 6.8 No significant effect of drug or diet on closed arm entries 
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Figure 6.9 No significant effect of drug or diet on open arm entries 
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Figure 6.10 No significant effect of drug or diet on time spent in the open arms 
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figure 6.11 No significant effect of drug or diet on time spent in the closed arms 
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Figure 6.12 No significant effect of drug or diet on time spent on the central 
square. 
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Corticosterone and RU 38486 injections in normal phase TO mice 
Mobile activity 
Mobile locomotor activity in all groups of mice decreased with time. 
There was a significant effect of drug treatment (F 5,39 = 3 P<0.05) on the total 
mobile activity for the whole test session. Analysis of the activity in the first five 
minute time bin revealed a significant increase in mobile activity (F3,39=3.7 
P<0.05) in the mice that had received the corticosterone injections compared 
with those that received the Tween vehicle (P<0.05), RU 28486 (P<0.005), and 
combined RU38486 and corticosterone (P<0.05). This data is illustrated in 
Figure 6.13. 
The increase m activity was short lasting with the activities at 5-15 
minutes showing no significant difference (Figure 6.14). In the final fifteen 
minutes of the session the mice treated with the combined injection showed a 
lower activity (F3,39=2.8, P<0.05) than tween treated mice (P<0.05) and 
corticosterone treated mice (P<0.05) (Figure 6.15).There was no significant 
difference in static activity between any of the groups (F> 1, P>O.l) (Figure 6.16, 
6.17 & 6.18). 
Rearing activity did not vary with time (F5,195 = 1.5 P>0.05). 
Corticosterone plus RU38486-treated mice showed significantly lower rearing 
behaviour (F 3,39 =3 P<0.05) over the thirty minute session than those mice that 
received the tween vehicle injection (P>0.05) (Figure 6.19) 
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Figure 6.13 
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Figure 6.13 Mobile locomotor activity counts (0-5 minutes)in nai"ve mice. 
Injections type had a significant effect (F3•41=3. 7 P<0.05). Post-hoc analysis 
showed that a corticosterone injection significantly increased mobile counts 
compared to tween vehicle (*P<0.05), RU 38486 (* *P<0.005) and the 
combination of corticosterone and RU 38486 (***P<0.05) 
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Figure 6.14 Mobile locomotor activity counts (5-15 minutes) in nai"ve mice. 
There was no significant difference in the total mobile counts from this time bin. 
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Figure 6.15 
3000 
2500 
~ 
s 
2000 
•Tween 
0 
oCORT u 1500 ~ 
•RU 38486 
.0 
0 1000 o CORT + RU 38486 ~ 
500 
0 
Experimental group 
Figure 6.15 Mobile locomotor activity counts (15-30 minutes)in nai"ve mice. 
There was a significant effect of treatment on activity (F3,39=2.8, P<0.05). Mice 
treated with the combination of corticosterone and RU 38486 showed 
significantly lower mobile counts than both tween treated mice (*P<0.05) and 
corticosterone treated mice (*P<0.05). 
Figure 6.16 
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Figure 6.16 No difference in static counts in nai"ve mice between the treatment 
groups in 0-5 minute time bin. 
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Figure 6.17 No difference in static counts between the treatment groups in 0-15 
minute time bin. 
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Figure 6.18 No difference in static counts between the treatment groups in the 
15-30 minute time bin (Figure 7.4c). 
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Figure 6.19 Rearing counts for the 30 minute session. There was an significant 
effect of treatment on rearing counts(F 3,39 =3 P<0.05).Post-hoc analysis 
demonstrated a significant difference between Tween and CORT + RV 38486 
injected mice (*P<0.05). 
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Aldosterone injections and locomotor activity 
Administration of aldosterone did not effect mobile, or rearing locomotor 
activity. The results of mobile locomotor activity after aldosterone injections can 
be seen in Figure 6.20. Rearing activity is shown in Figure 6.21. 
Aldosterone, at 4mg/kg, administration (Figure 6.22) altered static 
activity, (F 3,56 = 2.86, P<0.05) when accessed over the entire session. 
Figure 6.21 
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Figures 6.20 and 6.21 No change in mobile (6.20) nor rearing (6.21) activity 
after administration of 1,2, Or 4mglkg of aldosterone (aldos). The graphs show 
the number of counts at individual time bins (0-5, 5-10 etc). 
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Figure 6.22 Decreased static activity after administration of 4mglkg of 
aldosterone (*P<0.05). 
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Corticosterone injections after 24 hours abstinence 
Static and mobile counts for all the treatment groups were analysed. 
Rearing behaviour was not assessed as reliable measurements of this behaviour 
could not be obtained in this particular experiment due to computer malfunction. 
Mobile colllnts 
The diet the mice received had a significant effect on mobile locomotor 
activity (F=2 P<0.003). In the control mice injection, either corticosterone or 
tween vehicle- but not dose, also had a significant effect (F 4,24 = 10 P<0.001). 
Initially (five minute time bin) the tween vehicle injected mice showed 
significantly higher mobile activity than mice that received corticosterone. This 
effect was present at all doses (P<O.OO 1, 2.5mg/kg; P<O.OO 1, 5mg/kg; P<O.OO 1, 
lOmglkg; P<.001 20mg/kg). These results are illustrated in Figure 6.23a. The 
injections in the alcohol treated mice did not alter mobile locomotor activity 
(F=0.1 P=0.9) (Figure 6.23b). The same pattern was seen over the whole thirty 
minute session. Injection had a significant effect (F 4,69 =5.5 P<0.0001) with 
significant differences between tween-injected and each of the individual 
corticosterone doses (all at P<0.001) for the control diet mice. Whereas in the 
ethanol treated mice there was no difference between the different injection 
groups (Table 6.1 ). 
166 
ell 
c 
;:l 
0 
u 
Figure 6.23a Figure 6.23b 
1000 800 
800 700 
600 
600 
Cll 
~ 
400 
1::: 500 ;::l 0 
* u 
400 
200 300 
0 200 
0 5 10 15 20 25 0 5 10 15 
Corticosterone (mglkg) Corticosterone (mg/kg) 
Figure 6.23 (a) Mobile activity for the(first five minute time bin) in control diet 
mice. Corticosterone injections significantly reduced activity compared to 
vehicle injections (*P<O.OOJ) (b) Mobile activity counts (first five minute time 
bin) in alcohol diet treated mice that received corticosterone injections. There 
was no difference in activity in the different drug doses. 
Treatment 
Control diet 
Ethanol diet 
Table 6.1 
Tween 
2472±280* 601±187* 
1363±522** 964±173 
506±120* 
852±160 
857±259* 
1046±326 
Mobile activity for the whole 30 minute session was decreased by 
administration of corticosterone compared to vehicle injections in control 
mice (*P<O.OOJ ). Vehicle-injected alcohol-treated mice showed lower 
locomotor act1v1ty compared with vehicle-injected control m1ce 
(**P<0.05). 
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20 25 
Static count§ 
Static counts for the whole session were higher in the alcohol than the 
control group (F 1,12 = 8 P<0.005). Treatment type was also significant (F 9,64 =3 
P<0.005). There was a significant interaction between diet and treatment (F 4,64 
=2.5 P<0.05). There was no significant difference between control and ethanol 
diet treated mice that received the vehicle injections. Control and alcohol mice 
that received the lowest (2.5mg/kg) dose of corticosterone did not show 
significantly different static counts. Alcohol treated mice showed higher static 
activity than control diet mice when given corticosterone doses of 5mg/kg 
(P<O.Ol), lOmg/kg (P<O.Ol) and 20mg/kg (P<0.02). These results are illustrated 
in Figure 6.24 
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Figure 6.24 Graph of static activity counts in a 30 minute test session after 
corticosterone injections and liquid diet treatments. No significant difference in 
the static counts of mice that received tween injections or 2.5 mg/kg 
corticosterone injections. 5 mg/kg corticosterone significantly increased static 
counts in alcohol diet treated mice(*P<O.OOJ ). 10 mg/kg corticosterone 
significantly increased static counts in alcohol diet treated mice(*P<O.OOJ). 20 
mg/kg corticosterone significantly increased static counts in alcohol diet treated 
mice(*P<O.OOJ ). 
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Corticosterone injections after 6 days abstinence 
Diet treatment had a significant effect on mobile activity (F 9,65 = 7.6 
P<O.OOl). Control mice that received tween injections had higher mobile activity 
than alcohol treated mice given tween injections (P<O.Ol ). This difference in 
activity was present at the start of the session, the first five minute time bin 
(Figure 6.25) and continued over the entire session (Figure 6.26). Although the 
tween injections had an effect on mobile activity of the control mice compared 
with alcohol-treated mice, none of the corticosterone doses altered activity when 
comparing between diet treatments or within diet treatments. The absence of 
effect was seen initially (first five minute time bin) and over the whole 30 minute 
session. The mobile activity counts for I 0 mg/kg are not displayed owing to 
computer error during data acquisition. 
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Figure 6.25 Mobile locomotor activity during the first five minutes of activity 
testing. Control mice that received tween vehicle injections showed an increased 
activity compared with alcohol diet treated mice that received tween vehicle 
injections (*P<O.OJ ). 
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Figure 6.26 Mobile locomotor activity during the entire testing session. Control 
mice that received tween vehicle injections showed an increased activity 
compared with alcohol diet treated mice that received tween vehicle injections 
(*P<O.Ol). 
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Comparison of 24 hour and 6 day withdrawal mobile activity. 
Figures 6.27 shows a comparison between the mobile locomotor activity of the 
control mice at 24 hours withdrawn and 6 days withdrawn (Figure 2.27a) and 
the mobile locomotor activity of the alcohol treated mice at 24 hours withdrawn 
and 6 days withdrawn (Figure 2.27b). The mobile activity of the control mice 
receiving corticosterone injections showed lower mobile activity at 24 hours 
withdrawn compared to their 6 day alcohol abstinence counterparts (P<O.OOl). 
There was no difference to mobile locomotor activity in the alcohol diet treated 
mice at the different time points. 
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Figure 6.21_Comparison between mobile activity in the first five minutes in (a) 
control diet treated mice ( 6 days and 24 hour withdrawal) and (b) alcohol diet 
treated mice (6 days and 24 hour withdrawal).24 hour control diet treated mice 
had significantly lower activity than 6 day withdrawal control mice for all 
corticosterone doses (*P<O.OOJ). 
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Corticosterone levels 
Following the 23 day liquid diet treatment and six days of withdrawal the 
levels of total blood corticosterone levels in control and alcohol diet treated mice 
did not differ (Figure 6.28). The levels of free corticosterone (Fig 6.29) were 
significantly higher in alcohol treated mice compared to control mice (P<0.05). 
There was no difference in corticosterone levels in the cortex (Fig 6.30) 
or in the striatum between the two treatment groups (Fig 6.31). In the alcohol-
treated mice hippocampal corticosterone levels were significantly increased 
compared with control treated mice(P<O.OO 1) (Figure 6.32). 
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Figure 6.28 Total blood corticosterone levels in control and alcohol-treated 
mice. There was no significant difference between the two treatment groups. 
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Figure 6.29 Free blood corticosterone levels in control and alcohol-treated 
mice. The free corticosterone levels in alcohol diet treated mice were 
significantly higher than control diet treated mice (*P<0.05) 
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Figure 6.30 Corticosterone levels in the cortices of alcohol-treated and control 
mice. There was no significant difference between the two treatment groups. 
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Figure 6.31 Corticosterone levels in the striatum of alcohol-treated and control 
mice. There was no significant difference in the levels measured in the two 
treatment groups. 
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Figure 6.32 The Levels of corticosterone in the hippocampus after control or 
alcohol liquid diet. Mice that received alcohol liquid diet had significantly higher 
hippocampal corticosterone levels than mice that received control liquid diet 
(*P<0.002). 
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Discussion. 
Locomotor activity 
The administration of corticosterone to untreated mice produced a 
transient increase in mobile locomotor activity, apparent during the first five 
minutes of measurement. This increase in mobile activity ceased after five 
minutes. Previously reported corticosterone-induced increases in activity, that 
were measured in rats, started between five and ten minutes after injection and 
disappeared within 60 minutes of drug administration (Sandi et al., 1996). It is 
possible that corticosterone-induced activity in mice follows a more rapid time 
course than it does in rats. 
The mice that were treated with RU38486 and corticosterone in 
combination reduced lower mobile activity and reduced rearing behaviour in the 
last half of the test session (15-30 minutes). The RU38486 itself had no effect. 
This observation, though not conclus ive, would appear to suggest that 
corticosterone acting at mineralocorticoid (MR) receptors has decreased 
locomotor activity. RU38486 blocks glucoco1ticoid receptors. When 
administered in combination (RU38486 and corticosterone) the receptors 
available to the administered corticosterone should only be the MR. However, 
this is not supported by the results of the locomotor activity experiments 
conducted after the administration of the MR agonist aldosterone, none of the 
aldosterone doses altered locomotor activity. However, aldosterone does not 
interact with all the central MRs. Although MR can be defined by a high affinity 
for aldosterone, they also have a high affinity for corticosterone. It has been 
proposed that the two ligands do not compete for the same central receptors. 
Ligand transporters, and enzymatic selection have been proposed to confer 
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ligand receptor specificity in different brain regions (Sekle, I 997). With 
hindsight, aldosterone was not an ideal ligand to assess the influence of MR 
receptors on locomotor activity. A better choice could have been to study the 
effects of a selective MR antagonist, such as spironolactone on locomotor 
activity. 
When the effects of corticosterone on the alcohol-treated mice were 
examined appeared to contradict the initial experiments. There was no 
corticosterone-induced increase in activity in the mice that were tested 24 hours 
after the removal of the liquid diet in either the control fed mice or the alcohol 
diet fed mice. The control mice showed a reduction in locomotor activity for all 
the doses of corticosterone and this effect was seen for the entire testing period. 
This change could in part be explained by the time at which the animals were 
tested. The untreated mice were tested under their light phase and the treated 
mice were tested under their dark phase. The alcohol-treated mice were tested 
under dark phase because this is the period of time at which mice are active and 
so was believed to be the best period for behavioural testing. In addition to this 
difference the untreated mice were injected and immediately had their activity 
monitored whereas the liquid diet treated mice had a ten minute habituation to 
the chamber before injection and the measurement of activity. The habituation 
time was included as prior to the experiment it was assumed from the previous 
results that there would be an increase in activity and so by giving the mice a 
short time to habituate a lower baseline of activity would be achieved, so any 
increase in activity would be easier to detect. The lack of change in activity of 
the alcohol-treated mice can therefore be explained by those two factors, 
measurement at a different time of day and the inclusion of a period of 
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habituation at the start of the experiment. The effect of corticosterone on the 
control animals after 24 hours withdrawal (a reduction in activity) cannot be so 
easily explained. 
The reduction in activity seen was likely to be an artefact of the liquid 
diet treatment. When the mice undergo the liquid diet treatment the control mice 
only receive the same volume of diet as the alcohol treated mice will consume. 
The mice on the alcohol diet also tend to consume the diet steadily over the 24 
hour period, but the mice on the control diet consume their diet upon 
presentation. The limited access to the diet causes excessive consumption of the 
standard laboratory chow when the treatment schedule has finished. Firing rates, 
in alcohol-treated mice, in the VTA are decreased at twenty-four hours 
withdrawal (Bailey et al., 1997). This altered neuronal state could explain the 
difference in responses to corticosterone injections after binge eating in the 
control and alcohol-treated groups. 
In alcohol treated mice there was an increase in static counts at 
corticosterone doses of 5 mg/kg and above. This could have been an increase in 
either grooming, digging sawdust or an artefact of the reduced activity in the 
control mice. The decrease of mobile activity in the control mice makes the most 
plausible explanation in that the lower static counts seen are a result of sedation 
rather than an increase in activity in alcohol-treated mice. 
The results of the activity measurement after six days abstinence showed 
increased mobile activity in control mice after they received injections. The 
difference in mobile activity between the two groups following vehicle injection 
has not been shown before. The work by Manley & Little ( 1997) on the response 
of chronic liquid diet treated mice (using the same diet treatment schedule) to 
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amphetamine and cocaine administration showed no effect of vehicle injections 
on locomotor activity when the activity was measured at the same time point. 
Again this difference in results may be due to the testing being done in different 
photo-periods. The experiments performed by Manley were completed during the 
light phase unlike these experiments that were performed during the dark phase. 
The plus maze 
No increases in anxiety-like behaviour were seen in ethanol treated mice 
when compared to control treated animals whereas, a reduction in, entries onto, 
and time spent on, the open arms of the maze, has been demonstrated during 
acute withdrawal (16hrs) in mice. During alcohol acute withdrawal increases in 
plasma corticosterone have been demonstrated (Tabakoff et al., 1978) these are 
reported to disappear after 24hrs. 
Long lasting changes in the HPA axis have been demonstrated (e.g. Post, 
1992; Buwalda et al., 1999) after stress and after the inducement of consistent or 
repeatedly high levels of corticosterone. The changes have been shown following 
two short-lasting episodes of intensive stress in the rat model of social defeat 
(Buwalda et al, 1999). One week after the defeat Buwalda and colleagues 
showed a decrease in hippocampal and hypothalamic GR binding but no change 
in MR binding. After three weeks MR binding was increased in the hippocampus 
whereas GR binding had returned to control levels. 
The alterations in corticosterone levels in withdrawal could be expected 
on the previous evidence to produce a long lasting change in HP A function and 
alterations in corticosterone receptor function. Whether a change in HP A 
function could be demonstrated by the use of the elevated plus maze and the GR 
antagonist RU38486 is not clear. No significant change between any of the RU 
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38486 groups was detected. The previous plus maze studies that demonstrated an 
anxiolytic action of RU38486 used a pretest stress and only after the pretest 
stressor was the drug effective as an anxiolytic. In the present study the 
administration of alcohol was designated to be the pre-test stressor, albeit an 
ineffective one. Glucocorticoids have been reported to have opposing effects on 
anxiety-related behaviour. Adrenalectomy produces anxiogenic effects, whereas 
corticosterone administration produces anxiolytic effects (File & Pellow, 1985). 
However fear-motivated immobility has been reported to be abolished by 
adrenalectomy and restored after corticosterone replacement (Veldhuis et al., 
1982). Korte and colleagues ( 1996) have suggested a biphasic effect of 
corticosterone mediated by different corticosterone receptor subtypes at different 
locations. Fahkle and Eriksson (2000) have also recently shown that 
corticosterone implants in only selected brain regions (the ventral striatum) could 
alter alcohol intake. The present study was limited by the use of only the 
glucocorticoid antagonist. It would have been preferable to investigate the effects 
of a mineralocorticoid antagonists as well. An avenue for investigation of 
corticoid receptor function - radioligand and autoradiography was considered to 
further examine potential alterations during absence. 
The evidence from this study does not provide much information 
on the state of glucocorticoid receptors after alcohol treatment. The study does 
show that after six day withdrawal following chronic alcohol treatment there is 
no difference in anxiety related behavioural on the elevated plus maze. The 
simplest and most direct measure of corticoid receptor state (affinity constant; 
Kd and binding density; Bmax) would be to measure the receptors directly using 
homogenate radioligand binding. This is not as simple as it would appear for a 
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number of reasons. In vitro binding studies are commonly used to quantify 
soluble GR levels and levels of MR. 
A problem encountered when attempting to measure these receptors is the 
difficulty in removing the endogenous ligand. The normal procedure for removal 
of endogenous ligand in a binding assay for membrane bound receptors is to 
wash the ligand away using multiple homogenization and centrifugation steps. It 
is not possible to do this when measuring corticosterone receptors as they are 
soluble. Removal of endogenous corticosterone is normally achieved by 
Adrenalectomising the animal, this procedure will remove circulating 
corticosterone. The assay is performed 24 hours after the adrenalectomy, i.e. 
when there is no endogenous ligand remaining (Spencer et al., 1990). However, 
the measurements of cOiticosterone binding made after this may not present a 
true picture of the state of the receptors. Adrenalectomy-induced increases in GR 
binding sites occur in two distinct phases (McEwen et al., 1974). The first phase 
occurs between 2 and 16 hours after surgery and is thought to mirror the 
clearance of endogenous steroids. A second phase is 18-24 hours after surgery 
and is believed to be the result of de novo synthesis of receptors. These times 
may vary between laboratories owing to slightly different techniques or different 
rodent strains (O'Donnell et al., 1995). This means that when measuring receptor 
levels after adrenalectomy, there is only a two hour window to measure the 
receptors, i.e. when the endogenous ligand has been cleared but before the new 
receptors are made. It seems unlikely that an organism's response to 
adrenalectomy will in reality provide such a window. This would mean that any 
binding assay performed on adrenalectomised animals would have to be 
qualified. The effects of alcohol on corticosterone receptors during and after 
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alcohol administration is an important question, the effects of alcohol and 
adrenalectomy would provide very limited information. For these reasons 
biochemical measurements of corticosterone receptors were not attempted. 
Corticosterone levels 
Increased levels of free, but not total, circulating corticosterone were 
found in the mice that were withdrawn for six days from alcohol liquid diet. The 
levels of corticosterone found in the hippocampus of alcohol-treated mice were 
elevated. Long-term alcohol intake has been reported to produce morphological 
and neurochemical abnormalities in the CNS of both humans and experimental 
animals (Charness, 1983). Neuronal loss of between 10 and 30% in CA 1, CA3 
and the granular layer of the dentate gyms has been reported after long-term 
alcohol intake (Cadete et al., 1988). These changes have been found in animals 
withdrawn from alcohol and in some cases the deterioration has in fact increased 
during the abstinence phase (Cadete et al., 1991; King et al., 1988). Long-term 
alcohol consumption ( 13 months) followed by a six week withdrawal period 
showed that alcohol-treated rats were cognitively impaired relative to both 
animals on continuous alcohol consumption and age matched controls 
(Lukoyanov et al., 1999). It is possible that the increased hippocampal 
corticosterone levels reported in this study could provide a mechanism by which 
these cognitive impairments and neurodegeneration develop. Stress and 
increased glucocorticoid levels are now believed to have specific effects on 
cognitive function. Corticosterone has been shown to produce deficits in memory 
in animal models (Lupien & McEwen., 1997). Stress induced hippocampal 
atrophy is believed to be caused by excitatory amino acids acting via NMDA 
receptors in concert with glucocorticoids (McEwen, 1998). 
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In addition to the important role the hippocampus has in learning and 
memory, the hippocampus is also involved in the regulation of HPA activity 
(Jacobson & Sapolsky, 1991). Hippocampal influence on the HPA is largely 
inhibitory, acting to shut down HPA activity rather than being a site for the 
control of negative feedback. Thus impaired hippocampal function could lead to 
increased levels of HPA axis activity; increased release of CRF, ACTH and 
corticosterone. 
A degree of control of alcohol intake by the HPA has been shown in this 
thesis and by others (see Chapters One to Five), it is therefore not unreasonable 
to link impaired HPA regulation with alcohol intake. This increase in 
hippocampal corticosterone was observed in abstinent mice, which raises the 
question could this regionally specific rise in corticosterone be part of the 
mechanism governing the propensity of alcoholics to relapse? It has been 
suggested that a protracted withdrawal syndrome that may have detrimental long-
term effects on the psychological functioning and rates of relapse in alcohol 
dependent patients in treatment (Carlsson et al., 1996). De Soto et al., (1985) 
studied the symptomatology in alcoholics in various stages of abstinence, 
showing that in some patients affective and vegetative symptoms remain present 
for long periods of time. The elevated corticosterone levels reported in this 
chapter may help explain the extended withdrawal syndrome that has been 
reported. 
Recently, long-term changes in the HPA axis after chronic alcohol 
administration have been reported by other researchers (Rasmussen et al., 2000). 
However, in contrast to the present study, they reported reduced HPA axis 
activity; characterized by reduced pituitary POMC mRNA expression, reduced in 
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adrenal weight and an 'inferred' reduction in corticosterone levels (describing 
and 'trend' rather than statistical significance). These results were reported 
following 3 weeks abstinence from a 50 day liquid diet schedule in rats. 
Increased free corticosterone levels during acute withdrawal were also reported 
in their study, but they did not report on any measurement of free corticosterone 
following long-term abstinence. This would have enabled a more accurate 
comparison between the two studies. They found no statistically significant 
change in total corticosterone levels after abstinence (although they reported a 
trend) concurring with the present study. They concluded that HPA axis activity 
is reduced during abstinence, and reduced corticosterone levels, contributing to 
negative reinforcement, may be an important factor in relapse. In the present 
study it has been demonstrated that brain corticosterone levels can be different 
even when total plasma levels do not differ, perhaps their study may have 
benefited from measurement of brain corticosterone levels. 
Future work 
Although testing the activity of more doses of corticosterone, aldosterone 
and their respective antagonists may be useful in determining all the information 
about the influence of adrenal steroids on locomotor activity, further work on 
corticosterone administration and locomotor activity after liquid diet will 
probably not provide useful information about the relationship between 
corticosterone and dependence 
Increased anxiety is reported in humans during long-term abstinence, 
therefore assessments of anxiety-like behaviour in mice during abstinence may 
be useful. The influence of different doses of corticosterone, and the MR 
antagonist spironolactone would provide a more complete picture than just the 
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administration of RU 38486 did on long-term alterations in corticosterone 
responsiveness after chronic alcohol treatment. 
In situ-hybridization and immunohistochemical analysis of 
corticosterone, CRF, ACTH and their respective receptors as well as the 
measurement CRF and ACTH levels could provide a more detailed picture of the 
alterations in the HPA axis during long-term withdrawal. Measurement of these 
parameters at different time points during alcohol treatment and the subsequent 
withdrawal would also aid the understanding of the development of these 
changes. 
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Chapter seven 
Dopamine receptors and abstinence 
Introduction 
Dopamine 
In this chapter the focus of the work is on the long term effects of alcohol 
on the dopaminergic system. Dopamine is the major catecholamine in the central 
nervous system. It is involved in the regulation of a variety of functions , 
including locomotor activity, emotion and neuroendocrine secretion as well as 
reward and addiction. The introduction of molecular cloning procedures resulted 
in a major shift in the understanding of the dopaminergic receptor system. 
Although five dopamine receptor subtypes have been cloned (Sokoloff, 1995), 
the D l/D2 classification is sti ll relevant (J aber et al., 1996). D 1 and D5 receptors 
are classified as D 1-like, because they share a high sequence homology, 
stimulate adenylate cyclase and share classical D1 receptor pharmacology. The 
D2, D3 and D4 receptors are considered to be D2-like, mainly because of their 
homology and pharmacology (Jaber et al., 1996). 
The D I receptor is the most widespread dopamine receptor and is 
expressed at higher levels than any of the other dopamine receptors (Dearry et 
al., 1990). D1 and D2 receptors are found mainly in the striatum, nucleus 
accumbens, and the olfactory tubercle. Doparninergic neuron cell bodies are 
localised mainly in the substantia nigra pars compata, the ventral tegmental area 
and the hypothalamus. They define three main dopaminergic pathways the 
nigrostriatal, the mesolimbic, and the tuberoinfundibular. The mesolimbic 
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dopaminergic system consists of the cell bodies in the VT A which project to the 
limbic areas, such as the nucleus accumbens. 
The mesoBimlbk doJPiaminergic system a1111dl reward! 
The mesolimbic system can be implicated in the reinforcing properties of 
most dmgs of abuse (Wise et al., 1990; Koob 1992; Self & Nestler 1995). 
Rodents will self-administer alcohol (Gatto et al., 1994) and morphine (David 
and Cazala, 1994), directly into the VT A. Local injection in the VTA of opiates, 
amphetamine, cocaine or nicotine produced conditioned place preference 
(Bozarth and Wise, 1981 ). Different drugs of abuse, including opiates and 
psychostimulants (Nestler, 1992) and alcohol (Ortiz, 1995), have been reported 
to produce similar neurochemical changes in the mesolimbic dopamine pathway 
both during administration and acute withdrawal, despite the different initial 
target sites. Acute alcohol administration has been shown to increase the firing of 
VTA neurones both in vivo (Gessa et al., 1985) and in vitro (Brodie et al., 1991). 
Administration of alcohol into the VT A enhances dopamine release in the 
nucleus accumbens (Di Chiara & Imperato, 1985). Reductions in extracellular 
dopamine have been detected in the ventral striatum during withdrawal from 
alcohol, these reduced levels are seen 10 hours after withdrawal from chronic 
alcohol treatment but return to normal levels after 24 hours of withdrawal 
(Rossetti et al., 1992). 
In many cases there is evidence that the drug-induced changes in 
dopamine levels are correlated to changes in levels of dopaminergic metabolites 
in the limbic areas. The main pathways for the metabolism of dopamine involve 
the enzymes catechol-0-methyl transferase and monoamine oxidase, which 
produce dihydoxyphenyl acetic acid (DOPAC) and homovanillic acid (HV A). 
190 
Reggiani ( 1980) demonstrated increased levels of DOPAC in the striatum 
following acute administration of alcohol, and with chronic administration a 
tolerance to this effect was observed. Systemic administration of both dopamine 
agonists and antagonists appears to decrease alcohol reinforced responding 
(Pfeiffer et al 1988, Samson et al., 1992) but appeared to do so by different 
mechanisms; agonists altered the initial high rate of responding whereas 
antagonists caused early termination of the drinking period. 
Long term changes after chronic alcohol treatment 
Despite the knowledge of the acute mechanisms of the action of alcohol, 
much less is known about the chronic adaptations that alcohol produces in the 
brain after prolonged administration and long-term abstinence. However, it has 
been demonstrated that chronic alcohol consumption causes long term 
behavioural changes that are evident when other drugs of dependence are 
administered. Increased sensitisation to the locomotor effects of amphetamine, 
cocaine (Manley and Little, 1997) and of nicotine (Watson and Little, 1999) was 
first shown. These changes were seen when the psychostimulants were first given 
6 days and even two months after cessation of chronic alcohol intake, indicating 
that prolonged changes are caused by the alcohol. In addition to these 
behavioural studies, electrophysiological experiments suggest progressive 
changes following withdrawal from chronic alcohol consumption. After the same 
alcohol treatment schedule (23 day liquid diet schedule) the firing rate of 
dopamine-sensitive ventral tegmental neurones in vitro was very greatly 
decreased at 24h and at 6 days after cessation of alcohol intake, but had returned 
to normal levels by the 2 month interval (Bailey et al., 1998; Bailey, 1998). 
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The decreased VT A firing rate seen in studies performed this laboratory 
in vitro during and upto 72 hours after alcohol withdrawal has also been 
reported in rats in vivo (Diana et al., 1996). Liljequist ( 1978) found increased 
locomotor stimulant actions of dopamine, injected into the nucleus accumbens, 
up to 4 weeks after withdrawal from chronic ethanol intake. Increased acute 
locomotor stimulation by cocaine and increased striatal dopamine transporter 
density was found by Itzak and Martin (1999) after repeated injections of 
alcohol. Nestby et al (1997), also using alcohol injection, saw increased acute 
locomotor stimulation by morphine, but not amphetamine, and increased 
dopamine release from the caudate putamen in vitro, 3 weeks after cessation of 
alcohol treatment. Voluntary alcohol drinking increased dopamine release, and 
increased dopamine D 1-receptor stimulated adenyl cyclase activity after 3 weeks 
abstinence (Nestby et al., 1997). May (1982) found increased agonist affinity for 
Dl receptors 7 months after withdrawal from a alcohol treatment period of 36 
weeks. An investigation of monoamine and metabolite concentrations showed 
increased dopamine metabolite to dopamine ratios at the 2 month after the 
cessation of chronic alcohol administration (Bailey et al., 2000). There were no 
changes after chronic alcohol treatment in the release of dopamine from striatal 
or cerebrocortical slices in vitro (Bailey et al., 1998; Manley, 1997), suggesting 
that the release process at the terminal areas is unaltered by alcohol treatment 
and abstinence. 
Aims 
The hypothesis to be tested is that chronic alcohol consumption causes 
prolonged alterations in mesolimbic dopamine function. These changes may be 
responsible for the increased rewarding effects and increased sensitisation seen 
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for other drugs of dependence during the abstinence period after chronic alcohol 
intake. Potential alterations (measuring the affinity constant, Kd, and maximal 
binding, Bmax) in dopaminergic receptors Dl and D2 function were investigated 
using radioligand binding following six day withdrawal (seen Section Two, 
introduction) from 23 day alcohol administration via liquid diet. 
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Methods 
Under reverse phase lighting conditions, male TO mice (inhouse bred) 
25-35g, underwent a 23 day liquid diet treatment, as previously described 
(Chapter Six). Control animals were given isocalorific liquid diet containing no 
alcohol. Upon completion of the diet treatments at I 0 a. m., the diet was replaced 
with standard laboratory chow. The animals were humanely killed by cervical 
dislocation six days after the termination of the diet treatment. The brains were 
dissected over ice and the cerebral cortex and striatum removed. These samples 
were rapidly frozen (isopentane /acetone-dry ice freezing trap -40°C) and stored 
in the freezer until required for the binding assays (n=6 per group). 
Radiochemicals 
3H SCH23390 (70mCi/mol) and 3Hspiperone (65mCi/mol) were both 
purchased form Amersham, U.K. 
Dl Homogenate binding 
D1 receptor binding was performed using a the previously described 
procedure (Dewar et al., 1990). After thawing, the samples were homogenised 
(Ultra Turrax, IKA Labortechnik, Fisher Scientific) in 20 volumes (w/v) of 
modified Tris buffer pH 7.4 (50 mm TrisHCl, 20 mM NaCl, l mM MgCh, 2 mM 
CaC b). The suspension was then centrifuged for 30mins x 16,000 g at 4 °C. The 
supernatant was discarded, and the pellet resuspended and centrifuged under the 
same conditions for a further 30mins. The pellet was then resuspended in buffer 
to give a final tissue concentration of l Omg original wet weight in 1 ml of buffer. 
The membrane preparation (250j..tl) was incubated at room temperature for two 
hours with eH]SCH23390 ( 250j..tl, six concentrations, 150pM-4nM). Non-
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specific binding was defined by parallel incubations of l 00 mM butaclamol (ina 
volume of 500J..Ll buffer), for the total binding 500J..Ll of buffer was added. The 
total volume per assay tube was I ml. The assay was terminated by rapid filtration 
through GFC filters (presoaked in 0.1% polyethyleneimine) followed by three 
3ml washes of cold buffer. The filters were transferred to scintillation vials, 
scintillation fluid was added and the radioactivity counted. Protein content was 
assessed by the Lowry method (see below). Saturation curves were plotted using 
Graphpad Prism data analysis software. 
D2 homogenate binding 
A standard binding assay, which had been previously described by Dewar 
et al., (1990) was used to measure D2 receptor binding. After thawing the 
samples were homogenised in 20 volumes (w/v) of modified Tris buffer pH 7.4 
(50 mm TrisHCl, 20mM NaCl, I mM MgCb, 2mM CaC1 2). The suspension was 
then centrifuged for 30mins x16,000 g at 4°C. The supernatant was discarded, 
and the pellet resuspended and centrifuged under the same conditions for a 
further 30mins. The pellet was then resuspended in buffer to give a final tissue 
concentration of 1 Omg original weight in 1 ml of buffer. The membrane 
preparation was incubated at room temperature for two hours with eH]spiperone 
(250J..Ll, six concentrations, 0.25nM-6nM) and 1mM ketanserin (250J..Ll)to block 
5HT receptor binding. Non-specific binding was defined by parallel incubations 
of 100 mM sulpiride (250J..Ll). The assay was terminated by rapid filtration 
through GFC filters (presoaked in 0.1% polyethyleneimine) followed by three 
3ml washes of cold buffer. The filters were transferred to scintillation vials, 
scintillation fluid was added and the radioactivity counted. Protein content was 
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assessed by the Lowry method (see below). Saturation curves were plotted using 
Graphpad Prism data analysis. 
Protein assay 
The quantity of protein in each sample was assayed using a protein assay 
kit (Sigma) based Peterson's modification of the Lowry method (Lowry et al., 
1951; Peterson et al, 1977). The homogenates were diluted 1 in 100. To 1 OOJ..tl 
samples of the dilution 900J..tl of Lowry reagent was added. This reagent consists 
of 0.1% copper sulphate, 0.2% potassium tartrate, 10% sodium carbonate). The 
mixture was transferred to a 2.5ml cuvette and allowed to stand at room 
temperature (23°C) for 30 minutes. Folin and Ciocalteu 's reagent was then added 
and the cuvette was vortexed for 5-10 seconds, after which it was allowed to 
stand for 30 minutes. The absorbance at 740nm was measured using a 
spectrophotometer. The photometer was first calibrated using a blank cuvette that 
contained only distilled water. The protein levels were quantified (after suitable 
dilution of the sample- 11100) by comparison with a standard curve created 
from data using solutions of BSA at 50, 100, 200, 300, and 400J..tg/ml 
Statistical analysis 
The Bmax and Kd values of control and alcohol treated mice were 
compared for each brain region using an unpaired Student's t-test. This test was 
chosen as it is suitable for comparing two groups of parametric data. 
The Bmax and Kd values were measured from saturation curves generated by 
Graphpad prism. The data was fitted, by this program, to the line of best fit using 
the one binding site curve as multiple binding site curves were rejected as there 
was not a sufficient fit. 
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In both studies the Bmax values are expressed as mean fmol/mg 
protein ±SEM And the Kd values are expressed as mean nM ±SEM. In the 
striatum maximum binding (Bmax) of eH]SCH23390 was unaltered by 
diet treatment (Figure 7.1 b). The dissociation constant (Kd) of D 1 
receptors in the striatum was lower in the alcohol diet treated mice 
compared with the control diet treated mice (P<0.05) (Figure 7.1 a) 
eH]SCH23390 binding in the cortex of control diet and alcohol diet mice 
showed no change in Bmax (Figure 7.2a) between the two groups. The 
affinity of D1 receptors in the cortex was not affected by diet treatment 
(Figure 7 .2b ). D 1 receptor binding was higher in the striatum than in the 
cortex irrespective of the diet treatment. The binding in the striatum for D 1 
receptors was less variable than cortical binding. 
Both the Kd (Figure 7.3) and Bmax (Figure 7.4) ofD2 receptors in 
the cortex and the striatum were unaffected by diet treatment. 
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Fig 7.1: Six days after withdrawal from the alcohol diet (n-6 per group). The Dl-
like receptor ligand 3H-SCH23390 showed a significantly (*P< 0.002) higher 
affinity for striatal membranes (Figure 7.1 a), no differences in Bmax were seen 
in the striatum (Figure 7.1b). 
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Figure 7.2 Six days after withdrawal from the alcohol diet, no differences were 
seen in either the Kd (Figure 7.2a) or Bmax (figure 7.2b) values for binding of 
the Dl-like receptor in the cortex (n=6 per group). 
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Figure 7.1.2 To binding of [3H]SCH23990 in alcohol and control diet treated 
mice. Figure 7.1.2.a shows the saturation binding curve of [3H]SCH23990 to 
cortical membranes and Figure 7.1.2.b striatal binding. Scatchard plots 
(Scatchard, 1949) of the data are shown in Figure 7.1.2.c (cortex) and Figure 
7.1.2.a (the striatum) .. The Scatchard analysis gives a higher estimation of the 
Bmax values than the saturation curve. It should also be noted that additional 
saturation experiments with more concentration points and inhibition curves as 
well as autoradiography will provide greater detail and information on the 
'small' but significant change in Kd recorded in these studies. 
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Figure 7.3 Six days after withdrawal from the alcohol diet, no differences were 
seen in Kd values for the binding of [3 H) spiperone to D2-like receptors in the 
cortex or the striatum. 
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Figure 7.4 Six days after withdrawal from the alcohol diet, no changes in Bmax 
of [3H] spiperone binding to D2-like receptors were seen in either the cortex or 
the striatum. 
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Figure 7.5 To binding of [3H]spiperone in alcohol and control diet treated mice 
(Kd and Bmax values are presented in Figures 7.1a and 7.l)b. Figure 7.5a 
shows the saturation binding curve of [3H]spiperone to cortical membranes and 
Figure 7.5b shows the striatal binding. Scatchard plots (Scatchard, 1949) of the 
data are shown in Figure 7.5c (cortex) and Figure 7.5d (the striatum). 
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Figure 7.6 Samples of the total ( • ), specific ( <>) and non-specific (" ) binding of 
[
3H] SCH23390 and [3H] spiperone. Figure 7.6a [3H] spiperone binding to 
striatal membranes from control diet treated mice Figure 7. b tHJ spiperone 
binding to striatal membranes from alcohol diet treated mice. Figure 7.6c tHJ 
SCH23990 binding to striatal membranes from alcohol diet treated mice Figure 
7.6d [3H] SCH23990 binding to striatal membranes from control diet treated 
mice. 
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Discussion 
Increased affinity 
The ligand binding studies on D 1-like receptors and D2-like receptors 
indicated that, after the chronic alcohol intake, there was an increased receptor 
affinity for the D 1 receptor subtype in the striatum, revealed as a decrease in Kd 
values. There were no significant changes in Bmax of Kd in the cortex . There 
were no significant changes in Bmax in this area suggesting no change in 
receptor density. No changes in either measurement were observed in cortex. D2-
Iike receptor binding showed no changes in affinity nor receptor density in any of 
the brain areas studied. 
The increase in affinity seen in the present study differs form the affinity 
changes reported by May. The increase in affinity demonstrated in the present 
study was identified by a reduction in Kd in saturation binding studies using 
SCH23390. The alteration reported by May was an decrease in Ki measured 
using labelled SCH23390 and unlabeled dopamine as the competitor. The 
mechanism responsible for the increase in affinity may be different. In the 
Introduction the existence of multiple dopamine receptor subtypes was described. 
The Dl-like receptor consists of two distinct receptor types the Dl and the D5 
receptor (sometimes described as the Dla and Dlb receptor subtypes) (Sunahara 
et al., 1991). Both these receptors have the same affinity for SCH23390, but the 
D5 receptor has been reported to show a higher affinity for dopamine (Sunahara 
et al., 1991 ). May (1982) speculated that an increase in the number of D5 
receptors relative to 'D 1' receptors (high dopamine affinity D 1-like receptors) 
might have been responsible for the observed increase in affinity. This is not a 
possible explanation for the results in the present study as it is not possible to 
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distinguish D 1-like receptors on the basis of their binding to SCH23390. A 
conformational change in the receptor itself or linked to the receptors' signal 
transduction mechanism, would be the most likely mechanism for the observed 
change in affinity. 
A possible mechanism for relapse 
The observed increase in affinity is consistent with the increased 
locomotor stimulant effects of nicotine (Watson & Little 1999), and also of 
psychostimulant drugs (Manley & Little 1997). Sensitisation, seen after repeated 
administration of many abused drugs, has been implicated in drug dependence 
and relapse, as the phenomenon lasts for many months, possibly permanently, 
and it develops to the rewarding effects of the drugs (Robinson and Berridge, 
1993; Lett, 1989). 
A progressive series of changes in neuronal function appears to take place 
during the sensitisation process and further changes occur after cessation of 
repeated administration of psychostimulant drugs. For 3-4 days after repeated 
administration of amphetamine or cocaine, dopamine autoreceptors in the VT A 
show subsensitivity. At a later stage, there are transient increases in excitatory 
amino acid function (White, 1996). The results are also consistent with an 
increased D 1-like receptor stimulation of cAMP production several weeks after 
cessation of chronic ethanol treatment (Nestby, 1997) and the increase in affinity 
of D 1 receptors reported by May (1982). 
The increase in affinity of D 1-like receptors, which are primarily 
postsynaptic in location, would compensate for the decreased firing seen in the 
VTA following abstinence from chronic alcohol administration (Bailey et al., 
1997), so that overall synaptic efficiency at these sites would continue, and the 
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animals appear behaviourally overtly normal. Factors that affect relapse e.g. 
stress or a small priming dose of alcohol or another drug of abuse would enhance 
the resultant effects of released dopamine acting on the altered D 1 receptors 
leading to an increase in the rewarding effects of alcohol. 
There is considerable evidence that sensitisation to psychostimulants is 
mediated via the mesolimbic system (Sorg and Ulibarri, 1995; Henry and White, 
1992; Kita et al., 1992) and that D 1 receptors in particular are linked to 
sensitisation. It has been shown that D 1 receptor activation is necessary for the 
induction of sensitisation by amphetamine in the VT A (Vezina, 1996). D 1 
receptor antagonists have been shown to prevent the facilitation of amphetamine 
self-administration induced by prior exposure to the drug (Pierre & Vezina, 
1998). This would suggest that the changes in D 1 receptor affinity may 
predispose alcohol-dependent individuals to abuse of other drugs. 
D2-like receptors and chronic alcohol 
Although no changes in D2 receptors were found other researchers have 
reported changes after alcohol treatment. Chronic alcohol, administered as sole 
fluid, has been shown to increase the binding affinity of CHJ spiroperone during 
acute withdrawal; 24 hours after cessation of treatment, a down regulation of D2 
receptors occurs, with an upregulation apparent at five days in the caudate 
putamen, nucleus accumbens and olfactory tubercle (Rommelspacher et al 1992). 
Investigating earlier time points , Reggiani et al ( 1980) demonstrated an increase 
in 3H spiroperidol binding in the striatum, as measured three hours after chronic 
alcohol treatment. However, Hruska et al (1988) found no change in D2 
receptors density in the rat striatum at 24 hour withdrawal, whereas Muller et al 
(1980) demonstrated a decrease in D2 receptors in the nucleus accumbens but not 
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striatal areas. It appears from these reports and from the results of the present 
study that possible changes in D2 receptors do not persist beyond the acute 
withdrawal phase. Modell et al ( 1992) have reported that the dopamine 
antagonist haloperidol can rduce craving for alcohol in alcoholics withdrawn 
from alcohol for 2 to 14 weeks, although the drug had side-effects (sedation) 
which may have contributed to the results. 
Relapse and dopamine receptors. 
Investigations into the dopaminergic system and relapse has generally 
focused on the influence of the dopamine on relapse to cocaine. Reinstatement of 
cocaine administration in operant responding situations has been used to 
investigate the effect of dopamine D1 and D2like receptor agonists and 
antagonists (Self et al., 1996). The researchers tested the ability of compounds 
that selectively stimulate specific dopamine receptors to reinstate self-
administration of cocaine in animals who had stopped seeking this drug. In this 
study, rats were allowed to self-administer intravenous cocaine for 2 hours and 
then saline was substituted for 2 hours during which time the self-administration 
behaviour progressively diminished (to extinction). The researchers found that 
when a D2-like agonist was administered to these animals, a dramatic increase in 
cocaine-seeking behaviour was observed, while administration of aD 1-like 
agonist had no effect. They further tested whether the D1-like or D2-like agonists 
could block the effects of cocaine on reinitiating cocaine use. In these rats, 
providing a small priming dose of cocaine causes an increase in cocaine-seeking 
behaviour. While pretreatment with D2-like agonists in these animals caused 
dramatic potentiation of cocaine's priming effects, pretreatment with D 1-like 
agonists completely prevented cocaine's ability to reinstate cocaine use. These 
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results lead to the proposal that cocaine craving and relapse can be provoked by 
activating D2-like receptors, but activating D 1-Iike receptors actually prevented 
cocaine-seeking behaviour. Similar results and conclusions have been proposed 
by other researchers (Khroyan et al., 2000). 
The increased D 1 receptor affinity and the lack of change in D2 receptors 
demonstrated in the present study would appear to contradict these findings. 
There are a number of possible explanations, the first being that the mechanism 
behind relapse in alcohol dependence differs from the mechanism for relapse 
behind cocaine dependence. Another explanation may be that two hours is 
probably not sufficient time for long-term neurochemical changes to occur. The 
changes observed in the current study developed after 23 days of diet treatment 
and 6 days of abstinence, it would be doubtful whether these changes would be 
apparent after alcohol treatment for one day. The effects of D 1 and D2 drugs 
seen in the cocaine studies are as likely to be a consequence of selective receptor 
desensitisation or tolerance as they are to be a model of relapse. The changes of 
receptor affinity measured in the present study provide evidence for long-term 
changes following chronic alcohol treatment and withdrawal and could provide a 
start in the understanding of the neurochemical basis of relapse. 
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Further work. 
Receptor autoradiography would give better spatial resolution of the 
changes, and perhaps isolate them to a particular region of the striatum. The 
autoradiography should not be confined to the Dl receptor, the other dopamine 
receptors and the dopamine reuptake receptor should be investigated. The time 
points at which the experiments are done should also be extended to include 
measurements during the alcohol diet treatment and at more time intervals after 
the treatment. Binding during the acute phase of withdrawal and at time points 
after the six days, up to and including 2 months after the cessation of the 
treatment should be performed. The increase in responsiveness to 
psychostimulants reported by Manley and Little (1997) was apparent up to 2 
months after the cessation of the diet treatment. 
Experiments should be performed to ensure that the changes are not an 
artefact of the particular method of alcohol administration, e.g. inhalation 
chambers, or alcohol administered as sole fluid to a high alcohol preferring strain 
of rodent. Further work could also include investigations into other CNS receptor 
types. It would be na"ive to assume that a change in D 1 receptor affinity is the 
only measurable long-term change induced by chronic alcohol administration. 
These investigations could include glutamate receptors, 5HT receptors, voltage 
activated calcium channels and opiate receptors. This list is not exhaustive as 
alcohol is known to affect the functioning of numerous CNS systems. 
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Chapter Eight 
General Discussion 
Brain corticosterone levels 
This thesis describes a number of novel and important findings. Aside 
from the general theme of the thesis (alcohol dependence) a new methodology 
was developed. A method for measuring brain corticosterone levels could prove 
to be valuable tool in research. McEwen (1998) have described the relationship 
between corticosteroids and the 'ageing brain' . They have proposed that 
increased circulating corticosterone levels could produce hippocampal neuronal 
atrophy acting in concert with excitatory amino acids , measurement of the actual 
brain (hippocampal) corticosterone levels could be of benefit. A long list of 
research that could utilise this methodology mjght distract from the main theme 
of the Thesis. 
Summary 
Experiments that were performed for this thesis showed that the 
corticosterone synthesis inhibitor metyrapone, and ACTH 4_10 reduced the 
alcohol preference of high alcohol preferring mice C57. However, ACTH 4_10 
increased preference in low preferring mice as did the CRF antagonist, a-helical 
CRF. These results demonstrate the need to consider the role of the whole HPA 
axis on alcohol consumption rather than one of its components. This work has 
provided important information on the role of both of these peptides in alcohol 
consumption as well as avenues for future research. 
Vehicle injections, whether saline or tween, increased alcohol preference 
in low alcohol preferring mice and these injections were shown to increase free 
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circulating, and hippocampal, levels of corticosterone. The findings in these 
experiments are important in terms of general research. The effects of vehicle 
injections are not often considered in experimental work, and these studies have 
demonstrated clear behavioural changes induced by saline injections and by the 
insertion of a needle without any fluid being injected. 
Work performed in this study also demonstrated long-term changes in 
blood and brain corticosterone levels during abstinence. Increased receptor D 1 
receptor affinity during abstinence was also shown. These long-term changes 
provide important information about the neuronal processes that may determine 
the propensity of alcoholics to relapse. 
Dependence and relapse 
A mechanism by which corticosterone's influence on drug-dependence is 
exerted has been proposed by Piazza ( 1996). This proposal focuses on the 
interaction between the dopaminergic system and the effects of corticosterone on 
this system. The two systems are known to interact, corticosterone enhances 
dopamine release both in vivo (Rouge-Pant et al., 1998) and in vitro (Rouge-Pant 
et al., 1999). Concentrations of glucocorticoids can determine the level of 
dopamine release in the nucleus accumbens (Piazza et al., 1998) and increase 
excitatory amino acid activation in the VTA (Cho & Little, 1999). 
In basal conditions, sensitivity to the reinforcing effects of drugs of abuse 
are low, as glucocorticoid secretion and dopamine release are low. An acute 
stress increases corticosterone secretion, which enhances the release of 
mesolimbic dopamine, and so results in the reinforcing effects of drugs of abuse. 
This can lead to an increase in drug self administration. Activation of negative 
feedback by corticosterone returns the system to basal levels . The binding of 
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corticosterone to hippocampal corticosteroid receptors is a key step in the 
activation of the negative feedback. The repeated increase in the glucocorticoid 
induced by repetitive stress will progressively impair negative feedback and this 
will probably decrease the number of central glucocorticoid receptors in the 
hippocampus. An impairment of negative feedback will result in extended 
secretion of these hormones and elevate dopamine in the nucleus accumbens. 
Piazza proposed that these changes can in turn determine a long-lasting increase 
in the sensitivity to the reinforcing effects of drugs of abuse. Both in the increase 
in corticosterone levels and the increased D 1 receptor affinity, shown in the 
present study could influence relapse. The corticosterone, by the impairment of 
negative feedback causing elevated dopamine in the nucleus accumbens. The 
effects of this elevated dopamine would be amplified because of the increased 
receptor affinity. 
However, the role of the hypothalamic and pituitary peptides suggest this 
model may be over simplified. The increased HPA axis activity and the disrupted 
negative feedback in addition to higher circulating levels of corticosterone will 
also produce higher levels of both ACTH and CRF. These may decrease rather 
than increase alcohol consumption. The relative importance of corticosterone, 
ACTH and CRF needs to be assessed. The present study has demonstrated the 
profound actions of all three on alcohol consumption. The next stage of work 
should be to further understand combined influence of them rather than the 
isolated influence. The regulation of the HPA is such that if the levels of one 
component changes there is a reactive change in the others. 
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Final comments 
The importance of the problem of alcohol dependence for society cannot 
be over-emphasised, some of the array of problems (medical, social and 
economic) were outlined in the introduction to this thesis. The treatment of 
alcohol dependence by drugs has developed recently, and the reports on the 
effectiveness of the new dependence drugs such as acamprosate (Lhuintre et al., 
1985, 1990; Whitworth et al., 1996) and naltrexone (O'Malley et al., 1992; 
Volpicelli et al., 1992) are encouraging, but even with these therapies relapse 
rates are still high, 23% for acamprosate and 17% for naltrexone measured 
afterl2 week, the relapse rates increase further with time despite the medication 
(Swift, 1999). The work performed for this thesis has produced information 
towards the understanding of the neuronal basis of alcohol dependence, this may 
assist in the search for more effective pharmacotherapies for alcohol dependence. 
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